Processing 00000000.tx.1: The Structure of Human Prokallikrein 6Reveals a Novel Activation Mechanism for the Kallikrein Family* F. 

Phrase: "The Structure of Human Prokallikrein 6Reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "a Novel Activation Mechanism for the Kallikrein Family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "* F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.2: Xavier Gomis-Rth, lex Bays, Georgia Sotiropoulou**, Georgios Pampalakis, Theodoros Tsetsenis, Virtudes Villegas, Francesc X. 

Phrase: "Xavier Gomis-Rth,"

Phrase: "lex Bays,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0234880:bays [Individual Behavior]
   861   C3203003:Bays [Geographic Area]

Phrase: "Georgia Sotiropoulou"

Phrase: "*"

Phrase: "*,"

Phrase: "Georgios Pampalakis,"

Phrase: "Theodoros Tsetsenis,"

Phrase: "Virtudes Villegas,"

Phrase: "Francesc X."
Processing 00000000.tx.3: Avils, and Miquel Coll From the Institut de Biologia Molecular de Barcelona, Consejo Superior de Investigaciones Cientficas, c/Jordi Girona, 18-26,Barcelona 08034,Spain, Institut de Biotecnologia i de Biomedicina, Departament de Bioqumica i Biologia Molecular, Unitat de Cincies, Universitat Autnoma de Barcelona, Bellaterra, Barcelona 08193,Spain, and the Department of Pharmacy, School of Health Sciences, University of Patras, Rion, Patras 26500,Greece Received for publication, February 14,2002, and in revised form, May 16,2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES Zyme/protease M/neurosin/human kallikrein 6(hK6) is a member of the human kallikrein family of trypsin-like serine proteinases and was originally identified as being down-regulated in metastatic breast and ovarian tumors when compared with corresponding primary tumors. 

Phrase: "Avils,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0733431:Avil [Organic Chemical,Pharmacologic Substance]
   966   C1422473:AVIL [Gene or Genome]

Phrase: "and"

Phrase: "Miquel Coll From the Institut de Biologia Molecular de Barcelona,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3272373:COLL [Intellectual Product]

Phrase: "Consejo Superior de Investigaciones Cientficas,"

Phrase: "c/Jordi Girona,"

Phrase: "18-26,"

Phrase: "Barcelona 08034,"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "Institut de Biotecnologia i de Biomedicina,"

Phrase: "Departament de Bioqumica i Biologia Molecular, Unitat de Cincies,"

Phrase: "Universitat Autnoma de Barcelona,"

Phrase: "Bellaterra,"

Phrase: "Barcelona 08193,"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "and"

Phrase: "the Department of Pharmacy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "School of Health Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0036370:School Health [Health Care Activity]
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "University of Patras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "Rion,"

Phrase: "Patras 26500,"

Phrase: "Greece"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018226:Greece [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "February 14,"

Phrase: "2002,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "May 16,"

Phrase: "2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2825142:Experimental Result [Finding]
           Result
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Zyme/protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "M/"

Phrase: "neurosin/human kallikrein 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1416677:KALLIKREIN 6 [Gene or Genome]
           NEUROSIN
   812   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0086418:Human [Human]

Phrase: "(hK6"

Phrase: ")"

Phrase: "is"

Phrase: "a member of the human kallikrein family of trypsin-like serine proteinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C0086282:Family member [Family Group]
   751   C1611821:Family Member [Intellectual Product]
   736   C0680022:member [Population Group]
   736   C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "was"

Phrase: "originally"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "as"

Phrase: "being"

Phrase: "down-regulated in metastatic breast"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0006141:Breast [Body Part, Organ, or Organ Component]
   760   C0036525:Metastatic [Functional Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1268990:Breast [Body Part, Organ, or Organ Component]
   760   C1522484:metastatic [Quantitative Concept]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   704 E C1521735:Pectoral [Qualitative Concept]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "and"

Phrase: "ovarian tumors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0919267:Ovarian Tumors [Neoplastic Process]
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "when"

Phrase: "compared with corresponding primary tumors."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0677930:primary tumors [Neoplastic Process]
   760   C0027651:Tumors [Neoplastic Process]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1707455:Compared [Activity]
   726 E C1578706:Tumor [Intellectual Product]
   726 E C3273930:Tumor [Finding]
Processing 00000000.tx.4: Recent evidence suggests that hK6 may serve as a circulating tumor marker in ovarian cancers. 

Phrase: "Recent evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that hK6"

Phrase: "may"

Phrase: "serve as a circulating tumor marker"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0041365:Tumor Marker [Biologically Active Substance]
   753   C0005516:Marker [Clinical Attribute]
   753   C0027651:Tumor [Neoplastic Process]
   753   C0175630:Circulating [Functional Concept]
   753   C1578706:Tumor [Intellectual Product]
   753   C3273930:Tumor [Finding]

Phrase: "in ovarian cancers."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancers [Neoplastic Process]
  1000   C1140680:Ovarian Cancers [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]
Processing 00000000.tx.5: In addition, it was described in the brain of Parkinson's disease and Alzheimer's disease patients, where it is implicated in amyloid precursor protein processing. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "was"

Phrase: "described in the brain of Parkinson's disease"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0006111:Disease of brain, NOS [Disease or Syndrome]
           Brain Disease
   778   C0030567:Parkinson Disease [Disease or Syndrome]
   778   C1521736:Parkinson's Disease [Functional Concept]
   778   C2681933:PARKINSON DISEASE [Gene or Genome]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0012634:Disease [Disease or Syndrome]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Alzheimer's disease patients,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "where"

Phrase: "it"

Phrase: "is"

Phrase: "implicated in amyloid precursor protein processing."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033666:protein processing [Molecular Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
   753   C1709694:Processing [Activity]
Processing 00000000.tx.6: It is thus a biomarker for these diseases. 

Phrase: "It"

Phrase: "is"

Phrase: "thus"

Phrase: "a biomarker for these diseases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005516:Biomarker [Clinical Attribute]
Processing 00000000.tx.7: To examine the mechanism of activation of hK6, we have solved the structure of its proform, the first of a human kallikrein family member. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the mechanism of activation of hK6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "we"

Phrase: "have"

Phrase: "solved"

Phrase: "the structure of its proform,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678594:Structure [Spatial Concept]

Phrase: "the first of a human kallikrein family member."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205435:First [Quantitative Concept]
   744   C1279901:First [Qualitative Concept]
Processing 00000000.tx.8: The proenzyme displays a fold that exhibits chimeric features between those of trypsinogen and other family members. 

Phrase: "The proenzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014436:Proenzyme [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Fold [Spatial Concept]
  1000   C1880834:FOLD [Phenomenon or Process]

Phrase: "that"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "chimeric features between those of trypsinogen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "other family members."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086282:Family Members [Family Group]
   966 E C1611821:Family Member [Intellectual Product]
   861   C0015576:Family [Family Group]
   861   C0680022:members [Population Group]
   861   C1704727:Family [Conceptual Entity]
   827 E C2698041:Member [Professional or Occupational Group]
   789 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.9: It lacks the characteristic "kallikrein loop" and forms the six disulfide bridges of trypsin. 

Phrase: "It"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the characteristic ""kallikrein loop"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]

Phrase: "and"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the six disulfide bridges of trypsin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0012771:disulfide [Chemical Viewed Structurally]
   753   C0456378:bridges [Medical Device]
Processing 00000000.tx.10: Pro-hK6 displays a completely closed specificity pocket and a unique conformation of the regions involved in structural rearrangements upon proteolytic cleavage activation. 

Phrase: "Pro-hK6"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a completely closed specificity pocket"

Phrase: "and"

Phrase: "a unique conformation of the regions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0026377:Conformation [Spatial Concept]

Phrase: "involved in structural rearrangements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0678594:Structural [Spatial Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1511695:Rearrangements [Genetic Function]

Phrase: "upon proteolytic cleavage activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]
Processing 00000000.tx.11: This points to a novel activation mechanism, which could be extrapolated to other human kallikreins.  

Phrase: "This points to a novel activation mechanism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C2924612:Point A [Body Location or Region]
   714   C1552961:Point [Quantitative Concept]
   714   C2347617:point [Quantitative Concept]

Phrase: "which"

Phrase: "could"

Phrase: "be"

Phrase: "extrapolated to other human kallikreins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022478:Kallikreins [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0086418:Human [Human]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES The kallikreins constitute a subfamily of mammalian serine proteases, originally defined as enzymes cleaving vasoactive peptides (kinins) from plasma 2-globulin substrates called kininogens (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   813   C2825142:Experimental Result [Finding]
           Result
   762   C1274040:Result [Functional Concept]
   762   C1546471:Result [Idea or Concept]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The kallikreins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022478:Kallikreins [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "constitute"

Phrase: "a subfamily of mammalian serine proteases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1711207:Subfamily [Classification]

Phrase: "originally"

Phrase: "defined as enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0014442:Enzymes [Enzyme,Organic Chemical]
   790   C0014445:enzymes [Functional Concept]
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]

Phrase: "cleaving"

Phrase: "vasoactive peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(kinins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022714:Kinins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "from plasma 2-globulin substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710236:Substrate [Manufactured Object]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "kininogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022713:Kininogens [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0086509:Kininogen [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1537501:KININOGEN [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Their name was coined by Werle and co-workers (2) in the early 1930s while analyzing pancreatic fluids (from Greek "kallikreas," pancreas). 

Phrase: "Their name"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027365:Name [Intellectual Product]
  1000   C1547383:Name [Intellectual Product]

Phrase: "was"

Phrase: "coined by Werle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0524669:coined [Manufactured Object]

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "in the early 1930s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681752:1930s [Temporal Concept]

Phrase: "while"

Phrase: "analyzing"

Phrase: "pancreatic fluids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   983   C0030296:Pancreatic fluid [Body Substance]
   983   C0444147:Pancreatic fluid [Body Substance]
   983   C1546729:Pancreatic fluid [Intellectual Product]
   861   C0005889:Fluids [Body Substance]
   861   C0302908:fluids [Substance]
   861   C1521806:Fluids [Tissue]
   827 E C0444611:Fluid [Qualitative Concept]
   827 E C1704353:Fluid [Substance]

Phrase: "("

Phrase: "from Greek ""kallikreas,"

Phrase: """ pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.14: Initially, these enzymes were subdivided into two subgroups. 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "these enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "were"

Phrase: "subdivided into two subgroups."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205448:Two [Quantitative Concept]
   770   C1079230:subgroups [Virus]
   737 E C1515021:Subgroup [Classification]
Processing 00000000.tx.15: One was formed by plasma kallikreins, high molecular mass glycoproteins present in blood plasma, and the other comprised glandular, organ, and tissue kallikreins, medium-sized (~30-50-kDa) glycoproteins mainly occurring in pancreas, salivary glands, saliva, kidney, and urine (1, 3, 4). 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "formed by plasma kallikreins,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   799   C0313532:Plasma Kallikrein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0022478:Kallikreins [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0032105:Plasma [Body Substance]
   770   C0205431:Formed [Functional Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "high molecular mass glycoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017968:Glycoproteins [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "present in blood plasma,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0032105:Blood Plasma [Body Substance]
           Plasma
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0150312:Present [Quantitative Concept]
   770   C0229664:Blood [Body Substance]
   770   C0449450:Present [Idea or Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and"

Phrase: "the other comprised glandular, organ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0178784:Organ [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "tissue kallikreins,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0076726:Tissue Kallikreins [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1416669:KALLIKREIN, TISSUE [Gene or Genome]
   861   C0022478:Kallikreins [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "medium-sized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0456389:size [Spatial Concept]

Phrase: "(~30-50-kDa) glycoproteins mainly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017968:Glycoproteins [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "occurring in pancreas,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   790   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   756   C1709305:Occur [Activity]
   756   C2745955:OCCUR [Temporal Concept]

Phrase: "salivary glands,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0036098:Salivary Glands [Body Part, Organ, or Organ Component]
   966 E C1278917:Salivary gland [Body Part, Organ, or Organ Component]
   966 E C1519177:GLAND, SALIVARY [Tissue]
   861   C0442040:Salivary [Spatial Concept]
   861   C1285092:Glands [Body Part, Organ, or Organ Component]

Phrase: "saliva,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036087:saliva [Body Substance]
  1000   C1546769:Saliva [Intellectual Product]
  1000   C1608524:Saliva [Body Substance]

Phrase: "kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.16: Recently, kallikrein gene expression has been detected in an increasing number of organs, fluids, and tissues (e.g. central nervous system, glands (thyroid, thymus), prostate, seminal fluid, testis, ovary, uterus, colon, skin, heart, breast, lung, and trachea), many of them subjected to hormone regulation (5). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "kallikrein gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "detected in an increasing number of organs,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0178784:organs [Body Part, Organ, or Organ Component]
   748   C0237753:*Number [Quantitative Concept]
   748   C0442726:Detected [Finding]
   748   C0442808:Increasing [Functional Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "fluids,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0005889:Fluids [Body Substance]
  1000   C0302908:fluids [Substance]
  1000   C1521806:Fluids [Tissue]
   966 E C0444611:Fluid [Qualitative Concept]
   966 E C1704353:Fluid [Substance]

Phrase: "and"

Phrase: "tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "("

Phrase: "e.g. central nervous system,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "glands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285092:Glands [Body Part, Organ, or Organ Component]

Phrase: "(thyroid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040132:Thyroid, NOS [Body Part, Organ, or Organ Component]

Phrase: "thymus"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0040113:Thymus [Body Part, Organ, or Organ Component]
  1000   C1015036:Thymus [Plant]
  1000   C1515430:THYMUS [Tissue]
   944 E C1306748:Thymus gland [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ","

Phrase: "prostate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033572:Prostate [Body Part, Organ, or Organ Component]
  1000   C1278980:Prostate [Body Part, Organ, or Organ Component]

Phrase: "seminal fluid,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0036614:Seminal fluid [Body Substance]
  1000   C1546783:Seminal fluid [Intellectual Product]
  1000   C1578518:Seminal fluid [Substance]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1519232:Seminal [Clinical Attribute]
   861   C1704353:Fluid [Substance]

Phrase: "testis,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testis [Body Part, Organ, or Organ Component]
  1000   C1278981:Testis [Body Part, Organ, or Organ Component]
   916 E C0021358:Testes [Body Part, Organ, or Organ Component]
   907 E C0205070:Testicular [Spatial Concept]
   888 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: "ovary,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029939:Ovary [Body Part, Organ, or Organ Component]
  1000   C0227898:ovary [Body Part, Organ, or Organ Component]
  1000   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "uterus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042149:Uterus [Body Part, Organ, or Organ Component]
  1000   C1269032:Uterus [Body Part, Organ, or Organ Component]

Phrase: "colon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009368:Colon [Body Part, Organ, or Organ Component]
  1000   C1281569:Colon [Body Part, Organ, or Organ Component]

Phrase: "skin,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0444099:Skin [Body Substance]
  1000   C1123023:Skin [Body System]
  1000   C1278993:Skin [Body System]
   944 E C0221912:Cutaneous [Spatial Concept]
   944 E C0221928:Dermal [Qualitative Concept]
   944 E C1522447:Cutaneous [Functional Concept]
   877 E C0011646:Dermis [Tissue]

Phrase: "heart,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "breast,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0006141:Breast [Body Part, Organ, or Organ Component]
  1000   C1268990:Breast [Body Part, Organ, or Organ Component]
   944 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   944 E C1521735:Pectoral [Qualitative Concept]
   916 E C0817096:Chest [Body Location or Region]
   916 E C1527391:Chest [Body Location or Region]

Phrase: "lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "and"

Phrase: "trachea"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0040578:Trachea [Body Part, Organ, or Organ Component]
  1000   C1278905:Trachea [Body Part, Organ, or Organ Component]
  1000   C3146235:Trachea [Eukaryote]
   928 E C2945595:Tracheal [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "many of them"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439064:Many [Quantitative Concept]
   790   C0747726:many [Conceptual Entity]

Phrase: "subjected to hormone regulation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0920552:hormone regulation [Organism Function]
   770   C0019932:Hormone [Hormone]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.17: The enzymes described to date form a large family in rodents (6, 7), among them neuropsin (KLK81; Ref. 8), tonin (KLK2; Ref. 9), kallikrein 13(KLK13; 

Phrase: "The enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "described to date"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011008:Date [Temporal Concept]
   790   C1552738:described [Idea or Concept]
   790   C2348077:Date [Food]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a large family in rodents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0424972:Large family [Family Group]
   760   C0015576:Family [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "(6,"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "among them neuropsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416679:neuropsin [Gene or Genome]
  1000   C1426589:NEUROPSIN [Gene or Genome]

Phrase: "(KLK81"

Phrase: "; Ref. 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "tonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0087052:tonin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(KLK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0618743:KLK2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334308:KLK2 [Gene or Genome]

Phrase: "; Ref. 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "kallikrein 13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0084194:kallikrein-13 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1416673:KALLIKREIN 13 [Gene or Genome]
   861   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(KLK13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416673:KLK13 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.18: Ref. 

Phrase: "Ref."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425988:REF [Gene or Genome]
Processing 00000000.tx.19: 10), and 7S -nerve growth factor (KLK3; Ref. 11). 

Phrase: "10"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "7S -nerve growth factor"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   923   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0814002:Neural Growth [Cell Function,Organism Function]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0027740:Nerve [Tissue]
   812   C0027757:NERVE [Tissue]
   812   C0220844:growth [Physiologic Function]
   812   C1280541:Nerve [Body Part, Organ, or Organ Component]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0599851:Neural [Functional Concept]
   741 E C0027769:nervy [Sign or Symptom]

Phrase: "(KLK3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0138741:KLK3 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1366489:KLK3 [Gene or Genome]
  1000   C2987230:KLK3 [Gene or Genome]

Phrase: "; Ref. 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.20: In humans they currently encompass at least 15genes (5), ranging from the classic enzymes, tissue kallikrein (KLK1; Ref. 12), glandular kallikrein (KLK2; Ref. 13), and prostate-specific antigen (PSA; KLK3; Ref. 14) to the newly discovered gene products, like normal epithelium-specific 1gene (KLK10; Ref. 15), zyme/protease M/neurosin/human kallikrein 6(KLK6; 

Phrase: "In humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "they currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "encompass at least 15genes"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "ranging from the classic enzymes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
   760   C0439658:Classic [Qualitative Concept]
   760   C0439858:Classic [Qualitative Concept]
   726   C1514721:Range [Quantitative Concept]
   726   C2348147:Range [Quantitative Concept]
   726   C3542016:Range [Intellectual Product]

Phrase: "tissue kallikrein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0076726:Tissue Kallikrein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1416669:KALLIKREIN, TISSUE [Gene or Genome]
   861   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "(KLK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416669:KLK1 [Gene or Genome]

Phrase: "; Ref. 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "glandular kallikrein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0076726:Glandular Kallikrein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0618743:Kallikrein, Glandular [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334308:KALLIKREIN, GLANDULAR [Gene or Genome]
   861   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(KLK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0618743:KLK2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334308:KLK2 [Gene or Genome]

Phrase: "; Ref. 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "prostate-specific antigen"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0138741:Prostate-Specific Antigen [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1366489:PROSTATE-SPECIFIC ANTIGEN [Gene or Genome]
   913   C1704988:Prostate Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0456981:Specific antigen [Immunologic Factor]
   827   C0003320:Antigen [Immunologic Factor]
   827   C0033572:Prostate [Body Part, Organ, or Organ Component]
   827   C0205369:Specific [Qualitative Concept]
   827   C1278980:Prostate [Body Part, Organ, or Organ Component]
   827   C1552740:specific [Intellectual Product]
   727 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "(PSA"

Phrase: "; KLK3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0138741:KLK3 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1366489:KLK3 [Gene or Genome]
  1000   C2987230:KLK3 [Gene or Genome]

Phrase: "; Ref. 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "to the newly discovered gene products,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017337:Gene [Gene or Genome]
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "like normal epithelium-specific 1gene"

Phrase: "(KLK10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416670:KLK10 [Gene or Genome]

Phrase: "; Ref. 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "zyme/protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "M/"

Phrase: "neurosin/human kallikrein 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1416677:KALLIKREIN 6 [Gene or Genome]
           NEUROSIN
   812   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0086418:Human [Human]

Phrase: "(KLK6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416669:Klk6 [Gene or Genome]
  1000   C1416677:KLK6 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.21: Ref. 

Phrase: "Ref."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425988:REF [Gene or Genome]
Processing 00000000.tx.22: 16), and prostase (KLK4; Ref. 17). 

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "prostase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0908180:prostase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1416675:PROSTASE [Gene or Genome]

Phrase: "(KLK4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416675:KLK4 [Gene or Genome]

Phrase: "; Ref. 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.23: Kallikreins are secreted endopeptidases of ~230 amino acid residues (the classic chymotrypsin numbering (18) will be used throughout; see Fig. 1), initially synthesized as preproenzymes. 

Phrase: "Kallikreins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022478:Kallikreins [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "are"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "endopeptidases of ~230 amino acid residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   766   C1709915:Residue [Conceptual Entity]
   766   C1882936:RESIDUE [Phenomenon or Process]
   716 E C1609982:Residual [Qualitative Concept]

Phrase: "("

Phrase: "the classic chymotrypsin numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449788:numbering [Quantitative Concept]
   793 E C0237753:*Number [Quantitative Concept]

Phrase: "(18"

Phrase: ")"

Phrase: "will"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "throughout"

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "synthesized as preproenzymes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883254:Synthesized [Activity]
Processing 00000000.tx.24: These are proteolytically processed to render proenzymes by removal of the signal peptide, followed by activation to the mature forms. 

Phrase: "These"

Phrase: "are"

Phrase: "proteolytically"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "render"

Phrase: "proenzymes by removal of the signal peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0014436:Proenzymes [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "followed by activation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C1879547:Activation [Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "to the mature forms."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]
Processing 00000000.tx.25: This proceeds equally by limited proteolysis, normally targeted to an arginine/lysine-valine/isoleucine peptide bond, in the manner characteristic for serine proteases (19). 

Phrase: "This proceeds equally by limited proteolysis,"

Phrase: "normally"

Phrase: "targeted to an arginine/lysine-valine/isoleucine peptide bond,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0535233:arginine-lysine [Amino Acid, Peptide, or Protein]
   764   C0678595:peptide bond [Natural Phenomenon or Process]
   742   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0523728:Isoleucine [Laboratory Procedure]
   742   C1521840:Targeted [Functional Concept]
   708 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "in the manner"

Phrase: "characteristic for serine proteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.26: Kallikreins display mostly trypsin-like specificity, thus hydrolyzing peptide bonds preferentially after lysine and arginine residues of oligopeptide substrates (20). 

Phrase: "Kallikreins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022478:Kallikreins [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "mostly trypsin-like specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0037791:Specificity [Quantitative Concept]
   812   C1511884:Specificity [Quantitative Concept]
   741 E C0205369:Specific [Qualitative Concept]
   741 E C1552740:specific [Intellectual Product]

Phrase: "thus hydrolyzing peptide bonds preferentially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0678595:peptide bond [Natural Phenomenon or Process]
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "after"

Phrase: "lysine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "arginine residues of oligopeptide substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.27: Unlike trypsin, however, they do not display significant activity toward larger proteins. 

Phrase: "Unlike trypsin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "however,"

Phrase: "they"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "significant activity toward larger proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C1537044:protein activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.28: This specificity makes them candidate autoactivators or activating enzymes for other prokallikreins, putatively in cascade reactions similar to those described for blood coagulation, digestion, fibrinolysis, and apoptosis. 

Phrase: "This specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "them candidate autoactivators"

Phrase: "or"

Phrase: "activating enzymes for other prokallikreins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]

Phrase: "putatively in cascade reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1707310:Cascade [Manufactured Object]
   737   C0443286:Reaction [Functional Concept]
   737   C1114821:Reaction [Clinical Attribute]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "described for blood coagulation,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0005778:Blood coagulation [Organ or Tissue Function]
           Coagulation
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0229664:Blood [Body Substance]
   770   C0441509:Coagulation [Therapeutic or Preventive Procedure]
   770   C1328723:coagulation [Physiologic Function]
   770   C1552738:described [Idea or Concept]

Phrase: "digestion,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "fibrinolysis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0016017:Fibrinolysis [Physiologic Function]
  1000   C1305868:Fibrinolysis [Laboratory Procedure]
   928 E C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.29: In humans, tissue kallikrein gene family members consist of five coding exons and map in tandem to the same chromosomal locus (19q13.3-13.4) (5, 21), which shows genetic linkage to Alzheimer's disease (22) and which is nonrandomly rearranged in a variety of human solid tumors, like pancreatic carcinomas, astrocytomas, ovarian cancers, and thyroid tumors, among others (23-25). 

Phrase: "In humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "tissue kallikrein gene family members"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0086282:Family Members [Family Group]
   840   C1517488:Gene Family [Gene or Genome]
   806 E C1611821:Family Member [Intellectual Product]
   804   C0015576:Family [Family Group]
   804   C0680022:members [Population Group]
   804   C1704727:Family [Conceptual Entity]
   771 E C2698041:Member [Professional or Occupational Group]
   733 E C0241888:Familial [Functional Concept]

Phrase: "consist of five coding exons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0009219:Coding [Occupational Activity]
   760   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205451:Five [Quantitative Concept]
   760   C0332529:CONSIST [Qualitative Concept]
   726 E C0805701:Code [Intellectual Product]

Phrase: "and"

Phrase: "map in tandem to the same chromosomal locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0024779:Map [Manufactured Object]
   744   C1706473:Map [Conceptual Entity]
   731   C0814036:chromosome map [Intellectual Product]

Phrase: "(19q13.3-13.4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1520866:19q13.4 [Cell Component]
   875   C1520859:19q13.13 [Cell Component]
   861   C1520862:19q13.3 [Cell Component]
   812   C1520855:19q13 [Cell Component]

Phrase: ")"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "21"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "genetic linkage to Alzheimer's disease"
Meta Candidates (Total=14; Excluded=9; Pruned=0; Remaining=5)
   806   C0023745:genetic linkage [Molecular Function]
           linkage
   797   C0019247:Genetic disease [Disease or Syndrome]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   756 E C2316203:Genetic diseases [Finding]
   756 E C2924406:Genetic diseases [Laboratory Procedure]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "which"

Phrase: "is"

Phrase: "nonrandomly"

Phrase: "rearranged in a variety of human solid tumors,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0280100:solid tumors [Neoplastic Process]
   744   C0027651:Tumors [Neoplastic Process]
   744   C0086418:Human [Human]
   744   C0205208:Solid [Qualitative Concept]
   744   C0302909:Solid [Substance]
   744   C1378566:Solid [Biomedical or Dental Material]
   744   C1883525:Variety [Conceptual Entity]
   744   C2346866:Variety [Conceptual Entity]
   711 E C1578706:Tumor [Intellectual Product]
   711 E C3273930:Tumor [Finding]

Phrase: "like pancreatic carcinomas,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0235974:Pancreatic carcinoma [Neoplastic Process]
   861   C0007097:Carcinomas [Neoplastic Process]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "astrocytomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004114:Astrocytomas [Neoplastic Process]

Phrase: "ovarian cancers,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancers [Neoplastic Process]
  1000   C1140680:Ovarian Cancers [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "thyroid tumors,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0040136:thyroid tumors [Neoplastic Process]
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "among others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(23-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.30: Distinct members of the kallikrein family have been associated with cancer, and two members, PSA and glandular kallikrein, are used as biomarkers for the diagnosis and monitoring of prostate and breast cancer, whereas kallikrein 11has been assessed for ovarian carcinoma (26). 

Phrase: "Distinct members of the kallikrein family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0086282:Family Members [Family Group]
   767 E C1611821:Family Member [Intellectual Product]
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "have"

Phrase: "been"

Phrase: "associated with cancer,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0006826:Cancer [Neoplastic Process]
   790   C0998265:Cancer [Eukaryote]
   790   C1306459:Cancer [Finding]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "two members,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680022:members [Population Group]
   827 E C2698041:Member [Professional or Occupational Group]

Phrase: "PSA"

Phrase: "and"

Phrase: "glandular kallikrein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0076726:Glandular Kallikrein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0618743:Kallikrein, Glandular [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334308:KALLIKREIN, GLANDULAR [Gene or Genome]
   861   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "are"

Phrase: "used as biomarkers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0005516:Biomarkers [Clinical Attribute]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "for the diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "monitoring of prostate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150369:Monitoring [Health Care Activity]
   790   C1516647:monitoring [Research Activity]

Phrase: "and"

Phrase: "breast cancer,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0006142:Breast Cancer [Neoplastic Process]
  1000   C0678222:Breast Cancer [Neoplastic Process]
   950 E C0153661:thoracic cancer [Neoplastic Process]
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]

Phrase: "whereas"

Phrase: "kallikrein 11has"

Phrase: "been"

Phrase: "assessed for ovarian carcinoma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0029925:Ovarian Carcinoma [Neoplastic Process]
   833   C0677886:carcinoma, ovarian [Neoplastic Process]
   770   C0007097:Carcinoma [Neoplastic Process]
   770   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   770   C1516048:Assessed [Activity]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.31: Human kallikrein 6(hK6) is a member of the kallikrein gene family, and it is also known as protease M, neurosin, or zyme (16, 27, 28), a 223-amino acid serine proteinase with trypsin-like activity and restricted substrate specificity. 

Phrase: "Human kallikrein 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1416677:KALLIKREIN 6 [Gene or Genome]
   827   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0086418:Human [Human]

Phrase: "(hK6"

Phrase: ")"

Phrase: "is"

Phrase: "a member of the kallikrein gene family,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "also"

Phrase: "known as protease M,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1416677:PROTEASE M [Gene or Genome]
   819 E C0666066:M-protease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0205309:Known [Qualitative Concept]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1947941:Protease [Enzyme]

Phrase: "neurosin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416677:NEUROSIN [Gene or Genome]

Phrase: "or"

Phrase: "zyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416677:ZYME [Gene or Genome]
  1000   C2986866:ZYME [Gene or Genome]

Phrase: "(16,"

Phrase: "27,"

Phrase: "28"

Phrase: ")"

Phrase: ","

Phrase: "a 223-amino acid serine proteinase with trypsin-like activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   775   C2258563:proteinase A activity [Molecular Function]
   760   C2717971:Serine Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0377149:proteinase a [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1150095:proteinase activity [Molecular Function]
   757   C1622131:proteinase activity [Molecular Function]
           proteinase
   739   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C1947941:Proteinase [Enzyme]

Phrase: "and"

Phrase: "restricted substrate specificity."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0038592:Substrate Specificity [Quantitative Concept]
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   827   C1710236:Substrate [Manufactured Object]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.32: It derives from a 244-amino acid precursor containing a 16-residue presignal peptide and a 5-amino acid activation propeptide and is glycosylated at Asn132. 

Phrase: "It"

Phrase: "derives from a 244-amino acid precursor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a 16-residue presignal peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "a 5-amino acid activation propeptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1709708:Propeptide [Amino Acid, Peptide, or Protein]
   804   C1875696:PRO-PEPTIDE [Food]
   717   C0002511:amino acid activation [Molecular Function]

Phrase: "and"

Phrase: "is"

Phrase: "glycosylated at Asn132."
Processing 00000000.tx.33: This protein may have orthologues in mouse, rat, and monkey (28-31). 

Phrase: "This protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "have"

Phrase: "orthologues in mouse,"

Phrase: "rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "monkey"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026447:Monkey [Mammal]

Phrase: "(28-31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.34: It is distinct from neuropsin (KLK8), a hippocampal protease involved in kindling epileptogenesis in mice (32). 

Phrase: "It"

Phrase: "is"

Phrase: "distinct from neuropsin"

Phrase: "(KLK8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416679:KLK8 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "a hippocampal protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "involved in kindling epileptogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1314939:Involved [Functional Concept]
   770   C1720776:kindling [Pathologic Function]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.35: Like the other members of the human kallikrein family, the KLK6 gene lies at chromosome locus 19q13.4, telomeric to the PSA (KLK3) and KLK2 genes (5, 21). 

Phrase: "Like the"

Phrase: "other members of the human kallikrein family,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   774   C0086282:Family Members [Family Group]
   757 E C1611821:Family Member [Intellectual Product]
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "the KLK6 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416677:KLK6 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "lies at chromosome locus 19q13.4,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1520866:19q13.4 [Cell Component]
   783   C0008667:Chromosome 4 [Cell Component]
   753   C0008633:Chromosome [Cell Component]
   753   C1520855:19q13 [Cell Component]
   753   C1708726:Locus [Gene or Genome]

Phrase: "telomeric to the PSA (KLK3"

Phrase: ")"

Phrase: "and"

Phrase: "KLK2 genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1334308:KLK2 gene [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.36: (Pro)hK6 or its mRNA was found in human brain, spinal cord, cerebellum, kidney, uterus, mammary gland, pancreatic tissue, cerebrospinal fluid, prostate and salivary glands and, at a lower level, in spleen (16, 27, 28, 33, 34). 

Phrase: "(Pro)hK6"

Phrase: "or"

Phrase: "its mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "found in human brain,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0086418:Human [Human]
   770   C0150312:Found [Quantitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0243095:Find [Finding]

Phrase: "spinal cord,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "uterus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042149:Uterus [Body Part, Organ, or Organ Component]
  1000   C1269032:Uterus [Body Part, Organ, or Organ Component]

Phrase: "mammary gland,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
           Mammary
  1000   C1521747:GLAND, MAMMARY [Tissue]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "pancreatic tissue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "cerebrospinal fluid,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "prostate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033572:Prostate [Body Part, Organ, or Organ Component]
  1000   C1278980:Prostate [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "salivary glands"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0036098:Salivary Glands [Body Part, Organ, or Organ Component]
   966 E C1278917:Salivary gland [Body Part, Organ, or Organ Component]
   966 E C1519177:GLAND, SALIVARY [Tissue]
   861   C0442040:Salivary [Spatial Concept]
   861   C1285092:Glands [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: ","

Phrase: "at a lower level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "in spleen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "(16,"

Phrase: "27,"

Phrase: "28,"

Phrase: "33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.37: Immunohistochemical localization of hK6 in various tissues, showing epithelial cell secretion, has been published (35). 

Phrase: "Immunohistochemical localization of hK6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "in various tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "epithelial cell secretion,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1327616:Cell secretion [Cell Function]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   734   C0014597:Epithelial cell [Cell]

Phrase: "has"

Phrase: "been"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.38: It has also been detected in pathological tissues, as human colon adenocarcinoma and ovarian and breast cancer. 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "detected in pathological tissues,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0030664:Pathological [Biomedical Occupation or Discipline]
   770   C0040300:Tissues [Tissue]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1521733:Pathological [Functional Concept]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "as"

Phrase: "human colon adenocarcinoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0338106:Colon Adenocarcinoma [Neoplastic Process]
   827   C0001418:Adenocarcinoma [Neoplastic Process]
   827   C0009368:Colon [Body Part, Organ, or Organ Component]
   827   C1281569:Colon [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ovarian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205065:Ovarian [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "breast cancer."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0006142:Breast Cancer [Neoplastic Process]
  1000   C0678222:Breast Cancer [Neoplastic Process]
   950 E C0153661:thoracic cancer [Neoplastic Process]
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]
Processing 00000000.tx.39: In the metastatic breast tumor cell line BT474, estrogens and progestins up-regulate the expression of hK6 in a dose-dependent manner (36). 

Phrase: "In the metastatic breast tumor cell line BT474,"

Phrase: "estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "progestins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0033306:Progestins [Hormone,Pharmacologic Substance,Steroid]
   966 E C3536710:Progestin [Pharmacologic Substance]

Phrase: "up-regulate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "the expression of hK6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.40: The connection between breast and prostate cancer and steroid hormones has been established in many epidemiological studies (37). 

Phrase: "The connection between breast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449379:Connection [Intellectual Product]

Phrase: "and"

Phrase: "prostate cancer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0376358:Prostate Cancer [Neoplastic Process]
  1000   C0600139:Prostate Cancer [Neoplastic Process]
  1000   C2984325:Prostate cancer [Functional Concept]
  1000   C3541264:Prostate Cancer [Intellectual Product]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0033572:Prostate [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1278980:Prostate [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "steroid hormones"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0301818:steroid hormones [Hormone,Steroid]
   861   C0019932:Hormones [Hormone]
   861   C0038317:Steroid [Steroid]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "established in many epidemiological studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0002783:Epidemiological Studies [Research Activity]
   760   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   760   C0443211:Established [Qualitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1272684:Established [Qualitative Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.41: hK6 was shown to be down-regulated in the metastatic cells but strongly expressed, although less so than in normal tissues, in primary breast cancer cells, ovarian cancer tissue, and tumor cell lines, whereas no expression was detected in normal ovary (16). 

Phrase: "hK6"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "down-regulated in the metastatic cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0036525:Metastatic [Functional Concept]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1522484:metastatic [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "strongly"

Phrase: "expressed"

Phrase: ","

Phrase: "although"

Phrase: "less so than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0439092:Less Than [Intellectual Product]
           less
   790   C0547044:Less [Qualitative Concept]

Phrase: "in normal tissues,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0040300:Normal Tissue [Tissue]
           Tissues
   983   C0332441:Normal tissue [Finding]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "in primary breast cancer cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   906   C1512505:Breast Cancer Cell [Cell]
   861   C0334227:cancer cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   708   C1306459:primary cancer [Finding]

Phrase: "ovarian cancer tissue,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1518744:Ovarian Tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C1547928:Tissue [Intellectual Product]
   734   C0029925:ovarian cancer [Neoplastic Process]
   734   C1140680:Ovarian Cancer [Neoplastic Process]

Phrase: "and"

Phrase: "tumor cell lines,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0085983:Tumor Cell Lines [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
   734   C0431085:Tumor cell [Cell]
   734   C0597032:Tumor Cell [Cell]

Phrase: "whereas"

Phrase: "no expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected in normal ovary"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0567261:Normal ovary [Finding]
   770   C0029939:Ovary [Body Part, Organ, or Organ Component]
   770   C0205307:Normal [Qualitative Concept]
   770   C0227898:ovary [Body Part, Organ, or Organ Component]
   770   C0439166:% normal [Quantitative Concept]
   770   C0442726:Detected [Finding]
   770   C1278992:Ovary [Body Part, Organ, or Organ Component]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.42: Plasminogen was suggested as a putative target in the search for physiological substrates of hK6. 

Phrase: "Plasminogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "was"

Phrase: "suggested as a putative target"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]
   726   C1705535:Suggest [Idea or Concept]

Phrase: "in the search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552603:search [Intellectual Product]
  1000   C1706202:Search [Activity]

Phrase: "for physiological substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "of hK6."
Processing 00000000.tx.43: Proteolytic cleavage of plasminogen in vitro resulted in the generation of angiostatin and angiostatin-like fragments. 

Phrase: "Proteolytic cleavage of plasminogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "resulted in the generation of angiostatin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0079411:Generation [Temporal Concept]
   753   C0290149:Angiostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C3146294:Generation [Activity]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "and"

Phrase: "angiostatin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0290149:Angiostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "like fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.44: Angiostatin is an endogenous inhibitor of tumor angiogenesis and metastatic growth. 

Phrase: "Angiostatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0290149:Angiostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "an endogenous inhibitor of tumor angiogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596087:Angiogenesis inhibitor [Biologically Active Substance,Pharmacologic Substance]
   753   C0205227:Endogenous [Functional Concept]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "metastatic growth."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
Processing 00000000.tx.45: Therefore, this expression pattern suggests that hK6 contributes to several cancers in establishing breast and ovarian primary tumors and that it may function later during tumor progression as a potential metastasis and angiogenesis inhibitor (16, 38). 

Phrase: "Therefore,"

Phrase: "this expression pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that hK6"

Phrase: "contributes to several cancers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006826:Cancer [Neoplastic Process]
   770   C0998265:Cancer [Eukaryote]
   770   C1306459:Cancer [Finding]
   770   C1880177:Contribute [Activity]

Phrase: "in establishing breast"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]

Phrase: "and"

Phrase: "ovarian primary tumors"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   913   C0919267:Ovarian Tumors [Neoplastic Process]
   901   C0677930:primary tumors [Neoplastic Process]
   827   C0027651:Tumors [Neoplastic Process]
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "later during tumor progression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0178874:Tumor Progression [Neoplastic Process]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]

Phrase: "as a potential metastasis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0027627:Metastasis [Neoplastic Process]
   861   C2939420:metastasis [Neoplastic Process]
   789 E C0036525:Metastatic [Functional Concept]
   789 E C1522484:metastatic [Quantitative Concept]

Phrase: "and"

Phrase: "angiogenesis inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596087:Angiogenesis inhibitor [Biologically Active Substance,Pharmacologic Substance]
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1519670:angiogenesis [Neoplastic Process]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(16,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.46: The protein has also been found in adult but not in fetal brain. 

Phrase: "The protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "found in adult"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0001675:Adult [Age Group]
   790   C0150312:Found [Quantitative Concept]
   790   C1706450:Adult [Human]
   756 E C0243095:Find [Finding]

Phrase: "but"

Phrase: "not in fetal brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0440731:Fetal brain [Embryonic Structure]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0015965:Fetal [Embryonic Structure]
   770   C0521457:Fetal [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1518422:Not [Functional Concept]
Processing 00000000.tx.47: It is decreased in Parkinson's disease and Alzheimer's disease patients (33). 

Phrase: "It"

Phrase: "is"

Phrase: "decreased in Parkinson's disease"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.48: Cells transfected with the enzyme and amyloid precursor protein accumulate amyloidogenic fragments (28). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "and"

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "accumulate"

Phrase: "amyloidogenic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.49: Accordingly, hK6 has been implicated in the progression of Alzheimer's disease. 

Phrase: "Accordingly,"

Phrase: "hK6"

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the progression of Alzheimer's disease."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0242656:Disease Progression [Pathologic Function]
           progression
   774   C1947900:Disease progression NOS [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0449258:Progression [Functional Concept]
Processing 00000000.tx.50: This activity of hK6 in brain is consistent with the finding that its mRNA is induced in the perilesioned region upon injury of the central nervous system (39). 

Phrase: "This activity of hK6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "consistent with the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   783   C0332529:Consistency finding [Qualitative Concept]

Phrase: "that"

Phrase: "its mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "induced in the perilesioned region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0205263:Induced [Functional Concept]

Phrase: "upon injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "of the central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.51: These results and the fact that hK6 has been found in significantly increased concentrations in the serum of ovarian cancer patients and in the cerebrospinal fluid, plasma, and blood of Alzheimer's disease patients have led to the development of an immunofluorometric assay for the measurement of this new biomarker for breast and ovarian cancer and for Alzheimer's disease (40-42). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "and"

Phrase: "the fact"

Phrase: "that hK6"

Phrase: "has"

Phrase: "been"

Phrase: "found in significantly increased concentrations"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0086045:Concentrations [Mental Process]
   760   C0150312:Found [Quantitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0243095:Find [Finding]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "in the serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "of ovarian cancer patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1516213:Cancer Patient [Patient or Disabled Group]
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0029925:ovarian cancer [Neoplastic Process]
   734   C1140680:Ovarian Cancer [Neoplastic Process]

Phrase: "and in the cerebrospinal fluid,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007806:Cerebrospinal Fluid [Body Substance]
   806   C0007807:cerebrospinal fluid [Functional Concept]
   760   C0005889:FLUID [Body Substance]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1704353:Fluid [Substance]

Phrase: "plasma,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and"

Phrase: "blood of Alzheimer's disease patients"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0018939:Blood disease NOS [Disease or Syndrome]
   797   C1533163:Blood disease [Disease or Syndrome]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0229664:Blood [Body Substance]
   756 E C0042373:blood vessel disease [Disease or Syndrome]

Phrase: "have"

Phrase: "led to the development of an immunofluorometric assay"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   770   C0016350:Immunofluorometric Assay [Laboratory Procedure]
   767   C0872102:assay development [Diagnostic Procedure]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1527148:Development [Functional Concept]
   744   C1708698:LED [Manufactured Object]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "for the measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of this new biomarker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Biomarker [Clinical Attribute]

Phrase: "for breast"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0006141:Breast [Body Part, Organ, or Organ Component]
  1000   C1268990:Breast [Body Part, Organ, or Organ Component]
   944 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   944 E C1521735:Pectoral [Qualitative Concept]
   916 E C0817096:Chest [Body Location or Region]
   916 E C1527391:Chest [Body Location or Region]

Phrase: "and"

Phrase: "ovarian cancer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancer [Neoplastic Process]
  1000   C1140680:Ovarian Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "and for Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(40-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.52: hK6 is a serine proteinase expressed as an inactive zymogen to prevent proteolytic activity in the wrong environment. 

Phrase: "hK6"

Phrase: "is"

Phrase: "a serine proteinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2717971:Serine Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "expressed as an inactive zymogen to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0014436:zymogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205254:Inactive [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "proteolytic activity in the wrong environment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0597304:Proteolytic [Molecular Function]
   753   C1561536:*Activity [Idea or Concept]
   753   C1947941:proteolytic [Enzyme]
Processing 00000000.tx.53: Upon adequate stimulation, limited proteolysis is induced, leading to proenzyme activation. 

Phrase: "Upon adequate stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "limited proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597304:Proteolysis [Molecular Function]
   789 E C1947941:proteolytic [Enzyme]

Phrase: "is"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: ","

Phrase: "leading to proenzyme activation."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0014436:Proenzyme [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   770   C1879547:Activation [Activity]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.54: For the first time, we have analyzed the proform of a member of the (human) kallikrein family by x-ray crystallography, since no three-dimensional structure of a prokallikrein was available. 

Phrase: "For the first time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the proform of a member of the (human"

Phrase: ")"

Phrase: "kallikrein family by x-ray crystallography,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015576:Family [Family Group]
   753   C1704727:Family [Conceptual Entity]

Phrase: "since"

Phrase: "no three-dimensional structure of a prokallikrein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0450363:3-Dimensional [Spatial Concept]
   748   C0205449:Three [Quantitative Concept]
   748   C0678594:Structure [Spatial Concept]

Phrase: "was"

Phrase: "available."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]
Processing 00000000.tx.55: We present the essential features of the structural determinants for activation of human pro-hK6, which can be extrapolated to the other 14members of the family.  

Phrase: "We"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "the essential features of the structural determinants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: "for activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of human pro-hK6,"

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "extrapolated to the"

Phrase: "other 14members of the family."
Processing 00000000.tx.56: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES Protein Preparation-- Initial trials to produce homogenous protein including the residues of the chemical sequence of the hK6 precursor Ala10-Lys245 (chymotrypsin numbering (18); corresponds to Ala16-Lys244 of the sequential protein numbering (see Fig. 1)) failed due to autolysis after Arg76.2 Accordingly, this residue was mutated to glutamine. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C2825142:Experimental Result [Finding]
           Result
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Protein Preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "--"

Phrase: "Initial trials to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0008976:Trial [Research Activity]

Phrase: "produce"

Phrase: "homogenous protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the residues of the chemical sequence of the hK6 precursor Ala10-Lys245"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C1709915:Residue [Conceptual Entity]
   703   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(chymotrypsin numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449788:numbering [Quantitative Concept]
   827 E C0237753:*Number [Quantitative Concept]

Phrase: "(18"

Phrase: ")"

Phrase: ";"

Phrase: "corresponds to Ala16-Lys244 of the sequential protein numbering"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0449788:numbering [Quantitative Concept]
   742   C1548958:Sequential [Idea or Concept]
   742   C1705294:Sequential [Qualitative Concept]
   708 E C0237753:*Number [Quantitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ")"

Phrase: "failed due to autolysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0004372:Autolysis [Pathologic Function]
   770   C0231175:Failed [Functional Concept]
   770   C3146286:Due [Idea or Concept]

Phrase: "after Arg76.2 Accordingly,"

Phrase: "this residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "was"

Phrase: "mutated to glutamine."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.57: The N-glycosylation site at Asn132 prevented the protein from crystallizing, so it was also replaced by glutamine. 

Phrase: "The N-glycosylation site at Asn132"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017982:glycosylation [Natural Phenomenon or Process]
   753   C0205145:Site [Spatial Concept]
   753   C0376322:Glycosylation [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the protein from crystallizing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "so"

Phrase: "it"

Phrase: "was"

Phrase: "also"

Phrase: "replaced by glutamine."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1299987:Replaced by [Functional Concept]
           replaced
   790   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0559956:Replaced [Functional Concept]
   756 E C1554078:Replace [Idea or Concept]
Processing 00000000.tx.58: Finally, a further mutation occurred in the activation peptide region during PCR cloning (Q13R). 

Phrase: "Finally,"

Phrase: "a further mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "occurred in the activation peptide region"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0017446:Region [Geographic Area]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0205147:Region [Spatial Concept]
   753   C1709305:Occurred [Activity]
   753   C1879547:Activation [Activity]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: "during PCR cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009015:Cloning [Research Activity]

Phrase: "(Q13R"

Phrase: ")."
Processing 00000000.tx.59: This construct, harboring three mutations, was used to express the recombinant proteins used in the present study. 

Phrase: "This construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "three mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "the recombinant proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514798:recombinant [Organism]

Phrase: "used in the present study."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.60: The protein was heterologously overexpressed in yeast following an approach recently reported for other proproteases (43). 

Phrase: "The protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "heterologously"

Phrase: "overexpressed in yeast"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   756   C1514559:overexpress [Genetic Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "an approach recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "reported for other proproteases"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.61: Briefly, the vector pPIC9 containing the mutant gene was transformed into Pichia pastoris strain KM71 by the spheroblast method. 

Phrase: "Briefly,"

Phrase: "the vector pPIC9"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the mutant gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678941:mutant gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "transformed into Pichia pastoris strain KM71"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0031874:Pichia [Fungus]
   753   C0080194:Strain [Injury or Poisoning]
   753   C0456178:strain [Intellectual Product]
   753   C1510411:Transformed [Pathologic Function]
   753   C1518614:Strain [Organism]
   753   C2987481:Strain [Mental Process]

Phrase: "by the spheroblast method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.62: After expression at 30C, the culture supernatant containing pro-hK6 was separated by centrifugation and subjected to two steps of purification (hydrophobic and anion-exchange fast protein liquid chromatography). 

Phrase: "After expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "at 30C,"

Phrase: "the culture supernatant containing pro-hK6"

Phrase: "was"

Phrase: "separated by centrifugation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "subjected to two steps of purification"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0205448:Two [Quantitative Concept]
   753   C0243114:purification [Functional Concept]
   753   C1261552:steps [Conceptual Entity]
   753   C1998793:Purification [Functional Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719 E C1704379:Step [Functional Concept]
   719 E C1705117:Step [Quantitative Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]
   719 E C2825408:Step [Manufactured Object]

Phrase: "(hydrophobic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobic [Qualitative Concept]

Phrase: "and"

Phrase: "anion-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "exchange"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678640:exchange [Social Behavior]

Phrase: "fast protein liquid chromatography"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0599209:Fast Protein Liquid Chromatography [Laboratory Procedure]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0015663:Fast [Finding]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0302908:Liquid [Substance]
   812   C0456962:Fast [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   712 E C0302647:chromatograph [Medical Device]

Phrase: ")."
Processing 00000000.tx.63: A final size exclusion chromatography step resulted in highly purified protein, finally concentrated to 10mg/ml (in 10mM Tris-HCl, pH 8.5,10mM benzamidine). 

Phrase: "A final size exclusion chromatography step"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C1261552:Step [Conceptual Entity]
   804   C1704379:Step [Functional Concept]
   804   C1705117:Step [Quantitative Concept]
   804   C2825408:Step [Manufactured Object]
   717   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
   717   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]

Phrase: "resulted in highly purified protein,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205250:Highly [Qualitative Concept]
   760   C1998793:Purified [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "finally"

Phrase: "concentrated to 10mg/ml ("
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439526:/mL [Quantitative Concept]
   770   C1880165:Concentrated [Biomedical or Dental Material]
   737 E C1880310:Concentrate [Manufactured Object]
   737 E C2003864:Concentrate [Substance]

Phrase: "in 10mM Tris-HCl,"

Phrase: "pH 8.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10mM benzamidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.64: The presence of a single continuous protein chain was assessed by mass spectrometry and automated Edman degradation analysis of the N-terminal sequence. 

Phrase: "The presence of a single continuous protein chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "assessed by mass spectrometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C1516048:Assessed [Activity]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "automated Edman degradation analysis of the N-terminal sequence."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
Processing 00000000.tx.65: Pro-hK6 was activated to render fully active mature hK6 by trypsin and lysyl endopeptidase cleavage; 

Phrase: "Pro-hK6"

Phrase: "was"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "render"

Phrase: "fully active mature hK6 by trypsin"

Phrase: "and"

Phrase: "lysyl endopeptidase cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]
   734   C0126502:lysyl endopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.66: the active enzyme was tested for activity against the synthetic substrate N-benzoyl-L-arginine ethyl ester (Sigma). 

Phrase: "the active enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "tested for activity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0205177:Activity [Functional Concept]
   790   C0392366:tested [Intellectual Product]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "against the synthetic substrate N-benzoyl-L-arginine ethyl ester"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   890   C0053269:benzoyl-L-arginine ethyl ester [Organic Chemical,Pharmacologic Substance]
   835   C1506061:arginine ethyl ester [Amino Acid, Peptide, or Protein]
   793   C0014898:Ester [Organic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.67: This shows that our pro-hK6 form is not a nonactivable truncated species, as described in the form of subunit III for the serine protease proenzyme proprotease E (44). 

Phrase: "This"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "our pro-hK6 form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a nonactivable truncated species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "as"

Phrase: "described in the form of subunit III"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C0439070:III [Intellectual Product]
   748   C1522492:Form [Functional Concept]
   748   C1552738:described [Idea or Concept]
   748   C1705160:III [Qualitative Concept]
   748   C1711351:Subunit [Quantitative Concept]

Phrase: "for the serine protease proenzyme proprotease E (44"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   858   C0072325:protease E [Amino Acid, Peptide, or Protein,Enzyme]
   858   C1423848:protease E [Gene or Genome]
   827   C0036734:serine protease [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2717971:Serine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0014436:Proenzyme [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   799   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C1947941:Protease [Enzyme]

Phrase: ")."
Processing 00000000.tx.68: Crystallization and Data Collection-- The protein was crystallized using the sitting drop vapor diffusion method from equivolumetric drops of protein and precipitant solution (30% polyethylene glycol 4000,0.1M Tris-HCl, pH 8.5,0.2M MgCl2). 

Phrase: "Crystallization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010423:Crystallization [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "Data Collection"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0010995:Data Collection [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   861   C3245479:data [Medical Device]
   789 E C1516695:Collected [Idea or Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "crystallized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444626:Crystallized [Chemical Viewed Structurally]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the sitting drop vapor diffusion method from equivolumetric drops of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0025663:Method [Intellectual Product]
   738   C0449851:Method [Functional Concept]
   738   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "precipitant solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(30% polyethylene glycol 4000,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0032479:Polyethylene Glycol 4000 [Organic Chemical,Pharmacologic Substance]
   861   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   812   C0017945:Glycol [Organic Chemical]
   812   C0017951:Glycol [Organic Chemical]
   812   C0032487:polyethylene [Biomedical or Dental Material,Organic Chemical]
   812   C0137914:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   812   C0752345:Polyethylene [Biomedical or Dental Material,Organic Chemical]

Phrase: "0.1M Tris-HCl,"

Phrase: "pH 8.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.2M MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.69: Well shaped orthorhombic crystals belonging to space group P212121 (a=46.0, b=66.4, c=71.2) were obtained. 

Phrase: "Well shaped orthorhombic crystals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0427896:Crystals [Body Substance]
   812   C0444626:Crystals [Chemical Viewed Structurally]
   812   C1378554:Crystals [Biomedical or Dental Material]
   812   C1533132:Crystals [Body Substance]
   812   C2699477:Crystals [Laboratory Procedure]
   779 E C1704641:Crystal [Manufactured Object]

Phrase: "belonging to space group P212121"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1883067:Space [Spatial Concept]

Phrase: "(a=46.0,"

Phrase: "b=66.4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347469:/B [Quantitative Concept]

Phrase: "c=71.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0050322:c 2 [Lipid]
   827   C0450389:71 [Intellectual Product]
   827   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.70: These crystals diffract to better than 1.8- resolution and harbor one monomer in the asymmetric unit and 43% solvent (Vm=2.23/Da (45)). 

Phrase: "These crystals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0427896:Crystals [Body Substance]
  1000   C0444626:Crystals [Chemical Viewed Structurally]
  1000   C1378554:Crystals [Biomedical or Dental Material]
  1000   C1533132:Crystals [Body Substance]
  1000   C2699477:Crystals [Laboratory Procedure]
   966 E C1704641:Crystal [Manufactured Object]

Phrase: "diffract"

Phrase: "to better than 1.8- resolution"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0332272:Better [Qualitative Concept]
   753   C1514893:Resolution [Idea or Concept]
   753   C1706463:Resolution [Quantitative Concept]
   753   C1883351:To [Qualitative Concept]
   753   C2699488:Resolution [Conceptual Entity]
   719 E C0205170:Well [Qualitative Concept]
   719 E C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "harbor one monomer in the asymmetric unit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "43% solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Vm=2.23/Da (45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.71: A cryo-protecting solution consisted of mother liquor with 20% glycerol. 

Phrase: "A cryo-protecting solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "consisted of mother liquor"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0002638:Liquor [Body Substance]
   770   C0026591:Mother [Family Group]
   770   C0301611:Liquor [Food]
   737   C0332529:CONSIST [Qualitative Concept]
   715 E C1826438:MATER [Gene or Genome]
   715 E C2347083:Maternal [Family Group]

Phrase: "with 20% glycerol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.72: Crystals briefly soaked in this solution were immediately flash cryo-cooled in liquid nitrogen and stored for diffraction analysis. 

Phrase: "Crystals briefly"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0427896:Crystals [Body Substance]
   861   C0444626:Crystals [Chemical Viewed Structurally]
   861   C1378554:Crystals [Biomedical or Dental Material]
   861   C1533132:Crystals [Body Substance]
   861   C2699477:Crystals [Laboratory Procedure]
   827 E C1704641:Crystal [Manufactured Object]

Phrase: "soaked in this solution"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0037633:Solution [Substance]
   770   C0204774:soaked [Therapeutic or Preventive Procedure]
   770   C0525069:Solution [Biomedical or Dental Material]
   737 E C1549544:Soak [Functional Concept]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "flash"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181637:flash [Medical Device]
  1000   C0262485:Flash [Diagnostic Procedure]

Phrase: "cryo-"

Phrase: "cooled in liquid nitrogen"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]
   737   C1548792:Cool [Qualitative Concept]

Phrase: "and"

Phrase: "stored for diffraction analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C1698986:Store [Functional Concept]
Processing 00000000.tx.73: Diffraction data collection was performed at European Synchrotron Radiation Facility beamlines (Grenoble, France) with 165-mm marCCD and ADSC Quantum4 CCD detectors. 

Phrase: "Diffraction data collection"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0010995:Data Collection [Research Activity]
   827   C1511726:Data [Idea or Concept]
   827   C1516698:Collection [Functional Concept]
   827   C1704814:Collection [Idea or Concept]
   827   C3245479:data [Medical Device]
   755 E C1516695:Collected [Idea or Concept]

Phrase: "was"

Phrase: "performed at European Synchrotron Radiation Facility beamlines"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   778   C0599746:synchrotron radiation [Phenomenon or Process]
   748   C0034519:Radiation [Natural Phenomenon or Process]
   748   C0162738:Synchrotron [Manufactured Object]
   748   C0239307:European [Population Group]
   748   C0560559:Radiation [Quantitative Concept]
   748   C0851346:Radiation [Natural Phenomenon or Process]
   748   C0884358:Performed [Functional Concept]
   748   C1522449:Radiation [Therapeutic or Preventive Procedure]
   748   C1524020:Radiation [Therapeutic or Preventive Procedure]
   748   C1524021:Radiation [Research Activity]
   748   C1535514:European [Population Group]
   748   C1547538:Facility [Idea or Concept]
   714   C0872107:beamline [Manufactured Object]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Grenoble,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "with 165-mm marCCD"

Phrase: "and"

Phrase: "ADSC Quantum4 CCD detectors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0180392:Detectors [Medical Device]
   779 E C1705235:Detector [Manufactured Object]
Processing 00000000.tx.74: Data were processed with MOSFLM version 6.11b (46) and scaled, merged, and reduced with SCALA (47). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "processed with MOSFLM version 6.11b"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0333052:Version [Functional Concept]
   753   C1522240:Processed [Phenomenon or Process]
   753   C2607870:Version [Spatial Concept]
   719 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "(46"

Phrase: ")"

Phrase: "and"

Phrase: "scaled"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0175659:Scale [Medical Device]
   966   C0349674:Scale [Intellectual Product]
   966   C1947916:Scale [Activity]
   966   C3536777:Scale [Manufactured Object]

Phrase: ","

Phrase: "merged,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881786:Merged [Activity]

Phrase: "and"

Phrase: "reduced with SCALA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.75: Table I provides a summary for the data collection and processing.  

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a summary for the data collection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552616:summary [Intellectual Product]
   753   C1706244:Summary [Intellectual Product]

Phrase: "and"

Phrase: "processing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]
Processing 00000000.tx.76: View this table: [in this window] [in a new window]  Table I Data collection and refinement statistics Structure Solution and Refinement-- A preliminary search for sequence similarity of pro-hK6 within the Protein Data Bank revealed the closest relationship with murine neuropsin (PDB 1npm (32)). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Data collection"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0010995:Data Collection [Research Activity]
   812   C1511726:Data [Idea or Concept]
   812   C1516698:Collection [Functional Concept]
   812   C1704814:Collection [Idea or Concept]
   812   C3245479:data [Medical Device]
   741 E C1516695:Collected [Idea or Concept]

Phrase: "and"

Phrase: "refinement statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0038215:Statistics [Occupation or Discipline]
   861   C0600673:Statistics [Intellectual Product]
   827 E C2348149:Statistic [Quantitative Concept]
   827 E C2828391:Statistic [Quantitative Concept]

Phrase: "Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "Solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "Refinement"

Phrase: "-"

Phrase: "-"

Phrase: "A preliminary search for sequence similarity of pro-hK6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1552603:search [Intellectual Product]
   742   C1706202:Search [Activity]

Phrase: "within the Protein Data Bank"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1705318:Protein Data Bank [Intellectual Product]
   901   C0242356:Data Bank [Intellectual Product]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0442598:Bank [Manufactured Object]
   827   C0872261:Bank [Manufactured Object]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the closest relationship with murine neuropsin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C1821461:Close Relationship [Finding]
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "(PDB 1npm"

Phrase: "(32"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.77: Accordingly, these coordinates were used as a searching model to solve the structure by molecular replacement, using the stand alone version of AMoRe (48). 

Phrase: "Accordingly,"

Phrase: "these coordinates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0427184:coordinates [Finding]
  1000   C0700114:coordinates [Functional Concept]
  1000   C1707511:Coordinates [Spatial Concept]

Phrase: "were"

Phrase: "used as a searching model to"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C1273517:used [Finding]
   753   C3161035:Model [Intellectual Product]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719   C1552603:search [Intellectual Product]
   719   C1706202:Search [Activity]
   719 E C1947944:Use [Intellectual Product]

Phrase: "solve"

Phrase: "the structure by molecular replacement,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0026383:Molecular Structure [Molecular Sequence]
   760   C0678594:Structure [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the stand alone version of AMoRe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.78: These calculations, performed in the 15to 4.0- resolution range, confirmed P212121 as the correct space group. 

Phrase: "These calculations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1441506:Calculation [Activity]

Phrase: "performed in the 15to 4.0- resolution range,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0884358:Performed [Functional Concept]
   744   C1514721:Range [Quantitative Concept]
   744   C1514893:Resolution [Idea or Concept]
   744   C1706463:Resolution [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C2699488:Resolution [Conceptual Entity]
   744   C3542016:Range [Intellectual Product]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "confirmed P212121 as the correct space group."
Processing 00000000.tx.79: The rotation function (RF) showed a clear peak at Eulerian angles =26.7, =87.5, and =74.0. 

Phrase: "The rotation function (RF)"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a clear peak at Eulerian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0444505:Peak [Quantitative Concept]

Phrase: "angles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205143:Angle [Spatial Concept]

Phrase: "=26.7,"

Phrase: "=87.5,"

Phrase: "and ="

Phrase: "74.0."
Processing 00000000.tx.80: The correlation coefficient in amplitudes (CC (48)) for this solution equals 3.7%, the crystallographic Rfactor (see Table I for a definition; computed after data expansion to P1) equals 56.9%, and RF=9.5(second highest solution: CC=1.5%, Rfactor=57.2%, RF=8.0). 

Phrase: "The correlation coefficient in amplitudes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1707429:*Coefficient [Quantitative Concept]
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "(CC (48"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538933:CC [Cell Component]

Phrase: ")"

Phrase: ")"

Phrase: "for this solution equals 3.7%,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0037633:Solution [Substance]
   812   C0205163:Equals [Qualitative Concept]
   812   C0439089:Equals [Intellectual Product]
   812   C0525069:Solution [Biomedical or Dental Material]
   779 E C1549782:Equal [Idea or Concept]

Phrase: "the crystallographic Rfactor"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table I for a definition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"

Phrase: "computed after data expansion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1441526:Computed [Laboratory Procedure]
   770   C1511726:Data [Idea or Concept]
   770   C1880157:Computed [Activity]
   770   C3245479:data [Medical Device]

Phrase: "to P1)"

Phrase: "equals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205163:Equal [Qualitative Concept]
  1000   C0439089:Equals [Intellectual Product]
  1000   C1549782:Equal [Idea or Concept]

Phrase: "56.9%,"

Phrase: "and"

Phrase: "RF"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "=9.5"

Phrase: "(second highest solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: ":"

Phrase: "CC=1.5%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1705070:CC-1 [Gene or Genome]
   827   C3538933:CC [Cell Component]

Phrase: "Rfactor"

Phrase: "=57.2%,"

Phrase: "RF"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "=8.0"

Phrase: ")."
Processing 00000000.tx.81: The translation function also rendered a clear solution (26.7,87.5,74.0,0.3396,0.0569,0.2789; , , in degrees, and x, y, z in fractional cell coordinates; CC=17.1%; Rfactor=53.8%; second highest peak CC=11.2%, Rfactor=56.2%). 

Phrase: "The translation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040712:Translation [Intellectual Product]
  1000   C0597295:translation [Molecular Function]
  1000   C1519614:Translation [Genetic Function]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "also"

Phrase: "rendered"

Phrase: "a clear solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(26.7,"

Phrase: "87.5,"

Phrase: "74.0,"

Phrase: "0.3396,"

Phrase: "0.0569,"

Phrase: "0.2789"

Phrase: "; ,"

Phrase: ","

Phrase: "in degrees,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0449286:degrees [Quantitative Concept]
  1000   C0542560:degrees [Intellectual Product]
   966 E C0441889:Degree [Qualitative Concept]
   966 E C1561545:degree [Quantitative Concept]
   966 E C2348088:Degree [Quantitative Concept]

Phrase: "and"

Phrase: "x,"

Phrase: "y,"

Phrase: "z in fractional cell coordinates"

Phrase: "; CC=17.1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1705070:CC-1 [Gene or Genome]
   827   C3538933:CC [Cell Component]

Phrase: "; Rfactor"

Phrase: "=53.8%"

Phrase: "; second highest peak CC=11.2%,"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   799   C0205436:Second [Quantitative Concept]
   799   C0444505:Peak [Quantitative Concept]
   799   C0457385:Second [Temporal Concept]
   799   C0565930:/second [Quantitative Concept]
   799   C1522410:Highest [Qualitative Concept]
   799   C1561503:second [Idea or Concept]
   799   C1705190:Second [Qualitative Concept]
   799   C3538933:CC [Cell Component]
   766 E C0205250:High [Qualitative Concept]
   766 E C1299351:High [Qualitative Concept]
   766 E C2700149:HIGH [Intellectual Product]
   727 E C0027627:secondary [Neoplastic Process]
   727 E C0175668:Secondary [Temporal Concept]
   716 E C0489786:Height [Organism Attribute]

Phrase: "Rfactor"

Phrase: "=56.2%"

Phrase: ")."
Processing 00000000.tx.82: A final rigid body refinement with FITING (48) led to better figures, CC=20.0% and Rfactor=52.9% (28.3,87.7,72.0,0.3386,0.0553,and 0.2773). 

Phrase: "A final rigid body refinement with FITING"

Phrase: "(48"

Phrase: ")"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to better figures,"

Phrase: "CC=20.0%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538933:CC [Cell Component]

Phrase: "and"

Phrase: "Rfactor"

Phrase: "=52.9%"

Phrase: "(28.3,"

Phrase: "87.7,"

Phrase: "72.0,"

Phrase: "0.3386,"

Phrase: "0.0553,"

Phrase: "and"

Phrase: "0.2773"

Phrase: ")."
Processing 00000000.tx.83: The input coordinates were rotated and translated according to this solution and subjected to a simulated annealing refinement step and positional/temperature factor refinement using maximum likelihood as a criterion after performing bulk solvent correction and anisotropic temperature factor refinement (Rfactor=41.3%; free Rfactor=44.2%). 

Phrase: "The input coordinates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0427184:coordinates [Finding]
   861   C0700114:coordinates [Functional Concept]
   861   C1707511:Coordinates [Spatial Concept]

Phrase: "were"

Phrase: "rotated"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0231458:Rotated [Spatial Concept]
   928 E C0040480:Twisting [Physiologic Function]
   928 E C0231467:Twisted [Spatial Concept]
   928 E C1265748:Twisting [Pathologic Function]
   928 E C1881716:TWISTING [Phenomenon or Process]

Phrase: "and"

Phrase: "translated according to this solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037633:Solution [Substance]
   760   C0040710:translated [Occupational Activity]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C0680240:according [Social Behavior]

Phrase: "and"

Phrase: "subjected to a simulated annealing refinement step"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0284447:simulated [Biomedical or Dental Material]
   748   C1261552:Step [Conceptual Entity]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "positional/temperature factor refinement"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "maximum likelihood as a criterion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033204:Likelihood [Quantitative Concept]
   760   C0806909:Maximum [Quantitative Concept]
   760   C1552615:maximum [Quantitative Concept]
   760   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "after performing bulk solvent correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1705565:CORRECTION [Intellectual Product]
   812   C1947976:Correction [Functional Concept]

Phrase: "and"

Phrase: "anisotropic temperature factor refinement"

Phrase: "(Rfactor"

Phrase: "=41.3%"

Phrase: "; free Rfactor"

Phrase: "=44.2%"

Phrase: ")."
Processing 00000000.tx.84: Program CNS version 1.0(49) was used for this purpose. 

Phrase: "Program CNS version 1.0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0333052:Version [Functional Concept]
   804   C1709697:Program [Conceptual Entity]
   804   C2607870:Version [Spatial Concept]
   804   C2728259:Program [Pharmacologic Substance]
   804   C3484370:Program [Functional Concept]

Phrase: "(49"

Phrase: ")"

Phrase: "was"

Phrase: "used for this purpose."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   770   C1285529:Purpose [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.85: The subsequently computed A-weighted 2mFoDFc and mFoDFc electron density maps, inspected together with the initially refined model on a SGI Graphic Work station with the program TURBO-FRODO (50), showed the correctness of the solution and positive difference density for the regions diverging from the phasing model. 

Phrase: "The subsequently"

Phrase: "computed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441526:Computed [Laboratory Procedure]
  1000   C1880157:Computed [Activity]

Phrase: "A-weighted 2mFoDFc"

Phrase: "and"

Phrase: "mFoDFc electron density maps,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0024779:Map [Manufactured Object]
   812   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1706473:Map [Conceptual Entity]

Phrase: "inspected together with the initially refined model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205265:Initially [Temporal Concept]
   748   C1883357:Together [Qualitative Concept]
   748   C3161035:Model [Intellectual Product]

Phrase: "on a SGI Graphic Work station"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0043227:Work [Occupational Activity]
   812   C1883167:Station [Manufactured Object]
   741 E C0439835:Stationary [Qualitative Concept]

Phrase: "with the program TURBO-FRODO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1425059:FRODO [Gene or Genome]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the correctness of the solution"

Phrase: "and"

Phrase: "positive difference density for the regions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]

Phrase: "diverging from the phasing model."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C3161035:Model [Intellectual Product]
   726   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.86: At this stage, an electron density/model improvement step was undertaken with ARP/wARP (51) using all data up to 1.8- resolution and the warpNtrace-mode with protein sequence information. 

Phrase: "At this stage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "an electron density/model improvement step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1261552:Step [Conceptual Entity]
   804   C1704379:Step [Functional Concept]
   804   C1705117:Step [Quantitative Concept]
   804   C2825408:Step [Manufactured Object]

Phrase: "was"

Phrase: "undertaken with ARP/wARP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1823652:WARP [Gene or Genome]

Phrase: "(51"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "all data up to 1.8- resolution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "the warpNtrace-mode with protein sequence information."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1513371:Mode [Functional Concept]
   748   C1705738:Mode [Quantitative Concept]
   748   C2347637:Mode [Quantitative Concept]
   748   C2348146:Mode [Quantitative Concept]
Processing 00000000.tx.87: This calculation rendered excellent electron density maps (see Fig. 2, a and b) and a model consisting of five chains and 185residues identified within the sequence. 

Phrase: "This calculation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculation [Activity]

Phrase: "rendered"

Phrase: "excellent electron density maps"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0024779:Map [Manufactured Object]
   812   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1706473:Map [Conceptual Entity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "a model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "consisting of five chains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205451:Five [Quantitative Concept]
   770   C0337112:chains [Manufactured Object]
   770   C1524075:Chains [Idea or Concept]
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "185residues"

Phrase: "identified within the sequence."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0205396:Identified [Qualitative Concept]
   770   C1519249:Sequence [Functional Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
Processing 00000000.tx.88: In successive cycles, this model was improved by alternating manual model building and crystallographic refinement with CNS and refmac5 (52) under translations and liberations of pseudo-rigid bodies (TLS) refinement (53). 

Phrase: "In successive cycles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "improved by alternating manual model building"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C0024763:Manual [Intellectual Product,Manufactured Object]
   753   C0175674:Manual [Functional Concept]
   753   C0184511:Improved [Qualitative Concept]
   753   C0332270:Alternating [Functional Concept]
   753   C0332272:Improved [Qualitative Concept]
   753   C1547706:Building [Functional Concept]
   753   C1561611:Improved [Intellectual Product]
   753   C1999269:Building [Manufactured Object]
   753   C3161035:Model [Intellectual Product]
   719 E C1523987:Alternate [Conceptual Entity]

Phrase: "and"

Phrase: "crystallographic refinement with CNS"

Phrase: "and"

Phrase: "refmac5"

Phrase: "(52"

Phrase: ")"

Phrase: "under translations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0040712:Translations [Intellectual Product]
   966 E C0597295:translation [Molecular Function]
   966 E C1519614:Translation [Genetic Function]

Phrase: "and"

Phrase: "liberations of pseudo-rigid bodies"

Phrase: "(TLS) refinement"

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.89: In the final stages, solvent molecules were introduced where appropriate, if present in 2mFoDFc and mFoDFc maps contoured at 1and 2.5, respectively. 

Phrase: "In the final stages,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205088:final stages [Temporal Concept]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "solvent molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "where appropriate,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1548787:Appropriate [Qualitative Concept]
   789 E C0814634:appropriateness [Qualitative Concept]

Phrase: "if"

Phrase: "present in 2mFoDFc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "mFoDFc maps"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024779:Map [Manufactured Object]
   861   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1706473:Map [Conceptual Entity]

Phrase: "contoured at 1and 2.5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0302821:contoured [Inorganic Chemical]
   760   C0876954:contoured [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.90: The final model comprises the residues ranging from Lys15 to Ala244 of the chemical sequence of pro-hK6 and 158solvent molecules (labeled W 501to W 658). 

Phrase: "The final model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "ranging from Lys15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to Ala244"

Phrase: "of the chemical sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "of pro-hK6"

Phrase: "and"

Phrase: "158solvent molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "(labeled W 501to W 658"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C1708632:Labeled [Qualitative Concept]
   771 E C0181496:Label [Manufactured Object]
   771 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: ")."
Processing 00000000.tx.91: As observed in other serine proteinase zymogens, chain segments corresponding to parts of the calcium-binding loop (in particular, Ser78-Gln80), autolysis loop (Asp148-Phe151), and base-forming segment (Tyr188-Ser190) are flexible. 

Phrase: "As"

Phrase: "observed in other serine proteinase zymogens,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C2717971:Serine Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0014436:Zymogens [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1441672:Observed [Functional Concept]
   753   C1622131:proteinase [Molecular Function]
   753   C1947941:Proteinase [Enzyme]

Phrase: "chain segments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441635:Segment [Spatial Concept]
   777 E C0205122:Segmental [Spatial Concept]

Phrase: "corresponding to parts of the calcium-binding loop"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C1516144:Calcium Binding [Molecular Function]
   754   C1292711:Part of [Spatial Concept]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0243122:binding [Functional Concept]
   744   C0419518:Loop [Medical Device]
   744   C0445022:Loop [Spatial Concept]
   744   C0449719:parts [Spatial Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1709471:PARTS [Quantitative Concept]
   744   C2936886:Calcium [Pharmacologic Substance]

Phrase: "("

Phrase: "in particular, Ser78-Gln80"

Phrase: ")"

Phrase: ","

Phrase: "autolysis loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "(Asp148-Phe151"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "base-forming segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441635:Segment [Spatial Concept]
   755 E C0205122:Segmental [Spatial Concept]

Phrase: "(Tyr188-Ser190"

Phrase: ")"

Phrase: "are"

Phrase: "flexible."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443220:Flexible [Qualitative Concept]
   928 E C0242808:Flexibility [Qualitative Concept]
Processing 00000000.tx.92: Together with the first 3residues (Lys15-Val17), they have been tentatively traced based on very weak electron density and set to zero occupancy. 

Phrase: "Together with the first 3residues"

Phrase: "(Lys15-Val17"

Phrase: ")"

Phrase: ","

Phrase: "they"

Phrase: "have"

Phrase: "been"

Phrase: "tentatively"

Phrase: "traced"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "based on very weak electron density"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0596488:electron density [Molecular Sequence]
   753   C0004093:Weak [Sign or Symptom]
   753   C0013852:Electron [Quantitative Concept]
   753   C0178587:density [Quantitative Concept]
   753   C0442824:Very [Qualitative Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C1762617:Weak [Qualitative Concept]
   753   C3463986:Electron [Bird]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "set to zero occupancy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0036849:Set [Mental Process]
   770   C0919414:Zero [Quantitative Concept]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]
   770   C2827063:Occupancy [Qualitative Concept]
Processing 00000000.tx.93: All active residues lie within the allowed regions of a Ramachandran plot as determined with PROCHECK (54). 

Phrase: "All active residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "lie within the allowed regions of a Ramachandran plot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0683607:allowed [Social Behavior]
   708   C0017446:Region [Geographic Area]
   708   C0205147:Region [Spatial Concept]

Phrase: "as"

Phrase: "determined with PROCHECK"

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.94: The peptide bond Ile218-Pro219 is in the cis-conformation. 

Phrase: "The peptide bond Ile218-Pro219"

Phrase: "is in the cis-conformation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026377:Conformation [Spatial Concept]
   760   C1504308:Cis [Eukaryote]
Processing 00000000.tx.95: Table I provides a summary of the final refinement statistics. 

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a summary of the final refinement statistics."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1552616:summary [Intellectual Product]
   748   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.96: Miscellaneous-- Structure superimpositions were calculated with TURBO-FRODO (50), LSQKAB of the CCP4 suite (55), and LSQMAN of the RAVE package (Uppsala Software Factory; on the World Wide Web at alpha2.bmc.uu.se/~gerard/manuals). 

Phrase: "Miscellaneous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205395:Miscellaneous [Qualitative Concept]
  1000   C1706184:MISCELLANEOUS [Quantitative Concept]

Phrase: "--"

Phrase: "Structure superimpositions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0429562:Superimposition [Finding]

Phrase: "were"

Phrase: "calculated with TURBO-FRODO"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0444686:Calculated [Functional Concept]
   770   C1187412:Turbo [Eukaryote]
   770   C1425059:FRODO [Gene or Genome]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C2642881:Turbo [Eukaryote]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "LSQKAB of the CCP4 suite"

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "LSQMAN of the RAVE package"

Phrase: "(Uppsala Software Factory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442614:Factory [Manufactured Object]

Phrase: ";"

Phrase: "on the World Wide Web"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0282111:World Wide Web [Manufactured Object]
           Web
   827   C0332464:Wide [Spatial Concept]
   827   C2700280:World [Population Group]

Phrase: "at alpha2.bmc.uu.se/~gerard/manuals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0024763:manuals [Intellectual Product,Manufactured Object]
   766 E C0175674:Manual [Functional Concept]

Phrase: ")."
Processing 00000000.tx.97: Structure and sequence similarity searches were performed with the DALI server at www.ebi.ac.uk/dali (56) and the CE (Combinatorial Extension) server at cl.sdsc.edu/ce.html (57). 

Phrase: "Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "sequence similarity searches"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1552603:search [Intellectual Product]
   793   C1706202:Search [Activity]
   734   C1710052:Sequence Similarity [Quantitative Concept]

Phrase: "were"

Phrase: "performed with the DALI server"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0679792:server [Population Group]
   760   C0884358:Performed [Functional Concept]
   760   C1705194:Server [Manufactured Object]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at www.ebi.ac.uk/dali"

Phrase: "(56"

Phrase: ")"

Phrase: "and"

Phrase: "the CE (Combinatorial Extension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0231448:Extension [Functional Concept]
   827   C1880641:Extension [Conceptual Entity]

Phrase: ")"

Phrase: "server at cl.sdsc.edu/ce.html"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0679792:server [Population Group]
   748   C1705194:Server [Manufactured Object]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.98: Structural classifications are according to SCOP at scop.mrc-lmb.cam.ac.uk/scop. 

Phrase: "Structural classifications"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0008902:Classifications [Classification]
   827 E C0008903:classification [Functional Concept]
   827 E C0678229:classification [Occupational Activity]

Phrase: "are according to SCOP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0680240:according [Social Behavior]
   770   C1538638:SCOP [Gene or Genome]
   770   C1551058:Are [Quantitative Concept]
   770   C3538841:SCOP [Gene or Genome]

Phrase: "at scop.mrc-lmb.cam.ac.uk/scop."
Processing 00000000.tx.99: Figures were prepared with TURBO-FRODO and MOLSCRIPT (58). 

Phrase: "Figures"

Phrase: "were"

Phrase: "prepared with TURBO-FRODO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1187412:Turbo [Eukaryote]
   770   C1425059:FRODO [Gene or Genome]
   770   C2642881:Turbo [Eukaryote]
   737   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "MOLSCRIPT"

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.100: Model quality was assessed with PROCHECK (54). 

Phrase: "Model quality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332306:Quality [Qualitative Concept]

Phrase: "was"

Phrase: "assessed with PROCHECK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516048:Assessed [Activity]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.101: The final coordinates of pro-hK6 have been deposited with the Protein Data Bank (accession code 1gvl).  

Phrase: "The final coordinates of pro-hK6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0427184:coordinates [Finding]
   753   C0700114:coordinates [Functional Concept]
   753   C1707511:Coordinates [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "deposited with the Protein Data Bank"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1705318:Protein Data Bank [Intellectual Product]
   790   C0242356:Data Bank [Intellectual Product]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0333562:deposited [Functional Concept]
   753   C0442598:Bank [Manufactured Object]
   753   C0872261:Bank [Manufactured Object]
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "(accession code 1gvl"

Phrase: ")."
Processing 00000000.tx.102: RESULTS AND DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES Overall Structure-- Pro-hK6 displays a frustum-like shape with approximate overall dimensions of 504530with a larger flat frontal surface (according to the standard orientation; see Fig. 2c) and a smaller parallel surface at the back, where the N and C termini are located. 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   813   C2825142:Experimental Result [Finding]
           Result
   762   C1274040:Result [Functional Concept]
   762   C1546471:Result [Idea or Concept]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Overall Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "--"

Phrase: "Pro-hK6"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a frustum-"

Phrase: "like shape"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332479:Shape [Spatial Concept]
  1000   C0348078:shape [Qualitative Concept]
  1000   C0522512:Shape [Spatial Concept]

Phrase: "with approximate overall dimensions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439534:Dimensions [Quantitative Concept]
   721 E C1707753:Dimensionality [Spatial Concept]

Phrase: "of 504530with"

Phrase: "a larger flat frontal surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205148:Surface [Spatial Concept]

Phrase: "("

Phrase: "according to the standard orientation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0029266:Orientation [Mental Process]
   861   C1704322:orientation [Spatial Concept]
   861   C1704972:Orientation [Spatial Concept]
   861   C3539923:Orientation [Intellectual Product]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 2c"

Phrase: ")"

Phrase: "and"

Phrase: "a smaller parallel surface at the back, where"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0817086:Back surface [Body Location or Region]
   744   C0205148:Surface [Spatial Concept]

Phrase: "the N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C termini"

Phrase: "are"

Phrase: "located."
Processing 00000000.tx.103: It is composed of two hydrophobically interacting domains of about 120residues, the N-terminal one ranging approximately until Leu121 and further including Tyr234-Ala244 at the C terminus, and a C-terminal domain from Pro122 to Arg233, both characteristic for the serine proteinase fold (59, 60). 

Phrase: "It"

Phrase: "is"

Phrase: "composed of two hydrophobically interacting domains of about 120residues,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205448:Two [Quantitative Concept]
   708   C1880389:Domain [Functional Concept]
   708   C1883221:Domain [Conceptual Entity]
   708   C3541951:Domain [Intellectual Product]

Phrase: "the N-terminal one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "ranging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1514721:Range [Quantitative Concept]
   966   C2348147:Range [Quantitative Concept]
   966   C3542016:Range [Intellectual Product]

Phrase: "approximately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332232:Approximately [Qualitative Concept]

Phrase: "until"

Phrase: "Leu121"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Tyr234-Ala244 at the C terminus,"

Phrase: "and"

Phrase: "a C-terminal domain from Pro122"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "to Arg233,"

Phrase: "both characteristic for the serine proteinase fold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521970:Characteristic [Qualitative Concept]

Phrase: "(59,"

Phrase: "60"

Phrase: ")."
Processing 00000000.tx.104: Each domain features a six-stranded antiparallel -barrel, consisting of two intercalating Greek key motifs sharing the two central strands (see Fig. 2c), and an -helix (1 belongs to the C-terminal domain and 2 to the N-terminal one). 

Phrase: "Each domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "a six-stranded antiparallel -barrel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1552933:barrel [Quantitative Concept]
   812   C2700485:Barrel [Qualitative Concept]

Phrase: "consisting of two intercalating Greek key motifs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205448:Two [Quantitative Concept]
   748   C0337806:GREEK [Population Group]
   714   C0332529:CONSIST [Qualitative Concept]
   714   C1514562:Motif [Amino Acid Sequence]

Phrase: "sharing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Sharing [Social Behavior]

Phrase: "the two central strands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1704972:Strand [Spatial Concept]
   793   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 2c"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "an -helix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "belongs to the C-terminal domain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "2 to the N-terminal one"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205088:Terminal [Temporal Concept]
   753   C0205447:One [Quantitative Concept]
   753   C0740116:+2 [Quantitative Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C2827735:2+ [Quantitative Concept]
   753   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.105: Strands 1-6 make up the N-terminal -barrel (-barrel 1), and 7-12 make up the C-terminal one (-barrel 2). 

Phrase: "Strands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "1-6 make up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1881534:Make [Functional Concept]

Phrase: "the N-terminal -barrel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552933:barrel [Quantitative Concept]
   827   C2700485:Barrel [Qualitative Concept]

Phrase: "(-barrel 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552933:barrel [Quantitative Concept]
   861   C2700485:Barrel [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "7-12 make up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1881534:Make [Functional Concept]

Phrase: "the C-terminal one (-barrel 2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C1707271:C-Terminal [Amino Acid Sequence]
   804   C0205088:Terminal [Temporal Concept]
   804   C0205447:One [Quantitative Concept]
   804   C1552933:barrel [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C2700485:Barrel [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.106: The longitudinal axis of -barrel 1is approximately perpendicular to the frontal frustum back surface, whereas -barrel 2is almost parallel. 

Phrase: "The longitudinal axis of -barrel 1is"

Phrase: "approximately perpendicular to the frontal frustum back surface,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1295725:Perpendicular [Spatial Concept]
   744   C3272860:Perpendicular [Conceptual Entity]

Phrase: "whereas -"

Phrase: "barrel 2is almost parallel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2348042:Parallel [Qualitative Concept]
   812   C2826345:PARALLEL [Research Activity]
Processing 00000000.tx.107: At the interface between the barrels on the frontal surface, a shallow depression marks the active site cleft (see below). 

Phrase: "At the interface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708533:Interface [Manufactured Object]
  1000   C2698172:Interface [Intellectual Product]

Phrase: "between the barrels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552933:barrel [Quantitative Concept]
   966   C2700485:Barrel [Qualitative Concept]

Phrase: "on the frontal surface,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205148:Surface [Spatial Concept]

Phrase: "a shallow depression"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0011570:Depression [Mental or Behavioral Dysfunction]
   861   C0011581:Depression [Mental or Behavioral Dysfunction]
   861   C0344315:Depression [Finding]
   861   C0349217:depression nos [Mental or Behavioral Dysfunction]
   861   C0460137:Depression [Functional Concept]
   789 E C0549249:DEPRESSED [Finding]

Phrase: "marks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "the active site cleft"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205242:Cleft [Spatial Concept]
   734   C0205681:Active Site [Functional Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.108: The polypeptide chain is covalently cross-linked by six disulfide bridges (SS1-SS6; see Figs. 1 and 2c). 

Phrase: "The polypeptide chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "is"

Phrase: "covalently"

Phrase: "cross-linked by six disulfide bridges"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0178576:Cross Linked [Natural Phenomenon or Process]
   790   C0332220:cross linked [Functional Concept]
   753   C0012771:disulfide [Chemical Viewed Structurally]
   753   C0205452:Six [Quantitative Concept]
   753   C0456378:bridges [Medical Device]
   753   C2828360:Cross [Conceptual Entity]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "(SS1-SS6"

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Figs. 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "2c"

Phrase: ")."
Processing 00000000.tx.109: SS1 anchors the N-terminal segment to the C-terminal domain (at 8), and SS2 connects strand 2 with loop 34, harboring one of the catalytic residues, His57 (see below), and encompassing a single helical turn between Ala55 and Cys58. 

Phrase: "SS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2697310:SS1 [Finding]

Phrase: "anchors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293132:anchor [Therapeutic or Preventive Procedure]

Phrase: "the N-terminal segment to the C-terminal domain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0441635:Segment [Spatial Concept]

Phrase: "("

Phrase: "at 8"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "SS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2676468:SS2 [Finding]

Phrase: "connects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986575:Connect [Activity]

Phrase: "strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "2 with loop 34,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0419518:Loop [Medical Device]
   770   C0445022:Loop [Spatial Concept]
   770   C0740116:+2 [Quantitative Concept]
   770   C2827735:2+ [Quantitative Concept]
   770   C2981700:2+ [Classification]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "one of the catalytic residues,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "His57"

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "encompassing"

Phrase: "a single helical turn between Ala55"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0541749:turn [Finding]
   753   C1709743:Turn [Spatial Concept]

Phrase: "and"

Phrase: "Cys58."
Processing 00000000.tx.110: SS3-SS6 are located in the C-terminal domain. 

Phrase: "SS3-SS6"

Phrase: "are"

Phrase: "located in the C-terminal domain."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.111: In particular, SS3 anchors loop 122 to the segment connecting both domains on the back surface, SS5 fixes 1 to the flank of the -barrel moiety and SS6 links the activation segment undergoing major conformational changes upon activation (see below) with the top of the C-terminal barrel. 

Phrase: "In particular, SS3 anchors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1293132:anchors [Therapeutic or Preventive Procedure]

Phrase: "loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "122 to the segment connecting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441635:Segment [Spatial Concept]
   726   C2986575:Connect [Activity]

Phrase: "both domains on the back surface,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "SS5 fixes 1 to the flank of the -barrel moiety"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0230171:Flank [Body Location or Region]
   739   C1552933:barrel [Quantitative Concept]
   739   C2700485:Barrel [Qualitative Concept]
   706   C0231441:Fix [Finding]

Phrase: "and"

Phrase: "SS6"

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "the activation segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441635:Segment [Spatial Concept]
   789 E C0205122:Segmental [Spatial Concept]

Phrase: "undergoing"

Phrase: "major conformational changes upon activation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0301641:Conformational change [Molecular Function]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: "with the top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "of the C-terminal barrel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1552933:barrel [Quantitative Concept]
   827   C2700485:Barrel [Qualitative Concept]
   734   C1707271:C-Terminal [Amino Acid Sequence]
Processing 00000000.tx.112: View larger version (79K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(79K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.113: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.114: Primary and secondary structures of pro-hK6. 

Phrase: "Primary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205225:Primary [Qualitative Concept]
  1000   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "secondary structures of pro-hK6."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C0162807:Secondary Structure [Spatial Concept]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C0678594:structures [Spatial Concept]
Processing 00000000.tx.115: Shown is a structure-based sequence alignment of members of the kallikrein family of known three-dimensional structure, together with PSA and trypsinogen. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "a structure-based sequence alignment of members of the kallikrein family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0080143:Sequence Alignment [Molecular Biology Research Technique]
   738   C1706765:Alignment [Quantitative Concept]

Phrase: "of known three-dimensional structure,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0450363:3-Dimensional [Spatial Concept]
   812   C0205449:Three [Quantitative Concept]
   812   C0678594:Structure [Spatial Concept]
   741   C0439534:Dimension [Quantitative Concept]
   741   C1707753:Dimensionality [Spatial Concept]

Phrase: "together with PSA"

Phrase: "and"

Phrase: "trypsinogen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041243:Trypsinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.116: Displayed are the zymogen forms (pre and/or pro sequences are boxed) of hK6 (this work; SwissProt/TrEMBL (SP) sequence access code Q92876; kallikrein family ascription number KLK6 (3, 5)), mouse-brain neuropsin (PDB accession code 1npm; SP Q61955; KLK8 (32)), mouse glandular kallikrein 13(PDB 1ao5; 

Phrase: "Displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "are"

Phrase: "the zymogen forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "(pre"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332152:Pre [Temporal Concept]
  1000   C0740175:Pre [Qualitative Concept]
  1000   C2257086:PRE [Genetic Function]

Phrase: "and/or"

Phrase: "pro sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   861   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0162326:Sequences [Nucleotide Sequence]
   861   C2987124:PRO [Intellectual Product]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "boxed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179400:Box [Manufactured Object]
   966   C1533124:Box [Medical Device]

Phrase: ")"

Phrase: "of hK6"

Phrase: "("

Phrase: "this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "; SwissProt/TrEMBL"

Phrase: "(SP)"

Phrase: "sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "access code Q92876"

Phrase: "; kallikrein family ascription number KLK6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1416669:Klk6 [Gene or Genome]
   804   C1416677:KLK6 [Gene or Genome]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "mouse-brain neuropsin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0757902:neuropsin, mouse [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1416679:neuropsin [Gene or Genome]
   827   C1426589:NEUROPSIN [Gene or Genome]
   734   C1521713:Mouse Brain [Tissue]

Phrase: "(PDB accession code 1npm"

Phrase: "; SP Q61955"

Phrase: "; KLK8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416679:KLK8 [Gene or Genome]

Phrase: "(32"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "mouse glandular kallikrein 13"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C1453895:kallikrein 13, mouse [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0076726:Glandular Kallikrein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0084194:kallikrein-13 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0618743:Kallikrein, Glandular [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1334308:KALLIKREIN, GLANDULAR [Gene or Genome]
   861   C1416673:KALLIKREIN 13 [Gene or Genome]
   812   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]
   812   C0225353:Glandular [Qualitative Concept]
   812   C1285092:Glandular [Body Part, Organ, or Organ Component]

Phrase: "(PDB 1ao5"

Phrase: ";"
Processing 00000000.tx.117: SP P36368; 

Phrase: "SP P36368"

Phrase: ";"
Processing 00000000.tx.118: KLK13 (10)), rat glandular tonin (PDB 1ton; SP P00759; KLK2 (9)), mouse neuronal 7S -nerve growth factor (PDB 1sgf; SP P00756; KLK3 (77)), human PSA (SP P07288; KLK3), and bovine pancreatic trypsin (PDB 1tgb; SP P00760 (78)). 

Phrase: "KLK13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416673:KLK13 [Gene or Genome]

Phrase: "(10"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "rat glandular tonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0087052:tonin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(PDB 1ton"

Phrase: "; SP P00759"

Phrase: "; KLK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0618743:KLK2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334308:KLK2 [Gene or Genome]

Phrase: "(9"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "mouse neuronal 7S -nerve growth factor"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   861   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   858   C0814002:Neuronal Growth [Cell Function,Organism Function]
           Neural Growth
   858   C1514123:Mouse Nerve [Tissue]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0027740:Nerve [Tissue]
   799   C0027757:NERVE [Tissue]
   799   C0220844:growth [Physiologic Function]
   799   C1280541:Nerve [Body Part, Organ, or Organ Component]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0599851:Neural [Functional Concept]
   727 E C0027769:nervy [Sign or Symptom]

Phrase: "(PDB 1sgf"

Phrase: "; SP P00756"

Phrase: "; KLK3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0138741:KLK3 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1366489:KLK3 [Gene or Genome]
  1000   C2987230:KLK3 [Gene or Genome]

Phrase: "(77"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "human PSA (SP P07288"

Phrase: "; KLK3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0138741:KLK3 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1366489:KLK3 [Gene or Genome]
  1000   C2987230:KLK3 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "bovine pancreatic trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(PDB 1tgb"

Phrase: "; SP P00760"

Phrase: "(78"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.119: The sequence of mature porcine pancreatic kallikrein A (PDB 2pka; SP P00752; KLK1 (67)), for which the sequence upstream of the activation cleavage site has not been reported, is also shown. 

Phrase: "The sequence of mature porcine pancreatic kallikrein A (PDB 2pka"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C1519249:Sequence [Functional Concept]

Phrase: "; SP P00752"

Phrase: "; KLK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416669:KLK1 [Gene or Genome]

Phrase: "(67"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "for which"

Phrase: "the sequence upstream of the activation cleavage site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C1519249:Sequence [Functional Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "is"

Phrase: "also"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.120: This protein has been chemically sequenced, so that B in the sequence stands for aspartate/asparagine. 

Phrase: "This protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "chemically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220806:Chemically [Chemical]

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: ","

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that B in the sequence stands"

Phrase: "for aspartate/asparagine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003995:Asparagine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.121: The sequential pro-hK6 numbering is shown at the bottom, and the chymotrypsinogen-based numbering (18), used throughout, is on top. 

Phrase: "The sequential pro-hK6 numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0449788:numbering [Quantitative Concept]
   779 E C0237753:*Number [Quantitative Concept]

Phrase: "is"

Phrase: "shown at the bottom,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511276:Bottom [Spatial Concept]
   770   C1552825:bottom [Idea or Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "the chymotrypsinogen-based numbering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C2981742:Base Number [Conceptual Entity]
   827   C0449788:numbering [Quantitative Concept]
   793 E C0237753:*Number [Quantitative Concept]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "throughout,"

Phrase: "is on top."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704458:Top [Spatial Concept]
Processing 00000000.tx.122: The three introduced amino acid substitutions (Q13R/R76Q/N132Q) in this sequence are shown in boldface type. 

Phrase: "The three introduced amino acid substitutions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   771   C1555721:Substitution [Idea or Concept]
   771   C1706204:Substitution [Activity]

Phrase: "(Q13R/R76Q/N132Q"

Phrase: ")"

Phrase: "in this sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "shown in boldface type."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.123: Regular secondary structure elements correspond to pro-hK6; 

Phrase: "Regular secondary structure elements"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0162807:Secondary Structure [Spatial Concept]
   812   C0013879:Elements [Element, Ion, or Isotope]
   812   C0027627:secondary [Neoplastic Process]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]
   812   C0678594:Structure [Spatial Concept]
   779 E C1705248:Element [Conceptual Entity]

Phrase: "correspond to pro-hK6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2987124:PRO [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.124: the arrows represent -strands, and rods represent -helices. 

Phrase: "the arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "represent -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "strands,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1704972:Strand [Spatial Concept]
   966   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "rods"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0206427:Rods [Cell]
   966 E C1552915:rod [Quantitative Concept]
   966 E C1705186:Rod [Medical Device]
   966 E C1947942:Rod [Spatial Concept]
   966 E C2347970:rod [Quantitative Concept]
   966 E C2347971:rod [Quantitative Concept]

Phrase: "represent -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "helices."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1017315:helices [Eukaryote]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]
Processing 00000000.tx.125: The cysteine residues engaged in the formation of up to six disulfide bonds are boxed and marked with labels (SS1-SS6). 

Phrase: "The cysteine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "engaged in the formation of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0220781:formation [Biologic Function]
   760   C0425152:Engaged [Finding]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "up to six disulfide bonds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C1511997:Disulfide Bond [Amino Acid Sequence]
   827   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "are"

Phrase: "boxed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179400:Box [Manufactured Object]
   966   C1533124:Box [Medical Device]

Phrase: "and"

Phrase: "marked with labels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0181496:labels [Manufactured Object]
   790   C0522501:Marked [Qualitative Concept]
   790   C1706089:Marked [Qualitative Concept]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(SS1-SS6"

Phrase: ")."
Processing 00000000.tx.126: The 29"invariant" residues (70) in serine proteinases and the residue in the bottom of the S1 specificity pocket are shown with a gray background, characteristic residues for kallikreins (67) appear with a rhombus, the N-glycosylation site of hK6 is shown with a square, and the limited proteolysis activation site is indicated by vertical scissors. 

Phrase: "The 29""invariant"" residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "(70"

Phrase: ")"

Phrase: "in serine proteinases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C2717971:Serine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "and"

Phrase: "the residue in the bottom of the S1 specificity pocket"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1709915:Residue [Conceptual Entity]
   739   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "are"

Phrase: "shown with a gray background,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0556636:gray [Quantitative Concept]
   760   C1269776:Gray [Qualitative Concept]
   760   C1706907:Background [Conceptual Entity]
   726   C1547282:Show [Intellectual Product]

Phrase: "characteristic residues for kallikreins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(67"

Phrase: ")"

Phrase: "appear with a rhombus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0700364:APPEAR [Qualitative Concept]

Phrase: "the N-glycosylation site of hK6"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C2945843:Site of [Qualitative Concept]
   753   C0017982:glycosylation [Natural Phenomenon or Process]
   753   C0205145:Site [Spatial Concept]
   753   C0376322:Glycosylation [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "shown with a square,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205120:Square [Spatial Concept]
   770   C1552595:Square [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "the limited proteolysis activation site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "indicated by vertical scissors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0175735:Scissors [Medical Device]
   770   C0205128:Vertical [Spatial Concept]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.127: According to the chymotrypsinogen numbering, this cleavage occurs between residues Arg/Lys15 and Ile/Leu/Val16. 

Phrase: "According to the chymotrypsinogen numbering,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449788:numbering [Quantitative Concept]
   827 E C0237753:*Number [Quantitative Concept]

Phrase: "this cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "occurs between residues Arg/Lys15"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "Ile/Leu/Val16."
Processing 00000000.tx.128: View larger version (91K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(91K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.130: Structure solution and pro-hK6 topology. a, stereo schematic diagram displaying the A-weighted 2mFoDFc electron density map obtained after ARP/wARP refinement, superimposed with the model used for initial phasing, contoured at 1above average. b, same as a, with the final refined model superimposed. c, stereo ribbon plot of pro-hK6 shown in the traditional serine proteinase standard orientation (79) (i.e. looking into the active site cleft) with a bound substrate running from the left (nonprimed subsites prior to the scissile peptide bond; Ref. 64) to right (primed subsites). 

Phrase: "Structure solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "pro-hK6 topology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002812:Topology [Biomedical Occupation or Discipline]

Phrase: "a,"

Phrase: "stereo schematic diagram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681494:Diagram [Intellectual Product]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "the A-weighted 2mFoDFc electron density map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0024779:Map [Manufactured Object]
   799   C1706473:Map [Conceptual Entity]

Phrase: "obtained after ARP/wARP refinement,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1301820:Obtained [Functional Concept]
   760   C1823652:WARP [Gene or Genome]
   726 E C1706701:Obtain [Activity]

Phrase: "superimposed with the model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "used for initial phasing,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0205265:Initial [Temporal Concept]
   770   C1273517:used [Finding]
   770   C1279901:Initial [Qualitative Concept]
   770   C1555582:Initial [Idea or Concept]
   770   C1705685:INITIAL [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737   C0205390:Phase [Temporal Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "contoured at 1above average. b,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0302821:contoured [Inorganic Chemical]
   760   C0876954:contoured [Spatial Concept]
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]

Phrase: "same as a,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C1278655:SAME AS [Classification]
   790   C0445247:Same [Qualitative Concept]

Phrase: "with the final refined model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "superimposed. c,"

Phrase: "stereo ribbon plot of pro-hK6"

Phrase: "shown in the traditional serine proteinase standard orientation"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C2717971:Serine Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0029266:Orientation [Mental Process]
   744   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0443324:Traditional [Functional Concept]
   744   C1442989:Standard [Qualitative Concept]
   744   C1548559:Traditional [Idea or Concept]
   744   C1622131:proteinase [Molecular Function]
   744   C1704322:orientation [Spatial Concept]
   744   C1704972:Orientation [Spatial Concept]
   744   C1947941:Proteinase [Enzyme]
   744   C2828392:Standard [Intellectual Product]
   744   C3539923:Orientation [Intellectual Product]
   711   C1547282:Show [Intellectual Product]

Phrase: "(79"

Phrase: ")"

Phrase: "(i.e. looking into the active site cleft"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0233426:look [Organism Attribute]

Phrase: ")"

Phrase: "with a bound substrate running"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035953:Running [Daily or Recreational Activity]
   827   C2346414:Running [Finding]

Phrase: "from the left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "(nonprimed subsites prior to the scissile peptide bond"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1710234:Subsite [Spatial Concept]

Phrase: "; Ref. 64"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "to right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "(primed subsites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710234:Subsite [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.131: The regular secondary structure elements are displayed as arrows (-strands) and ribbons (-helices) and labeled (1-12 and 1-2). 

Phrase: "The regular secondary structure elements"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0162807:Secondary Structure [Spatial Concept]
   812   C0013879:Elements [Element, Ion, or Isotope]
   812   C0027627:secondary [Neoplastic Process]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]
   812   C0678594:Structure [Spatial Concept]
   779 E C1705248:Element [Conceptual Entity]

Phrase: "are"

Phrase: "displayed as arrows"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C0870432:displayed [Functional Concept]
   756 E C1705417:Display [Manufactured Object]

Phrase: "(-strands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1704972:Strand [Spatial Concept]
   966   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "and"

Phrase: "ribbons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709956:Ribbon [Medical Device]
   966   C3541837:ribbon [Cell Component]

Phrase: "(-helices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1017315:helices [Eukaryote]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]

Phrase: ")"

Phrase: "and"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(1-12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "1-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.132: The side chains of the residues of the catalytic triad (light gray) and the six disulfide bonds (dark gray; SS1-SS6) are also shown as stick models and labeled. 

Phrase: "The side chains of the residues of the catalytic triad"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0337112:chains [Manufactured Object]
   739   C0441987:Side [Spatial Concept]
   739   C1524075:Chains [Idea or Concept]

Phrase: "(light gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0556636:gray [Quantitative Concept]
   861   C1269776:Gray [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the six disulfide bonds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C1511997:Disulfide Bond [Amino Acid Sequence]
   827   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "(dark gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0556636:gray [Quantitative Concept]
   861   C1269776:Gray [Qualitative Concept]

Phrase: "; SS1-SS6"

Phrase: ")"

Phrase: "are"

Phrase: "also"

Phrase: "shown as stick models"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1706582:Stick [Biomedical or Dental Material]
   770   C1706583:Stick [Quantitative Concept]
   770   C3161035:Models [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "labeled."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.133: The N and C termini and the positions of characteristic structural loops are also indicated, and poorly defined and undefined main-chain stretches (see "Experimental Procedures") are shown as dark gray coils. 

Phrase: "The N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C termini"

Phrase: "and"

Phrase: "the positions of characteristic structural loops"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:positions [Spatial Concept]

Phrase: "are"

Phrase: "also"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "and"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "and"

Phrase: "undefined main-chain stretches"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0270814:Stretches [Disease or Syndrome]
   779 E C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")"

Phrase: "are"

Phrase: "shown as dark gray coils."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0332582:Dark [Qualitative Concept]
   760   C0444764:Coils [Spatial Concept]
   760   C0556636:gray [Quantitative Concept]
   760   C1269776:Gray [Qualitative Concept]
   760   C1705945:COILS [Intellectual Product]
   726 E C1413568:COIL [Gene or Genome]
   726   C1547282:Show [Intellectual Product]
   726 E C1705946:Coil [Medical Device]
Processing 00000000.tx.134: The N-terminal segment on the surface protrudes from the molecular body (see Fig. 2c) at the back frustum surface and is only visible in electron density due to inter-main-chain interactions between Lys15-Val17 and His91-Pro92 of a symmetry-related molecule, as observed in the structure of proprotease E (61). 

Phrase: "The N-terminal segment on the surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0441635:Segment [Spatial Concept]

Phrase: "protrudes from the molecular body"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 2c"

Phrase: ")"

Phrase: "at the back frustum surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0817086:Back surface [Body Location or Region]
   827   C0205148:Surface [Spatial Concept]

Phrase: "and"

Phrase: "is"

Phrase: "only visible in electron density"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205379:Visible [Qualitative Concept]

Phrase: "due to"

Phrase: "inter-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205103:Inter- [Spatial Concept]
  1000   C1548610:Inter [Temporal Concept]

Phrase: "main-chain interactions between Lys15-Val17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "His91-Pro92 of a symmetry-related molecule,"

Phrase: "as"

Phrase: "observed in the structure of proprotease E (61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0678594:Structure [Spatial Concept]
   744   C1441672:Observed [Functional Concept]

Phrase: ")."
Processing 00000000.tx.135: The main chain enters the molecular body at His27, leading to the first strand of -barrel 1.

Phrase: "The main chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "the molecular body at His27,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "leading to the first strand of -barrel 1."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   744   C0205435:First [Quantitative Concept]
   744   C0332152:Leading [Temporal Concept]
   744   C1279901:First [Qualitative Concept]
   744   C1522538:Leading [Functional Concept]
   744   C1552933:barrel [Quantitative Concept]
   744   C1704972:Strand [Spatial Concept]
   744   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C2700485:Barrel [Qualitative Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.136: Embedded between 4 and 5 of this barrel and similarly to other known serine proteinases, a surface-exposed cation-lacking calcium-binding loop (62) Lys70-Gln80 is placed, folded back on top of its flanking strands 4 and 5 and approaching loop 12. 

Phrase: "Embedded between 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707903:Embedded [Laboratory Procedure]

Phrase: "and"

Phrase: "5 of this barrel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439084:>5 [Quantitative Concept]
   770   C0728893:+5 [Quantitative Concept]
   770   C1552933:barrel [Quantitative Concept]
   770   C2700485:Barrel [Qualitative Concept]

Phrase: "and"

Phrase: "similarly to other known serine proteinases,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C2717971:Serine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0205309:Known [Qualitative Concept]
   719 E C1622131:proteinase [Molecular Function]
   719 E C1947941:Proteinase [Enzyme]

Phrase: "a surface-exposed cation-lacking calcium-binding loop"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   845   C1523815:cation binding [Molecular Function]
   818   C1516144:Calcium Binding [Molecular Function]
   795   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   795   C0006726:Calcium [Inorganic Chemical]
   795   C0243122:binding [Functional Concept]
   795   C0419518:Loop [Medical Device]
   795   C0445022:Loop [Spatial Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(62"

Phrase: ")"

Phrase: "Lys70-Gln80"

Phrase: "is"

Phrase: "placed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0442504:Place [Spatial Concept]
   966   C1704765:Place [Functional Concept]
   966   C1882509:Place [Activity]
   966   C3496241:place [Disease or Syndrome]

Phrase: ","

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "back on top of its flanking strands 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0205095:Back of [Spatial Concept]
           Back
   744   C0004600:Back [Body Location or Region]
   744   C0460009:Back [Body Location or Region]
   744   C1995000:Back [Body Location or Region]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "approaching loop 12."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   827   C0449445:approaching [Spatial Concept]
Processing 00000000.tx.137: The tip of Lys70 occupies the approximate position of a calcium ion in trypsin, which displays metal-coordinating glutamate residues at positions 70and 80(see Fig. 

Phrase: "The tip of Lys70"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1710425:Tip [Medical Device]
   770   C3282898:Tip [Qualitative Concept]

Phrase: "occupies"

Phrase: "the approximate position of a calcium ion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0733755:Position [Spatial Concept]

Phrase: "in trypsin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "which"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "metal-coordinating glutamate residues at positions 70and 80"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.138: 1). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.139: This loop is fully ordered, except for the central residues Ser78-Gln80, which are flexible. 

Phrase: "This loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "is"

Phrase: "fully"

Phrase: "ordered"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1705176:Ordered [Qualitative Concept]
  1000   C1705178:Ordered [Activity]
   966 E C1705175:Order [Intellectual Product]
   966 E C1705177:Order [Classification]
   966 E C1882348:Order [Qualitative Concept]

Phrase: ","

Phrase: "except for the central residues Ser78-Gln80,"

Phrase: "which"

Phrase: "are"

Phrase: "flexible."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443220:Flexible [Qualitative Concept]
   928 E C0242808:Flexibility [Qualitative Concept]
Processing 00000000.tx.140: In this region, at the lower right part of the molecule (see Fig. 2c), an autolysis-sensitive point is located after Arg76, which when processed leads to an inactive species. 

Phrase: "In this region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "at the lower right part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449719:Part [Spatial Concept]
   827   C1709471:Part [Quantitative Concept]

Phrase: "of the molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 2c"

Phrase: ")"

Phrase: ","

Phrase: "an autolysis-sensitive point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "is"

Phrase: "located after Arg76,"

Phrase: "which"

Phrase: "when"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "leads to an inactive species."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0205254:Inactive [Qualitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1705920:Species [Conceptual Entity]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.141: This cleavage was observed during the purification of the protein and may have (auto)regulatory functions as observed in chymotrypsinogen, which is cut during activation at its autolysis loop beside the primary activation point (63). 

Phrase: "This cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "observed during the purification of the protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0597301:protein purification [Laboratory Procedure]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243114:purification [Functional Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "may"

Phrase: "have"

Phrase: "(auto)regulatory functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]

Phrase: "as"

Phrase: "observed in chymotrypsinogen,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008746:Chymotrypsinogen [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1441672:Observed [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "cut during activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0000925:Cut [Injury or Poisoning]
   790   C1879547:Activation [Activity]
   790   C1883724:CUT [Phenomenon or Process]

Phrase: "at its autolysis loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "beside the primary activation point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.142: In order to obtain stable, proteolytically unprocessed protein, this residue was mutated to glutamine in the present study (see "Experimental Procedures" and Fig. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "stable, proteolytically unprocessed protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "this residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "was"

Phrase: "mutated to glutamine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "in the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.143: 1). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.144: After leaving -barrel 1,a 26-residue linker (Ala109-Thr134) running across the smaller back frustum surface leads to -barrel 2.

Phrase: "After leaving -barrel 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552933:barrel [Quantitative Concept]
   827   C2700485:Barrel [Qualitative Concept]

Phrase: "a 26-residue linker"

Phrase: "(Ala109-Thr134"

Phrase: ")"

Phrase: "running across the smaller back frustum surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035953:Running [Daily or Recreational Activity]
   748   C2346414:Running [Finding]

Phrase: "leads"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C0181586:leads [Medical Device]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to -barrel 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1552933:barrel [Quantitative Concept]
   827   C1883351:To [Qualitative Concept]
   827   C2700485:Barrel [Qualitative Concept]
Processing 00000000.tx.145: Before entering its first strand, however, the main chain describes a wide loop, passing over -hairpin 1011 and harboring at position Asn132 (mutated to glutamine in the present study) an N-glycosylation site that accounts for additional 9kDa in the molecular mass of the native protein (16). 

Phrase: "Before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "entering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522196:ENTER [Functional Concept]

Phrase: "its first strand,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704972:Strand [Spatial Concept]
   861   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "however,"

Phrase: "the main chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "describes"

Phrase: "a wide loop,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "passing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828386:Pass [Finding]

Phrase: "over -hairpin 1011"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205136:Over [Spatial Concept]
   827   C0450317:1011 [Intellectual Product]

Phrase: "and"

Phrase: "harboring at position Asn132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0475311:Harbor [Manufactured Object]

Phrase: "("

Phrase: "mutated to glutamine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "in the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "an N-glycosylation site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1513806:N-Glycosylation Site [Amino Acid Sequence]
   827   C0017982:glycosylation [Natural Phenomenon or Process]
   827   C0205145:Site [Spatial Concept]
   827   C0376322:Glycosylation [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "that accounts for additional 9kDa"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1551359:account [Idea or Concept]
   726   C2741673:Account # [Clinical Attribute]
   726   C2981730:Account [Classification]

Phrase: "in the molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]

Phrase: "of the native protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0302891:Native [Functional Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.146: After the first strand of -barrel 2and spatially adjacent to the calcium-binding loop, in the middle lower part of the molecule (Fig. 2c), the surface-located autolysis loop, so called again by similarity with other known serine proteinases, is found, running from Gly142 to Asp153. 

Phrase: "After the first strand of -barrel 2and"

Phrase: "spatially adjacent to the calcium-binding loop,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "in the middle lower part"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   885   C0442056:Medial part [Spatial Concept]
   827   C0441994:Lower [Spatial Concept]
   827   C0449719:Part [Spatial Concept]
   827   C1548802:Lower [Body Location or Region]
   827   C1709471:Part [Quantitative Concept]
   827   C2003888:Lower [Activity]
   793 E C0205251:low [Qualitative Concept]
   793 E C1299352:Low [Qualitative Concept]
   793 E C1550472:low [Idea or Concept]

Phrase: "of the molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "(Fig. 2c"

Phrase: ")"

Phrase: ","

Phrase: "the surface-located autolysis loop,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]

Phrase: "so called again by similarity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037640:SO [Geographic Area]
   760   C2348205:Similarity [Qualitative Concept]
   726   C0679006:Call [Mental Process]
   726   C1947967:Call [Functional Concept]

Phrase: "with other known serine proteinases,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C2717971:Serine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   793 E C1622131:proteinase [Molecular Function]
   793 E C1947941:Proteinase [Enzyme]

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: ","

Phrase: "running from Gly142"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0035953:Running [Daily or Recreational Activity]
   790   C2346414:Running [Finding]
   756 E C0600140:run [Finding]
   756 E C1704688:Run [Functional Concept]

Phrase: "to Asp153."
Processing 00000000.tx.147: This loop is also fully defined, except for the central three residues Asp148-Phe151 (note that the experimentally determined autolysis-sensitive point is not in the autolysis loop in pro-hK6). 

Phrase: "This loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "is"

Phrase: "also fully"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: ","

Phrase: "except for the central three residues Asp148-Phe151"

Phrase: "("

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the experimentally determined autolysis-sensitive point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1552961:Point [Quantitative Concept]
   804   C2347617:point [Quantitative Concept]

Phrase: "is"

Phrase: "not in the autolysis loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004372:Autolysis [Pathologic Function]
   760   C0419518:Loop [Medical Device]
   760   C0445022:Loop [Spatial Concept]
   760   C1518422:Not [Functional Concept]

Phrase: "in pro-hK6"

Phrase: ")."
Processing 00000000.tx.148: The main chain then enters strand 8, and at its exit site, again on the molecular surface, it features helix 1 (Ser164-Tyr172), which, after passing through 9, enters the active site and substrate-binding site base-forming segment Asp189-Ser195. 

Phrase: "The main chain then"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "strand 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704972:Strand [Spatial Concept]
   861   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and at its exit site,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0449669:exit site [Spatial Concept]
   760   C0205145:Site [Spatial Concept]
   760   C0337094:Exit [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C1515981:And [Idea or Concept]
   760   C1550550:exit [Temporal Concept]
   760   C2825164:Site [Spatial Concept]

Phrase: "again on the molecular surface,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205148:Surface [Spatial Concept]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: "it"

Phrase: "features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "helix 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "(Ser164-Tyr172"

Phrase: ")"

Phrase: ","

Phrase: "which,"

Phrase: "after"

Phrase: "passing through 9,"

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "the active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "substrate-binding site base-forming segment Asp189-Ser195."
Processing 00000000.tx.149: This segment harbors the connecting disulfide bridge SS6 and is flexible from Tyr188 to Ser190. 

Phrase: "This segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441635:Segment [Spatial Concept]
   928 E C0205122:Segmental [Spatial Concept]

Phrase: "harbors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "the connecting disulfide bridge SS6"

Phrase: "and"

Phrase: "is"

Phrase: "flexible from Tyr188"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0443220:Flexible [Qualitative Concept]
   718 E C0242808:Flexibility [Qualitative Concept]

Phrase: "to Ser190."
Processing 00000000.tx.150: After hairpin 1011 of the barrel, the main chain enters section Gly216-Tyr228, including the entrance frame-forming segment Val213-Cys220 and the back-forming region Gly226-Tyr228. 

Phrase: "After hairpin 1011"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450317:1011 [Intellectual Product]

Phrase: "of the barrel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552933:barrel [Quantitative Concept]
  1000   C2700485:Barrel [Qualitative Concept]

Phrase: "the main chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: "Gly216-Tyr228,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the entrance frame-forming segment Val213-Cys220"

Phrase: "and"

Phrase: "the back-forming region Gly226-Tyr228."
Processing 00000000.tx.151: It is located on the front surface and anchored via SS6 to the previously mentioned base-forming segment. 

Phrase: "It"

Phrase: "is"

Phrase: "located on the front surface"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205094:front [Spatial Concept]
   760   C0205148:Surface [Spatial Concept]
   760   C0836835:Forehead surface [Body Location or Region]

Phrase: "and"

Phrase: "anchored via SS6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1293132:anchored [Therapeutic or Preventive Procedure]

Phrase: "to the previously mentioned base-forming segment."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0441635:Segment [Spatial Concept]
   733 E C0205122:Segmental [Spatial Concept]
Processing 00000000.tx.152: This region is involved in shaping the S1 pocket (see below). 

Phrase: "This region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "involved in shaping"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332479:shaping [Spatial Concept]
   790   C0522512:shaping [Spatial Concept]
   790   C1314939:Involved [Functional Concept]
   756 E C0348078:shape [Qualitative Concept]

Phrase: "the S1 pocket"

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.153: Following this and after passing through strand 12, the main chain runs over -barrel 1,reaching the opposite surface and the C terminus in the form of helix 2, which packs against the strands of the second Greek key motif of -barrel 1. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "this"

Phrase: "and after passing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "through strand 12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704972:Strand [Spatial Concept]
   861   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the main chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "runs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:Runs [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "over -barrel 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205136:Over [Spatial Concept]
   827   C1552933:barrel [Quantitative Concept]
   827   C2700485:Barrel [Qualitative Concept]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "the opposite surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205148:Surface [Spatial Concept]

Phrase: "and"

Phrase: "the C terminus in the form of helix 2,"

Phrase: "which"

Phrase: "packs against the strands"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1968515:Pack [Medical Device]
   770   C2825051:Pack [Drug Delivery Device]
   770   C2828395:Pack [Activity]
   737   C1704972:Strand [Spatial Concept]
   737   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the second Greek key motif of -barrel 1."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   795   C0205436:Second [Quantitative Concept]
   795   C0337806:GREEK [Population Group]
   795   C0457385:Second [Temporal Concept]
   795   C0565930:/second [Quantitative Concept]
   795   C1514562:Motif [Amino Acid Sequence]
   795   C1552933:barrel [Quantitative Concept]
   795   C1561503:second [Idea or Concept]
   795   C1705190:Second [Qualitative Concept]
   795   C2700485:Barrel [Qualitative Concept]
   724 E C0027627:secondary [Neoplastic Process]
   724 E C0175668:Secondary [Temporal Concept]
Processing 00000000.tx.154: Active Site Cleft and Specificity Pocket of Pro-hK6-- The essential residues shaping the active site and the specificity pocket (S1 site (64)) are provided by the loops connecting the third and fourth and the fifth and sixth -strands of each barrel on the frustum front. 

Phrase: "Active Site Cleft"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205242:Cleft [Spatial Concept]
   734   C0205681:Active Site [Functional Concept]

Phrase: "and"

Phrase: "Specificity Pocket of Pro-hK6"

Phrase: "-"

Phrase: "-"

Phrase: "The essential residues shaping"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332479:shaping [Spatial Concept]
   827   C0522512:shaping [Spatial Concept]
   793 E C0348078:shape [Qualitative Concept]

Phrase: "the active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "the specificity pocket"

Phrase: "(S1 site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(64"

Phrase: ")"

Phrase: ")"

Phrase: "are"

Phrase: "provided by the loops"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0181687:loops [Medical Device]
   770   C1999230:Provided [Activity]
   737 E C0419518:Loop [Medical Device]
   737 E C0445022:Loop [Spatial Concept]

Phrase: "connecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986575:Connect [Activity]

Phrase: "the third"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "and"

Phrase: "fourth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205438:Fourth [Quantitative Concept]
  1000   C1706303:Fourth [Qualitative Concept]

Phrase: "and"

Phrase: "the fifth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205439:Fifth [Quantitative Concept]

Phrase: "and"

Phrase: "sixth -strands of each barrel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1704972:Strand [Spatial Concept]
   726   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "on the frustum front."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205094:front [Spatial Concept]
   789 E C0205123:Frontal [Spatial Concept]
   768 E C0016540:Forehead [Body Location or Region]
Processing 00000000.tx.155: The active site cleft is centered on the catalytic residue Ser195, which together with residues His57 and Asp102 establishes the charge-relay system characteristic of serine proteinases. 

Phrase: "The active site cleft"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205242:Cleft [Spatial Concept]
   734   C0205681:Active Site [Functional Concept]

Phrase: "is"

Phrase: "centered on the catalytic residue Ser195,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0007382:Catalytic [Natural Phenomenon or Process]
   753   C0205099:centered [Spatial Concept]
   753   C1709915:Residue [Conceptual Entity]
   753   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "which together with residues His57"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1883357:Together [Qualitative Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "Asp102"

Phrase: "establishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the charge-relay system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "characteristic of serine proteinases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]
Processing 00000000.tx.156: His57 and Asp102 are provided by loops 34 and 56, respectively, of -barrel 1,whereas Ser195 is presented to the active site cleft by the end of the activation segment prior to strand 10 of -barrel 2(see Fig. 

Phrase: "His57"

Phrase: "and"

Phrase: "Asp102"

Phrase: "are"

Phrase: "provided by loops 34"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0181687:loops [Medical Device]
   770   C1999230:Provided [Activity]
   737 E C0419518:Loop [Medical Device]
   737 E C0445022:Loop [Spatial Concept]

Phrase: "and"

Phrase: "56,"

Phrase: "respectively,"

Phrase: "of -barrel 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332285:Of [Spatial Concept]
   827   C1552933:barrel [Quantitative Concept]
   827   C2700485:Barrel [Qualitative Concept]

Phrase: "whereas"

Phrase: "Ser195"

Phrase: "is"

Phrase: "presented to the active site cleft"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0205681:Active Site [Functional Concept]
   753   C0205145:Site [Spatial Concept]
   753   C0205177:Active [Functional Concept]
   753   C0205242:Cleft [Spatial Concept]
   753   C0449450:Presented [Idea or Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
   719 E C0150312:Present [Quantitative Concept]

Phrase: "by the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the activation segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441635:Segment [Spatial Concept]
   789 E C0205122:Segmental [Spatial Concept]

Phrase: "prior to strand 10 of -barrel 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1552933:barrel [Quantitative Concept]
   804   C1704972:Strand [Spatial Concept]
   804   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C2700485:Barrel [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.157: 2c). 

Phrase: "2c"

Phrase: ")."
Processing 00000000.tx.158: Substrate binding is achieved in mature serine proteinases by the extended segment Ser214-Gly216 (see Fig. 4b), which binds the peptide main chain via its own main chain, generating an antiparallel -ribbon. 

Phrase: "Substrate binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "achieved in mature serine proteinases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C2717971:Serine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205286:Mature [Temporal Concept]
   726 E C1622131:proteinase [Molecular Function]
   726 E C1947941:Proteinase [Enzyme]

Phrase: "by the extended segment Ser214-Gly216"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 4b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the peptide main chain via its own main chain,"

Phrase: "generating"

Phrase: "an antiparallel -ribbon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1709956:Ribbon [Medical Device]
   861   C3541837:ribbon [Cell Component]
Processing 00000000.tx.159: The first two residues are in the "active" extended conformation, but the chain deviates at Gly216, turning back to cover the S1 pocket. 

Phrase: "The first two residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "are in the ""active"" extended conformation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0026377:Conformation [Spatial Concept]
   753   C0205177:Active [Functional Concept]
   753   C0231448:Extended [Functional Concept]
   753   C0231449:Extended [Spatial Concept]
   753   C0439792:extended [Spatial Concept]
   753   C1551058:Are [Quantitative Concept]

Phrase: "but"

Phrase: "the chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337112:Chain [Manufactured Object]
  1000   C1524075:Chain [Idea or Concept]

Phrase: "deviates at Gly216,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0012727:deviate [Spatial Concept]

Phrase: "turning"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0541749:turning [Finding]
   966 E C1709743:Turn [Spatial Concept]

Phrase: "back to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004600:Back [Body Location or Region]
   861   C0205095:Back [Spatial Concept]
   861   C0460009:Back [Body Location or Region]
   861   C1995000:Back [Body Location or Region]

Phrase: "cover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0180153:cover [Medical Device]
  1000   C1707529:Cover [Medical Device]
  1000   C1999244:Cover [Functional Concept]

Phrase: "the S1 pocket."
Processing 00000000.tx.160: The oxyanion hole, which stabilizes the negatively charged transition state reaction intermediate, is provided by atoms Gly193 N and Ser195 N, although only the latter is in the position probably required in the active enzyme. 

Phrase: "The oxyanion hole,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0544726:Hole [Finding]
   861   C1823381:hole [Gene or Genome]
   861   C1881060:HOLE [Event]

Phrase: "which"

Phrase: "stabilizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "the negatively charged transition state reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]

Phrase: "intermediate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "is"

Phrase: "provided by atoms Gly193 N"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0567415:Atoms [Element, Ion, or Isotope]
   760   C1999230:Provided [Activity]
   726 E C1706222:Atom [Conceptual Entity]

Phrase: "and"

Phrase: "Ser195 N,"

Phrase: "although"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the latter"

Phrase: "is in the position probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0733755:Position [Spatial Concept]
   760   C0750492:Probably [Idea or Concept]

Phrase: "required in the active enzyme."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0205177:Active [Functional Concept]
   760   C1514873:Required [Functional Concept]
Processing 00000000.tx.161: The active site and S1 pocket base-forming segment, running from Asp189 to Ser195, is folded outward, occupying the space of the autolysis loop and the enzyme moiety-penetrating N terminus in mature enzymes (see below). 

Phrase: "The active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "S1 pocket base-forming segment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   897   C2331190:S1 segment [Body Part, Organ, or Organ Component]
   804   C0441635:Segment [Spatial Concept]
   733 E C0205122:Segmental [Spatial Concept]

Phrase: "running from Asp189"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0035953:Running [Daily or Recreational Activity]
   790   C2346414:Running [Finding]
   756 E C0600140:run [Finding]
   756 E C1704688:Run [Functional Concept]

Phrase: "to Ser195,"

Phrase: "is"

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "outward,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439788:Outward [Spatial Concept]

Phrase: "occupying"

Phrase: "the space of the autolysis loop"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883067:Space [Spatial Concept]

Phrase: "and"

Phrase: "the enzyme moiety-penetrating N terminus in mature enzymes"

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.162: This drags region Asn217-Ser222 inward by means of SS6, thus blocking the S1 pocket via the side chain of Ile218, linked to Pro219 by a cis-peptide bond. 

Phrase: "This drags region Asn217-Ser222"

Phrase: "inward by means of SS6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439786:Inward [Spatial Concept]

Phrase: "thus"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the S1 pocket via the side chain of Ile218,"

Phrase: "linked to Pro219"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]

Phrase: "by a cis-peptide bond."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0678595:peptide bond [Natural Phenomenon or Process]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.163: The S1 site of pro-hK6 is mainly determined in its depth by Gly216 and Gly226 that form a narrow slot-like pocket that can receive large substrate side chains in P1 in the mature enzyme. 

Phrase: "The S1 site of pro-hK6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "mainly"

Phrase: "determined in its depth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205125:Depth [Spatial Concept]

Phrase: "by Gly216"

Phrase: "and"

Phrase: "Gly226"

Phrase: "that"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a narrow slot-"

Phrase: "like pocket"

Phrase: "that"

Phrase: "can"

Phrase: "receive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "large substrate side chains in P1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337112:chains [Manufactured Object]
   753   C0441987:Side [Spatial Concept]
   753   C1524075:Chains [Idea or Concept]

Phrase: "in the mature enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.164: It is shaped at its bottom by the side chains of Val213 and Tyr228 and by the main-chain segments Trp215-Cys220 and Asp189-Gln192. 

Phrase: "It"

Phrase: "is"

Phrase: "shaped at its bottom"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0332479:shaped [Spatial Concept]
   770   C0522512:shaped [Spatial Concept]
   770   C1511276:Bottom [Spatial Concept]
   770   C1552825:bottom [Idea or Concept]
   737 E C0348078:shape [Qualitative Concept]

Phrase: "by the side chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337112:chains [Manufactured Object]
   861   C0441987:Side [Spatial Concept]
   861   C1524075:Chains [Idea or Concept]

Phrase: "of Val213"

Phrase: "and"

Phrase: "Tyr228"

Phrase: "and by the main-chain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205225:Main [Qualitative Concept]
   760   C0337112:Chain [Manufactured Object]
   760   C1515981:And [Idea or Concept]
   760   C1524075:Chain [Idea or Concept]
   760   C1542147:Main [Qualitative Concept]

Phrase: "segments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441635:Segment [Spatial Concept]

Phrase: "Trp215-Cys220"

Phrase: "and"

Phrase: "Asp189-Gln192."
Processing 00000000.tx.165: Asp189, residing at the bottom of the pocket in mature enzymes (see below), is flexible in our proenzyme structure but will account for the trypsin-like preference for lysine and arginine residues in P1. 

Phrase: "Asp189,"

Phrase: "residing at the bottom of the pocket"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1511276:Bottom [Spatial Concept]
   748   C1552825:bottom [Idea or Concept]
   714   C2982691:Reside [Activity]

Phrase: "in mature enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "flexible in our proenzyme structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443220:Flexible [Qualitative Concept]

Phrase: "but"

Phrase: "will"

Phrase: "account for the trypsin-like preference"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0558295:preference [Idea or Concept]
   753   C1549513:Preference [Idea or Concept]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "for lysine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "arginine residues in P1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.166: Asp194, which upon activation will become engaged with the newly formed N terminus in an internal salt bridge, is folded outward and interacts with Trp141 N and is trapped by the end of loop 12 and the beginning of strand 2 in a similar manner as other zymogens like chymotrypsinogen A and C and proproteinase E (61, 65). 

Phrase: "Asp194,"

Phrase: "which upon activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "will"

Phrase: "become"

Phrase: "engaged with the newly formed N terminus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205431:Formed [Functional Concept]
   748   C0425152:Engaged [Finding]
   748   C0750546:newly [Idea or Concept]

Phrase: "in an internal salt bridge,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0036140:Salt [Chemical Viewed Structurally]
   827   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0206136:Salt [Food,Inorganic Chemical]
   827   C0456378:Bridge [Medical Device]
   755 E C1537053:salty [Qualitative Concept]
   727 E C0678584:saltiness [Qualitative Concept]

Phrase: "is"

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "outward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439788:Outward [Spatial Concept]

Phrase: "and"

Phrase: "interacts with Trp141 N"

Phrase: "and"

Phrase: "is"

Phrase: "trapped by the end of loop 12"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0184047:Trapped [Medical Device]
   748   C0419518:Loop [Medical Device]
   748   C0444930:End [Spatial Concept]
   748   C0445022:Loop [Spatial Concept]
   748   C2746065:End [Temporal Concept]
   746   C3548406:terminal loop [Cell Component]

Phrase: "and"

Phrase: "the beginning of strand 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439659:Beginning [Temporal Concept]

Phrase: "in a similar manner"

Phrase: "as other zymogens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014436:Zymogens [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   900 E C0015852:Fermentation [Molecular Function]

Phrase: "like chymotrypsinogen A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008747:Chymotrypsinogen A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413806:CHYMOTRYPSINOGEN A [Gene or Genome]
   861   C0008746:Chymotrypsinogen [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "C"

Phrase: "and"

Phrase: "proproteinase E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072011:pro-proteinase E [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(61,"

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.167: Unlike other zymogens like proproteinase E and trypsinogen, however, it is not engaged in a "second triad" (66), as the positions corresponding to the second histidine and serine residues are Leu40 and Ala32, respectively, in pro-hK6. 

Phrase: "Unlike other zymogens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014436:Zymogens [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   900 E C0015852:Fermentation [Molecular Function]

Phrase: "like proproteinase E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072011:pro-proteinase E [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "trypsinogen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041243:Trypsinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "however,"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "engaged in a ""second triad"""
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0076994:triad [Biomedical or Dental Material,Organic Chemical]
   760   C0205436:Second [Quantitative Concept]
   760   C0425152:Engaged [Finding]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1179122:triad [Cell Component]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]

Phrase: "(66"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "the positions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:positions [Spatial Concept]
   916 E C0240795:POSITIONAL [Finding]

Phrase: "corresponding to the second histidine"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0175668:Secondary to [Temporal Concept]
   760   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]

Phrase: "and"

Phrase: "serine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "Leu40"

Phrase: "and"

Phrase: "Ala32,"

Phrase: "respectively,"

Phrase: "in pro-hK6."
Processing 00000000.tx.168: Comparison with Related Serine (Pro)Proteinases-- Pro-hK6 has the archetypal structure of trypsinogen/chymotrypsinogen-like serine (pro)proteinases, consisting of the two interacting -barrels and the two -helices. 

Phrase: "Comparison with Related Serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "(Pro)Proteinases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2987124:PRO [Intellectual Product]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "--"

Phrase: "Pro-hK6"

Phrase: "has"

Phrase: "the archetypal structure of trypsinogen/chymotrypsinogen-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "like serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(pro)proteinases,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2987124:PRO [Intellectual Product]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "consisting of the two interacting -barrels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205448:Two [Quantitative Concept]
   719   C0332529:CONSIST [Qualitative Concept]
   719   C1552933:barrel [Quantitative Concept]
   719   C2700485:Barrel [Qualitative Concept]

Phrase: "and"

Phrase: "the two -helices."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1017315:helices [Eukaryote]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]
Processing 00000000.tx.169: These regions, including between 196and 211structurally aligned residues, superimpose well in pro-hK6 and neuropsin (49% sequence identity; see Fig. 1 and Table II), bovine trypsin/trypsinogen (44%), and porcine pancreatic kallikrein (44%), with higher sequence identity than to other kallikreins (40-42%). 

Phrase: "These regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "including between 196and 211structurally aligned residues,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0332257:Including [Functional Concept]
   753   C1706765:Aligned [Quantitative Concept]
   719 E C1552866:include [Idea or Concept]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]
   719 E C2369992:Align [Pharmacologic Substance]
   719 E C2700399:Include [Activity]

Phrase: "superimpose"

Phrase: "well in pro-hK6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205170:Well [Qualitative Concept]
   770   C2987124:PRO [Intellectual Product]
   770   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "neuropsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416679:neuropsin [Gene or Genome]
  1000   C1426589:NEUROPSIN [Gene or Genome]

Phrase: "(49% sequence identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0424215:Identity [Mental Process]
   827   C2003939:Identity [Finding]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Table II"

Phrase: ")"

Phrase: ","

Phrase: "bovine trypsin/trypsinogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0370107:Trypsin+Trypsinogen [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041243:Trypsinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(44%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "porcine pancreatic kallikrein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0752224:Pancreatic Kallikrein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(44%"

Phrase: ")"

Phrase: ","

Phrase: "with higher sequence identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0424215:Identity [Mental Process]
   827   C2003939:Identity [Finding]

Phrase: "than"

Phrase: "to other kallikreins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022478:Kallikreins [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(40-42%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.170: The sequence identity with bovine chymotrypsinogen A is significantly lower (38%). 

Phrase: "The sequence identity with bovine chymotrypsinogen A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0424215:Identity [Mental Process]
   748   C2003939:Identity [Finding]

Phrase: "is"

Phrase: "significantly lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441994:Lower [Spatial Concept]
   861   C1548802:Lower [Body Location or Region]
   861   C2003888:Lower [Activity]

Phrase: "(38%"

Phrase: ")."
Processing 00000000.tx.171: Pro-hK6 has chimeric features between the other kallikrein family members and trypsinogen. 

Phrase: "Pro-hK6"

Phrase: "has"

Phrase: "chimeric features between the"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]

Phrase: "other kallikrein family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "trypsinogen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041243:Trypsinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.172: Unlike most of the former, but similarly to the latter, pro-hK6 lacks the kallikrein loop (see below and Fig. 1), important for kallikrein specificity and a point at which the polypeptide is cleaved and where an N-glycosylation site is located in kallikrein A, kallikrein-13, and other family members although not in pro-hK6 (67). 

Phrase: "Unlike most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "of the former,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "but"

Phrase: "similarly to the latter,"

Phrase: "pro-hK6"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the kallikrein loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: "and"

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "important for kallikrein specificity"

Phrase: "and"

Phrase: "a point at which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C2924612:A point [Body Location or Region]
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "the polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "and"

Phrase: "where"

Phrase: "an N-glycosylation site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1513806:N-Glycosylation Site [Amino Acid Sequence]
   827   C0017982:glycosylation [Natural Phenomenon or Process]
   827   C0205145:Site [Spatial Concept]
   827   C0376322:Glycosylation [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "located in kallikrein A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "kallikrein-13,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0084194:kallikrein-13 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1416673:KALLIKREIN 13 [Gene or Genome]
   861   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "other family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086282:Family Members [Family Group]
   966 E C1611821:Family Member [Intellectual Product]
   861   C0015576:Family [Family Group]
   861   C0680022:members [Population Group]
   861   C1704727:Family [Conceptual Entity]
   827 E C2698041:Member [Professional or Occupational Group]
   789 E C0241888:Familial [Functional Concept]

Phrase: "although"

Phrase: "not in pro-hK6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1518422:Not [Functional Concept]
   770   C2987124:PRO [Intellectual Product]

Phrase: "(67"

Phrase: ")."
Processing 00000000.tx.173: However, only 3of the 15human kallikreins have the complete loop, believed to confer specificity for kininogenase activity (5). 

Phrase: "However,"

Phrase: "only 3of"

Phrase: "the 15human kallikreins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022478:Kallikreins [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "have"

Phrase: "the complete loop,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confer"

Phrase: "specificity for kininogenase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.174: The classic kallikreins display five disulfide bonds, a subset of the six found in bovine trypsin, whereas pro-hK6 and most of the recently sequenced members also display the sixth (see Fig. 1 and Ref. 5). 

Phrase: "The classic kallikreins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022478:Kallikreins [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "five disulfide bonds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C1511997:Disulfide Bond [Amino Acid Sequence]
   827   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "a subset of the six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515021:Subset [Classification]

Phrase: "found in bovine trypsin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0007452:Bovine [Mammal]
   770   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0150312:Found [Quantitative Concept]
   770   C1140701:bovine [Mammal]
   737 E C0243095:Find [Finding]

Phrase: "whereas"

Phrase: "pro-hK6"

Phrase: "and"

Phrase: "most of the recently sequenced members also"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205393:Most [Quantitative Concept]
   748   C0332185:Recently [Temporal Concept]
   748   C0680022:members [Population Group]
   714   C0004793:Sequence [Nucleotide Sequence]
   714   C0162326:Sequence [Nucleotide Sequence]
   714   C0162327:Sequence [Nucleotide Sequence]
   714   C1519249:Sequence [Functional Concept]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "the sixth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205440:Sixth [Quantitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Ref. 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.175: Our human proenzyme further displays an intermediate helix 1 conformationally equivalent to that of trypsin and distinct from kallikrein A.

Phrase: "Our human proenzyme further"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014436:Proenzyme [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "an intermediate helix 1 conformationally equivalent to that of trypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205163:Equivalent [Qualitative Concept]
   739   C0439185:equivalent [Quantitative Concept]

Phrase: "and"

Phrase: "distinct from kallikrein A."
Processing 00000000.tx.176: This feature constitutes one of the most evident changes between the latter two (67). 

Phrase: "This feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "constitutes"

Phrase: "one of the most evident changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "between the latter two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "(67"

Phrase: ")."
Processing 00000000.tx.177: Moreover, like kallikrein A, pro-hK6 has a deletion at position 37belonging to loop 12, which adopts an equivalent conformation, distinct from trypsin. 

Phrase: "Moreover,"

Phrase: "like kallikrein A,"

Phrase: "pro-hK6"

Phrase: "has"

Phrase: "a deletion at position 37belonging to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "12,"

Phrase: "which"

Phrase: "adopts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "an equivalent conformation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "distinct from trypsin."
Processing 00000000.tx.178: It also has the characteristic cis-Pro219, part of an extended loop forming an enlarged bump from His217 to Cys220, and a specific orientation of the carbonyl-oxygen of cis-Pro219, which points out of the pocket in contrast to other serine proteinases (67). 

Phrase: "It also"

Phrase: "has"

Phrase: "the characteristic cis-Pro219,"

Phrase: "part of an extended loop"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "an enlarged bump from His217"

Phrase: "to Cys220,"

Phrase: "and"

Phrase: "a specific orientation of the carbonyl-oxygen of cis-Pro219,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0029266:Orientation [Mental Process]
   739   C1704322:orientation [Spatial Concept]
   739   C1704972:Orientation [Spatial Concept]
   739   C3539923:Orientation [Intellectual Product]

Phrase: "which"

Phrase: "points out of the pocket"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]

Phrase: "in contrast to other serine proteinases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C2717971:Serine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "(67"

Phrase: ")."
Processing 00000000.tx.179: This feature is present in all kallikreins but missing in trypsin (Fig. 1). 

Phrase: "This feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "is"

Phrase: "present in all kallikreins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "missing in trypsin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1551393:Missing [Idea or Concept]
   790   C1705492:Missing [Qualitative Concept]
   790   C3272743:MISSING [Qualitative Concept]
   756 E C2349206:Miss [Conceptual Entity]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.180: When compared with the latter, kallikrein A shows large deviations in the external loops, mostly surrounding the substrate binding site and forming a more compact rampart around it (67). 

Phrase: "When"

Phrase: "compared with the latter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "kallikrein A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "large deviations in the external loops,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0012727:Deviation [Spatial Concept]
   719   C0205419:Deviation [Qualitative Concept]
   719   C1705236:Deviation [Finding]

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the substrate binding site"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C1710236:Substrate [Manufactured Object]
   827   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "a more compact rampart around it (67"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1551750:Rampart [Population Group]

Phrase: ")."
Processing 00000000.tx.181: This contributes to the generally restricted accessibility of the kallikrein substrate-binding site compared with bovine trypsin, possibly to achieve distinct specificity or the prevention of unwanted inhibition by proteinaceous inhibitors targeting trypsin. 

Phrase: "This"

Phrase: "contributes to the generally restricted accessibility of the kallikrein substrate-binding site"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   753   C0005456:Binding Site [Receptor]
   753   C0682969:Binding Site [Amino Acid Sequence]
   751   C2945843:Site of [Qualitative Concept]
   736   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   736   C0205145:Site [Spatial Concept]
   736   C0243122:binding [Functional Concept]
   736   C0443288:Restricted [Functional Concept]
   736   C0814423:accessibility [Qualitative Concept]
   736   C1145667:Binding [Activity]
   736   C1167622:Binding [Molecular Function]
   736   C1515974:Site [Body Location or Region]
   736   C1710236:Substrate [Manufactured Object]
   736   C1880177:Contribute [Activity]
   736   C2825164:Site [Spatial Concept]
   715   C1882940:Restriction Site [Nucleotide Sequence]

Phrase: "compared with bovine trypsin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007452:Bovine [Mammal]
   770   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1140701:bovine [Mammal]
   770   C1707455:Compared [Activity]

Phrase: "possibly to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2362652:Possibly [Qualitative Concept]

Phrase: "achieve"

Phrase: "distinct specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "or"

Phrase: "the prevention of unwanted inhibition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0199176:Prevention [Therapeutic or Preventive Procedure]
   760   C1706420:PREVENTION [Research Activity]
   760   C2700409:prevention [Qualitative Concept]

Phrase: "by proteinaceous inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "trypsin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.182: The specificity determining aspartate at position 189is common to most kallikreins except PSA, which, like chymotrypsin, has a serine at this position. 

Phrase: "The specificity determining aspartate at position 189is"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "common to most kallikreins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]

Phrase: "except PSA,"

Phrase: "which,"

Phrase: "like chymotrypsin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "has"

Phrase: "a serine at this position."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.183: This explains its dual trypsin- and chymotrypsin-like specificity (68). 

Phrase: "This"

Phrase: "explains"

Phrase: "its dual trypsin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "chymotrypsin-like specificity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]
   734   C1413809:chymotrypsin-like [Gene or Genome]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.184: Further exceptions are human KLK7 (asparagine), KLK9 (glycine), and KLK15 (glutamate) (5). 

Phrase: "Further exceptions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1554961:exception [Idea or Concept]
   827   C1705847:Exception [Conceptual Entity]

Phrase: "are"

Phrase: "human KLK7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416677:Klk7 [Gene or Genome]
   861   C1416678:KLK7 [Gene or Genome]

Phrase: "(asparagine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003995:Asparagine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "KLK9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416680:KLK9 [Gene or Genome]

Phrase: "(glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "KLK15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0966207:KLK15 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367517:KLK15 [Gene or Genome]

Phrase: "(glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.185: 27of the reported "invariant" amino acids (29-31, depending on the source (59, 69, 70)) surrounding the active site of trypsin-like serine proteinases and involved in catalysis or substrate anchoring are totally conserved in pro-hK6. 

Phrase: "27of"

Phrase: "the reported ""invariant"" amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "(29-31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "depending on the source"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449416:Source [Finding]
   770   C1705919:Source [Idea or Concept]
   737   C0725813:depend [Medical Device]

Phrase: "(59,"

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "70"

Phrase: ")"

Phrase: ")"

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the active site of trypsin-like serine proteinases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205681:Active Site [Functional Concept]
   770   C2945843:Site of [Qualitative Concept]
   744   C0205145:Site [Spatial Concept]
   744   C0205177:Active [Functional Concept]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "involved in catalysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007382:Catalysis [Natural Phenomenon or Process]
   790   C1314939:Involved [Functional Concept]

Phrase: "or"

Phrase: "substrate anchoring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1293132:Anchoring [Therapeutic or Preventive Procedure]
   861   C1624581:anchoring [Molecular Function]

Phrase: "are"

Phrase: "totally"

Phrase: "conserved in pro-hK6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2987124:PRO [Intellectual Product]
Processing 00000000.tx.186: Of the other two residues, Leu155 in trypsin is conservatively exchanged for an isoleucine, as in kallikrein A, and trypsin Pro161 is not conserved in most of the other kallikrein sequences either (see Fig. 1).  

Phrase: "Of the"

Phrase: "other two residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "Leu155 in trypsin"

Phrase: "is"

Phrase: "conservatively"

Phrase: "exchanged for an isoleucine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0523728:Isoleucine [Laboratory Procedure]
   737   C0678640:exchange [Social Behavior]

Phrase: "as in kallikrein A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "trypsin Pro161"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "conserved in most of the"

Phrase: "other kallikrein sequences either"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.187: View this table: [in this window] [in a new window]  Table II Structural similarity between human pro-hK6 and other serine (pro)proteinases Despite the similarity mentioned above, the loops and segments connecting the regular secondary structure elements form a completely novel structure (see Fig. 3, a-d), not attributable to crystallographic contacts in the crystal and accounting for a unique serine proproteinase fold. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table II Structural similarity between human pro-hK6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "other serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(pro)proteinases Despite the similarity"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2987124:PRO [Intellectual Product]
   726 E C1622131:proteinase [Molecular Function]
   726 E C1947941:Proteinase [Enzyme]

Phrase: "mentioned"

Phrase: "above,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "the loops"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0181687:loops [Medical Device]
   966 E C0419518:Loop [Medical Device]
   966 E C0445022:Loop [Spatial Concept]

Phrase: "and"

Phrase: "segments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0441635:Segment [Spatial Concept]
   916 E C0205122:Segmental [Spatial Concept]

Phrase: "connecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986575:Connect [Activity]

Phrase: "the regular secondary structure elements"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0162807:Secondary Structure [Spatial Concept]
   812   C0013879:Elements [Element, Ion, or Isotope]
   812   C0027627:secondary [Neoplastic Process]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]
   812   C0678594:Structure [Spatial Concept]
   779 E C1705248:Element [Conceptual Entity]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a completely novel structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a-d),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "not attributable to crystallographic contacts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596130:Attributable [Mental Process]

Phrase: "in the crystal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0427896:Crystal [Body Substance]
  1000   C0444626:Crystal [Chemical Viewed Structurally]
  1000   C1533132:Crystal [Body Substance]
  1000   C1704641:Crystal [Manufactured Object]

Phrase: "and"

Phrase: "accounting for a unique serine proproteinase fold."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0000938:Accounting [Occupational Activity]
Processing 00000000.tx.188: These zones include the entrance frame (Val213-Cys220) with the connecting disulfide bridge SS6 (Cys191-Cys220) and loop Gly216-Gly226, containing the back-forming segment (Gly226-Tyr228), and the base-forming region Asp189-Ser195, flattened on top of the C-terminal -barrel on its front. 

Phrase: "These zones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C1710706:Zone [Spatial Concept]
   916 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the entrance frame"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0080089:Frame [Nucleotide Sequence]
   861   C0180979:Frame [Medical Device]
   861   C1705858:Frame [Manufactured Object]

Phrase: "(Val213-Cys220"

Phrase: ")"

Phrase: "with the connecting disulfide bridge SS6"

Phrase: "(Cys191-Cys220"

Phrase: ")"

Phrase: "and"

Phrase: "loop Gly216-Gly226,"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the back-forming segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441635:Segment [Spatial Concept]
   755 E C0205122:Segmental [Spatial Concept]

Phrase: "(Gly226-Tyr228"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the base-forming region Asp189-Ser195,"

Phrase: "flattened on top of the C-terminal -barrel"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1707271:C-Terminal [Amino Acid Sequence]
   744   C0016203:Flattened [Functional Concept]
   744   C0205088:Terminal [Temporal Concept]
   744   C1552933:barrel [Quantitative Concept]
   744   C1704458:Top [Spatial Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C2700485:Barrel [Qualitative Concept]

Phrase: "on its front."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205094:front [Spatial Concept]
   928 E C0205123:Frontal [Spatial Concept]
   907 E C0016540:Forehead [Body Location or Region]
Processing 00000000.tx.189: The unique orientation of these regions is accompanied by further singularities in the regions corresponding to the so-called autolysis and calcium-binding loops (Fig. 3, a-d). 

Phrase: "The unique orientation of these regions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0029266:Orientation [Mental Process]
   753   C1704322:orientation [Spatial Concept]
   753   C1704972:Orientation [Spatial Concept]
   753   C3539923:Orientation [Intellectual Product]

Phrase: "is"

Phrase: "accompanied by further singularities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1517331:Further [Spatial Concept]
   737 E C0205108:far [Spatial Concept]

Phrase: "in the regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "corresponding to the so-called autolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0004372:Autolysis [Pathologic Function]
   719   C0679006:Call [Mental Process]
   719   C1947967:Call [Functional Concept]

Phrase: "and"

Phrase: "calcium-binding loops"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   901   C1516144:Calcium Binding [Molecular Function]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0181687:loops [Medical Device]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C2936886:Calcium [Pharmacologic Substance]
   793 E C0419518:Loop [Medical Device]
   793 E C0445022:Loop [Spatial Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a-d)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.190: Although partially undefined, the latter is positioned ~10 further away (as calculated for Gln75 C-, at the center of the loop) when compared with trypsin(ogen) and with other (also cation-depleted) kallikrein structures. 

Phrase: "Although"

Phrase: "partially undefined,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750600:undefined [Idea or Concept]

Phrase: "the latter"

Phrase: "is"

Phrase: "positioned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0733755:Position [Spatial Concept]

Phrase: "~10 further away"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1517331:Further [Spatial Concept]
   793 E C0205108:far [Spatial Concept]

Phrase: "("

Phrase: "as"

Phrase: "calculated for Gln75"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "C-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "at the center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "of the loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: ")"

Phrase: "when"

Phrase: "compared with trypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1707455:Compared [Activity]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "and with other"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "(also cation-depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]

Phrase: ")"

Phrase: "kallikrein structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]
Processing 00000000.tx.191: The latter both display remarkably similar main-chain conformations despite the lack of sequence similarity. 

Phrase: "The latter"

Phrase: "both"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "remarkably similar main-chain conformations despite the lack of sequence similarity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   738   C0205225:Main [Qualitative Concept]
   738   C0337112:Chain [Manufactured Object]
   738   C1524075:Chain [Idea or Concept]
   738   C1542147:Main [Qualitative Concept]
   704   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.192: This distinct arrangement induces the shift of the autolysis loop in pro-hK6, which invades the space released by the calcium-binding loop. 

Phrase: "This distinct arrangement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449830:Arrangement [Spatial Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the shift of the autolysis loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333051:Shift [Functional Concept]
   753   C2347509:Shift [Phenomenon or Process]

Phrase: "in pro-hK6,"

Phrase: "which"

Phrase: "invades"

Phrase: "the space"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883067:Space [Spatial Concept]

Phrase: "released by the calcium-binding loop."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   790   C1516144:Calcium Binding [Molecular Function]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0243122:binding [Functional Concept]
   753   C0391871:Released [Functional Concept]
   753   C0419518:Loop [Medical Device]
   753   C0445022:Loop [Spatial Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1283071:Released [Functional Concept]
   753   C2936886:Calcium [Pharmacologic Substance]
   719 E C0030685:Release [Health Care Activity]
   719 E C0439180:% release [Quantitative Concept]
   719 E C0680255:release [Health Care Activity]
   719 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.193: The former is unique in being 2residues shorter than in trypsin and other related serine proteinases (see Fig. 1) and even 4residues shorter than in kallikrein A.

Phrase: "The former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "is"

Phrase: "unique in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1710548:Unique [Qualitative Concept]

Phrase: "being"

Phrase: "2residues"

Phrase: "shorter than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1282927:short [Qualitative Concept]
   799   C1806781:Short [Quantitative Concept]
   799   C2350002:Short [Quantitative Concept]

Phrase: "in trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "other related serine proteinases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C2717971:Serine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   793 E C1622131:proteinase [Molecular Function]
   793 E C1947941:Proteinase [Enzyme]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "even 4residues"

Phrase: "shorter than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1282927:short [Qualitative Concept]
   799   C1806781:Short [Quantitative Concept]
   799   C2350002:Short [Quantitative Concept]

Phrase: "in kallikrein A."
Processing 00000000.tx.194: This zone shows high conformational variability among serine (pro)proteinases (see Fig. 3), although none is as close to the calcium-binding loop as in pro-hK6. 

Phrase: "This zone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1710706:Zone [Spatial Concept]
   928 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "high conformational variability among serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2827666:Variability [Conceptual Entity]

Phrase: "(pro)proteinases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2987124:PRO [Intellectual Product]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "none"

Phrase: "is as close"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0587267:Close [Functional Concept]

Phrase: "to the calcium-binding loop"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C1516144:Calcium Binding [Molecular Function]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0243122:binding [Functional Concept]
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "as in pro-hK6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2987124:PRO [Intellectual Product]
Processing 00000000.tx.195: On the other side of this loop, these changes lead the end of the base-forming segment (distinct from Ala183-Asp194; see Fig. 3, a-d) to occupy the free space. 

Phrase: "On the"

Phrase: "other side of this loop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0441987:Side [Spatial Concept]

Phrase: "these changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "the end of the base-forming segment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0444930:End [Spatial Concept]
   748   C2746065:End [Temporal Concept]

Phrase: "(distinct from Ala183-Asp194"

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a-d) to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "occupy"

Phrase: "the free space."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883067:Space [Spatial Concept]
Processing 00000000.tx.196: Upon further transmission of these changes, loop Gly216-Lys224, together with disulfide bond SS6, collapses into the molecule, with a maximum distance of 6-7 for Cys220. 

Phrase: "Upon further transmission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040722:transmission [Idea or Concept]
   861   C0242781:Transmission [Pathologic Function]
   861   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "of these changes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "loop Gly216-Lys224,"

Phrase: "together with disulfide bond SS6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1511997:Disulfide Bond [Amino Acid Sequence]

Phrase: "collapses into the molecule,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0332521:Collapses [Phenomenon or Process]
   737 E C0036974:collapse [Pathologic Function]
   737 E C0344329:Collapse [Finding]
   737 E C1880118:COLLAPSE [Phenomenon or Process]

Phrase: "with a maximum distance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0012751:Distance [Quantitative Concept]
   789 E C0443203:Distant [Spatial Concept]

Phrase: "of 6-7"

Phrase: "for Cys220."
Processing 00000000.tx.197: View larger version (42K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.198: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.199: Unique structural features in pro-hK6. 

Phrase: "Unique structural features in pro-hK6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.200: Shown are superimpositions of the C- traces of the protein segments corresponding to the N-terminal region, the calcium-binding loop, the autolysis loop, the activation segment around Asp189-Gly196, and segment Gly216-Gly226 of pro-hK6 (yellow sticks) with distinct serine proproteases chymotrypsinogen A (PDB 2cga; magenta sticks) and chymotrypsinogen C (PDB 1pyt; cyan) (a) and trypsinogen (PDB 1tgn; green) and proprotease E (PDB 1pyt; dark blue) (b) and with closely related active serine proteinases kallikrein A (PDB 2pka; red) and tonin (PDB 1ton; pink) (c) and neuropsin (PDB 1npm; black) and trypsin (PDB 2ptn; orange) (d). 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "superimpositions of the C- traces of the protein segments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0429562:Superimposition [Finding]

Phrase: "corresponding to the N-terminal region,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017446:Region [Geographic Area]
   753   C0205088:Terminal [Temporal Concept]
   753   C0205147:Region [Spatial Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]

Phrase: "the calcium-binding loop,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C1516144:Calcium Binding [Molecular Function]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0243122:binding [Functional Concept]
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "the autolysis loop,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "the activation segment around Asp189-Gly196,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441635:Segment [Spatial Concept]

Phrase: "and"

Phrase: "segment Gly216-Gly226 of pro-hK6"

Phrase: "(yellow sticks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706582:Stick [Biomedical or Dental Material]
   827   C1706583:Stick [Quantitative Concept]

Phrase: ")"

Phrase: "with distinct serine proproteases chymotrypsinogen A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0008747:Chymotrypsinogen A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1413806:CHYMOTRYPSINOGEN A [Gene or Genome]
   804   C0008746:Chymotrypsinogen [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(PDB 2cga"

Phrase: "; magenta sticks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706582:Stick [Biomedical or Dental Material]
   827   C1706583:Stick [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "chymotrypsinogen C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0382351:chymotrypsinogen C [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0008746:Chymotrypsinogen [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(PDB 1pyt"

Phrase: "; cyan"

Phrase: ")"

Phrase: "(a)"

Phrase: "and"

Phrase: "trypsinogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041243:Trypsinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(PDB 1tgn"

Phrase: "; green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "proprotease E (PDB 1pyt"

Phrase: "; dark blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: "(b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and with closely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "active serine proteinases kallikrein A (PDB 2pka"

Phrase: "; red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "tonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0087052:tonin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(PDB 1ton"

Phrase: "; pink"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332585:Pink [Qualitative Concept]

Phrase: ")"

Phrase: "(c)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "neuropsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416679:neuropsin [Gene or Genome]
  1000   C1426589:NEUROPSIN [Gene or Genome]

Phrase: "(PDB 1npm"

Phrase: "; black"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(PDB 2ptn"

Phrase: "; orange"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0440277:Orange [Food]
  1000   C0475654:orange [Food]
  1000   C1313858:Orange [Qualitative Concept]

Phrase: ")"

Phrase: "("

Phrase: "d)."
Processing 00000000.tx.201: In all cases, the orientation corresponds to that of Fig. 

Phrase: "In all cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the orientation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0029266:Orientation [Mental Process]
  1000   C1704322:orientation [Spatial Concept]
  1000   C1704972:Orientation [Spatial Concept]
  1000   C3539923:Orientation [Intellectual Product]

Phrase: "corresponds to that of Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349966:Fig [Food]
   760   C1337208:FIG [Food]
Processing 00000000.tx.202: 2c, further rotated clockwise ~90. 

Phrase: "2c,"

Phrase: "further rotated clockwise ~90."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   812   C0231458:Rotated [Spatial Concept]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]
   812   C1517331:Further [Spatial Concept]
   779 E C0205108:far [Spatial Concept]
   741 E C0040480:Twisting [Physiologic Function]
   741 E C0231467:Twisted [Spatial Concept]
   741 E C1265748:Twisting [Pathologic Function]
   741 E C1881716:TWISTING [Phenomenon or Process]
Processing 00000000.tx.203: Selected pro-hK6 residues are labeled. 

Phrase: "Selected pro-hK6 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "labeled."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.204: The surface-located segment Ser130-Thr134 also adopts a distinct conformation (not being involved in any intra- or inter-molecular contacts), with a maximum deviation of ~7 . It is folded toward -hairpin 1011 at Thr133 and Ala131. 

Phrase: "The surface-located segment Ser130-Thr134 also"

Phrase: "adopts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a distinct conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "being"

Phrase: "involved in any intra-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0347985:Intra [Temporal Concept]
   770   C1314939:Involved [Functional Concept]

Phrase: "or"

Phrase: "inter-molecular contacts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0332158:contact [Functional Concept]
   793   C0337611:Contact [Population Group]
   793   C1705415:Contact [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "with a maximum deviation of ~7 ."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0012727:Deviation [Spatial Concept]
   812   C0205419:Deviation [Qualitative Concept]
   812   C0806909:Maximum [Quantitative Concept]
   812   C1552615:maximum [Quantitative Concept]
   812   C1705236:Deviation [Finding]
   812   C2826546:MAXIMUM [Quantitative Concept]
   741 E C0205289:Maximal [Qualitative Concept]

Phrase: "It"

Phrase: "is"

Phrase: "folded toward -hairpin 1011"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332462:Folded [Spatial Concept]
   770   C0450317:1011 [Intellectual Product]
   770   C1880834:FOLDED [Phenomenon or Process]

Phrase: "at Thr133"

Phrase: "and"

Phrase: "Ala131."
Processing 00000000.tx.205: This region, including the only glycosylation site at position 132,may play a role in a regulatory autoactivation/autoinactivation mechanism or in promoting sugar-mediated adhesion to cells or other molecules, where its activity is required. 

Phrase: "This region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the only glycosylation site at position 132,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0017982:glycosylation [Natural Phenomenon or Process]
   748   C0205145:Site [Spatial Concept]
   748   C0376322:Glycosylation [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in a regulatory autoactivation/autoinactivation mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "or in promoting sugar-mediated adhesion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0001511:Adhesion [Pathologic Function]
   753   C0007004:Sugar [Carbohydrate]
   753   C0033414:Promoting [Activity]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0175633:Adhesion [Natural Phenomenon or Process]
   753   C0242209:Sugar [Carbohydrate,Pharmacologic Substance]

Phrase: "to cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "other molecules,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "where"

Phrase: "its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.206: Finally, the final refined structure has a unique rotamer of the side chain of active-site Ser195. 

Phrase: "Finally,"

Phrase: "the final refined structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "has"

Phrase: "a unique rotamer of the side chain of active-site Ser195."
Processing 00000000.tx.207: Two solvent molecules and His57 N2 coordinate its O atom in a tetrahedral manner. 

Phrase: "Two solvent molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "His57 N2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441960:N2 [Finding]

Phrase: "coordinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0427184:coordinate [Finding]
  1000   C0700114:coordinate [Functional Concept]
  1000   C1707511:Coordinate [Spatial Concept]

Phrase: "its O atom in a tetrahedral manner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0567415:Atom [Element, Ion, or Isotope]
   748   C1706222:Atom [Conceptual Entity]
Processing 00000000.tx.208: The unique feature resides in the gauche conformation of its 1 angle (+67), rendering a high steric hindrance to the interaction with a substrate scissile peptide bond. 

Phrase: "The unique feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521970:Feature [Qualitative Concept]
   861   C1706388:Feature [Conceptual Entity]
   861   C2346469:Feature [Qualitative Concept]
   861   C2348519:Feature [Qualitative Concept]

Phrase: "resides in the gauche conformation of its 1 angle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0026377:Conformation [Spatial Concept]
   742   C0205143:Angle [Spatial Concept]
   742   C2982691:Reside [Activity]

Phrase: "(+67"

Phrase: ")"

Phrase: ","

Phrase: "rendering"

Phrase: "a high steric hindrance to the interaction"

Phrase: "with a substrate scissile peptide bond."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0678595:peptide bond [Natural Phenomenon or Process]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.209: The side chain can only approach the substrate if the angle becomes negative (gauche+), as observed in all other zymogen and active protease structures analyzed (see Fig. 3, a-d; values oscillate between 43 and 96). 

Phrase: "The side chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337112:Chain [Manufactured Object]
   861   C0441987:Side [Spatial Concept]
   861   C1524075:Chain [Idea or Concept]

Phrase: "can"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "if"

Phrase: "the angle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205143:Angle [Spatial Concept]

Phrase: "becomes"

Phrase: "negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: "(gauche+"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "observed in all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "other zymogen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014436:zymogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   907 E C0015852:Fermentation [Molecular Function]

Phrase: "and"

Phrase: "active protease structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a-d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "; values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "oscillate between 43"

Phrase: "and"

Phrase: "96"

Phrase: ")."
Processing 00000000.tx.210: Proposed Activation Mechanism-- Pro-hK6 is activated in vivo probably by limited proteolysis of peptide bond Lys15-Leu16, either autolytically or by another yet unknown proteinase with a compatible expression pattern. 

Phrase: "Proposed Activation Mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "--"

Phrase: "Pro-hK6"

Phrase: "is"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "in vivo probably by limited proteolysis of peptide bond Lys15-Leu16,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   756   C0678595:peptide bond [Natural Phenomenon or Process]
   756   C1515655:In Vivo [Spatial Concept]
           vivo
   738   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   738   C0439801:Limited [Functional Concept]
   738   C0597304:Proteolysis [Molecular Function]
   738   C0750492:Probably [Idea or Concept]
   738   C3542948:Limited [Intellectual Product]

Phrase: "either autolytically"

Phrase: "or by another yet unknown proteinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0439673:Unknown [Qualitative Concept]
   753   C1622131:proteinase [Molecular Function]
   753   C1947941:Proteinase [Enzyme]

Phrase: "with a compatible expression pattern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.211: As previously mentioned, pro-hK6 displays the closest structural and sequential similarity with neuropsin (see Fig. 4), although the base-forming segment Ala183-Ser195 is one residue longer in neuropsin. 

Phrase: "As"

Phrase: "previously"

Phrase: "mentioned"

Phrase: ","

Phrase: "pro-hK6"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "the closest structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "sequential similarity with neuropsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similarity [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the base-forming segment Ala183-Ser195"

Phrase: "is"

Phrase: "one residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "longer in neuropsin."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0205166:Long [Qualitative Concept]
   756   C1706317:Long [Qualitative Concept]
   706 E C1444754:Length [Quantitative Concept]
   706 E C1706316:LENGTH [Research Activity]
Processing 00000000.tx.212: This causes significant structural changes in this loop and in that of the disulfide-connected segment Gly216-Gly226, endowing hK6 with a slightly different substrate specificity upon maturation. 

Phrase: "This causes significant structural changes in this loop"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   744   C0678594:Structural [Spatial Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "and in that of the disulfide-connected segment Gly216-Gly226,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0012771:disulfide [Chemical Viewed Structurally]
   739   C0441635:Segment [Spatial Concept]
   739   C1515981:And [Idea or Concept]

Phrase: "endowing"

Phrase: "hK6 with a slightly different substrate specificity"

Phrase: "upon maturation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678723:Maturation [Organism Function]
  1000   C0870861:maturation [Phenomenon or Process]
  1000   C1254042:Maturation [Physiologic Function]
Processing 00000000.tx.213: Both proteins have been detected in mammalian brain (32) and, like other homologues such as myelencephalon-specific protease (71), KLK14 (72), reelin (73), spinesin (74), and neurotrypsin (75), show higher expression levels in the central nervous system than in most peripheral tissues. 

Phrase: "Both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "detected in mammalian brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0024660:Mammalian [Mammal]
   770   C0442726:Detected [Finding]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(32"

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "like other homologues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1334043:Homologue [Gene or Genome]

Phrase: "such as myelencephalon-specific protease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0667265:myelencephalon-specific protease [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025148:Myelencephalon [Body Part, Organ, or Organ Component]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0205369:Specific [Qualitative Concept]
   827   C1269575:Myelencephalon [Body Part, Organ, or Organ Component]
   827   C1552740:specific [Intellectual Product]
   827   C1947941:Protease [Enzyme]
   827   C1959627:Myelencephalon [Body Part, Organ, or Organ Component]

Phrase: "(71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "KLK14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416674:KLK14 [Gene or Genome]

Phrase: "(72"

Phrase: ")"

Phrase: ","

Phrase: "reelin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419337:REELIN [Gene or Genome]
  1000   C3537331:Reelin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(73"

Phrase: ")"

Phrase: ","

Phrase: "spinesin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1423044:SPINESIN [Gene or Genome]

Phrase: "(74"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "neurotrypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0666548:neurotrypsin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418967:NEUROTRYPSIN [Gene or Genome]

Phrase: "(75"

Phrase: ")"

Phrase: ","

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "higher expression levels in the central nervous system"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "than"

Phrase: "in most peripheral tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.214: A recent report has even shown that high levels of plasma kallikrein are present in the brain, where it could play a role in the nervous system (76). 

Phrase: "A recent report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "has"

Phrase: "even"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that high levels of plasma kallikrein"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "present in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "where"

Phrase: "it"

Phrase: "could"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the nervous system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(76"

Phrase: ")."
Processing 00000000.tx.215: Both pro-hK6 and neuropsin share, besides a sequence identity of 49%, the absence of the kallikrein loop (see Fig. 1) and the presence of the sixth SS bond found in bovine trypsin, although absent in other kallikrein structures. 

Phrase: "Both pro-hK6"

Phrase: "and"

Phrase: "neuropsin share,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0237876:Share [Social Behavior]

Phrase: "besides a sequence identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0424215:Identity [Mental Process]
   861   C2003939:Identity [Finding]

Phrase: "of 49%,"

Phrase: "the absence of the kallikrein loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "the presence of the sixth SS bond"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "found in bovine trypsin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0007452:Bovine [Mammal]
   770   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0150312:Found [Quantitative Concept]
   770   C1140701:bovine [Mammal]
   737 E C0243095:Find [Finding]

Phrase: "although"

Phrase: "absent in other kallikrein structures."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]
Processing 00000000.tx.216: Accordingly, neuropsin, the only brain-associated kallikrein of known structure (32), can be considered as a valid model for active hK6 and thus suggests which structural rearrangements would possibly occur upon pro-hK6 activation (see above and Fig. 4). 

Phrase: "Accordingly,"

Phrase: "neuropsin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416679:neuropsin [Gene or Genome]
  1000   C1426589:NEUROPSIN [Gene or Genome]

Phrase: "the only brain-associated kallikrein of known structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "can"

Phrase: "be"

Phrase: "considered as a valid model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0750591:considered [Idea or Concept]
   760   C2349099:Valid [Qualitative Concept]
   760   C3161035:Model [Intellectual Product]

Phrase: "for active hK6"

Phrase: "and"

Phrase: "thus"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "which structural rearrangements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangements [Genetic Function]

Phrase: "would"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "occur upon pro-hK6 activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709305:Occur [Activity]
   760   C1879547:Activation [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C2987124:PRO [Intellectual Product]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "and"

Phrase: "Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.217: View larger version (51K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(51K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.218: 4.  

Phrase: "4."
Processing 00000000.tx.219: Proposed activation of pro-hK6. 

Phrase: "Proposed activation of pro-hK6."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]
Processing 00000000.tx.220: a, superimposition of the C- traces of pro-hK6 (dark sticks) and neuropsin (light sticks) shown in standard orientation. b, close up view of the regions of pro-hK6 putatively involved in major structural rearrangements upon activation (dark sticks and labels) superimposed with the equivalent zones of neuropsin (light trace and labels), considered as a structural homologue of active hK6. 

Phrase: "a,"

Phrase: "superimposition of the C- traces of pro-hK6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0429562:Superimposition [Finding]

Phrase: "(dark sticks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706582:Stick [Biomedical or Dental Material]
   827   C1706583:Stick [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "neuropsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416679:neuropsin [Gene or Genome]
  1000   C1426589:NEUROPSIN [Gene or Genome]

Phrase: "(light sticks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706582:Stick [Biomedical or Dental Material]
   827   C1706583:Stick [Quantitative Concept]

Phrase: ")"

Phrase: "shown in standard orientation. b,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0029266:Orientation [Mental Process]
   760   C1442989:Standard [Qualitative Concept]
   760   C1704322:orientation [Spatial Concept]
   760   C1704972:Orientation [Spatial Concept]
   760   C2828392:Standard [Intellectual Product]
   760   C3539923:Orientation [Intellectual Product]
   726   C1547282:Show [Intellectual Product]

Phrase: "close up view of the regions of pro-hK6 putatively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0449911:View [Spatial Concept]

Phrase: "involved in major structural rearrangements"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205164:Major [Qualitative Concept]
   760   C0678594:Structural [Spatial Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1511695:Rearrangements [Genetic Function]

Phrase: "upon activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "(dark sticks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706582:Stick [Biomedical or Dental Material]
   827   C1706583:Stick [Quantitative Concept]

Phrase: "and"

Phrase: "labels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0181496:labels [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: ")"

Phrase: "superimposed with the equivalent zones of neuropsin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205163:Equivalent [Qualitative Concept]
   748   C0439185:equivalent [Quantitative Concept]
   748   C1416679:neuropsin [Gene or Genome]
   748   C1426589:NEUROPSIN [Gene or Genome]
   714   C1710706:Zone [Spatial Concept]

Phrase: "(light trace"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0442822:Trace [Quantitative Concept]
   861   C1524031:Trace [Qualitative Concept]
   861   C1883002:Trace [Functional Concept]

Phrase: "and"

Phrase: "labels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0181496:labels [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: ")"

Phrase: ","

Phrase: "considered as a structural homologue of active hK6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Active [Functional Concept]
   744   C0678594:Structural [Spatial Concept]
   744   C0750591:considered [Idea or Concept]
   744   C1334043:Homologue [Gene or Genome]
Processing 00000000.tx.221: c, scheme highlighting the proposed structural rearrangements observed on going from pro-hK6 (dark coil) to neuropsin (light coil). 

Phrase: "c,"

Phrase: "scheme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519193:Scheme [Intellectual Product]

Phrase: "highlighting"

Phrase: "the proposed structural rearrangements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511695:Rearrangements [Genetic Function]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "on going from pro-hK6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720176:On [Functional Concept]
   760   C1720294:On [Intellectual Product]

Phrase: "(dark coil"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0444764:coil [Spatial Concept]
   861   C1413568:COIL [Gene or Genome]
   861   C1705946:Coil [Medical Device]

Phrase: ")"

Phrase: "to neuropsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416679:neuropsin [Gene or Genome]
  1000   C1426589:NEUROPSIN [Gene or Genome]

Phrase: "(light coil"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0444764:coil [Spatial Concept]
   861   C1413568:COIL [Gene or Genome]
   861   C1705946:Coil [Medical Device]

Phrase: ")."
Processing 00000000.tx.222: Thus, upon proteolytic cleavage of the pro-hK6 target bond (Fig. 4c, ), the new N-terminal segment Leu16-Pro28 would fold toward the molecular surface, mainly due to two concerted ~90 rotations around the peptide bond between Lys24 and Thr25 and around Cys157 C--C-, the position of Cys157 C- in neuropsin and pro-hK6 being just 0.8away. 

Phrase: "Thus,"

Phrase: "upon proteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "of the pro-hK6 target bond"

Phrase: "(Fig. 4c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the new N-terminal segment Leu16-Pro28"

Phrase: "would"

Phrase: "fold toward the molecular surface,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "mainly due to two concerted ~90 rotations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0035868:Rotations [Functional Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0439083:>90 [Quantitative Concept]
   748   C0439087:<90 [Quantitative Concept]
   748   C3146286:Due [Idea or Concept]
   714 E C0677597:Rotation [Functional Concept]

Phrase: "around the peptide bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0678595:peptide bond [Natural Phenomenon or Process]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "between Lys24"

Phrase: "and"

Phrase: "Thr25"

Phrase: "and around Cys157"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "C--C-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "the position of Cys157 C- in neuropsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0733755:Position [Spatial Concept]

Phrase: "and"

Phrase: "pro-hK6"

Phrase: "being"

Phrase: "just 0.8away."
Processing 00000000.tx.223: This would displace the connected Cys22 (4for its C- atom) and probably cause the establishment of a main-chain hydrogen bond between Ile155 O and Cys22 N in the mature enzyme. 

Phrase: "This"

Phrase: "would"

Phrase: "displace"

Phrase: "the connected Cys22"

Phrase: "(4for"

Phrase: "its C- atom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0567415:Atom [Element, Ion, or Isotope]
   861   C1706222:Atom [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the establishment of a main-chain hydrogen bond"

Phrase: "between Ile155 O"

Phrase: "and"

Phrase: "Cys22 N in the mature enzyme."
Processing 00000000.tx.224: The preceding segment Leu16-Pro21 could be rotated toward the molecular body, forming a further double main-chain hydrogen bond between Gly20 and Cys157. 

Phrase: "The preceding segment Leu16-Pro21"

Phrase: "could"

Phrase: "be"

Phrase: "rotated toward the molecular body,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0231458:Rotated [Spatial Concept]
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "a further double main-chain hydrogen bond between Gly20"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0020276:hydrogen bond [Natural Phenomenon or Process]
   742   C0020275:Hydrogen [Element, Ion, or Isotope]
   742   C0523702:HYDROGEN [Laboratory Procedure]
   742   C0885426:hydrogen [Inorganic Chemical]

Phrase: "and"

Phrase: "Cys157."
Processing 00000000.tx.225: In this movement, Leu16 penetrates the protein moiety originating a displacement of segment Gly188A-Asp194 (Fig. 4c, ), which would be folded inward with a maximum displacement of ~10 for Asp189 C-. 

Phrase: "In this movement,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026649:Movement [Organism Function]

Phrase: "Leu16"

Phrase: "penetrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "the protein moiety"

Phrase: "originating"

Phrase: "a displacement of segment Gly188A-Asp194"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012725:Displacement [Mental Process]
   753   C0012727:Displacement [Spatial Concept]
   753   C0456080:Displacement [Qualitative Concept]
   753   C2347509:Displacement [Phenomenon or Process]

Phrase: "(Fig. 4c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "would"

Phrase: "be"

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "inward with a maximum displacement of ~10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439786:Inward [Spatial Concept]

Phrase: "for Asp189"

Phrase: "C-."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.226: This is mainly permitted by a ~150 rotation around Gly188A N-C, facilitated by the absence of a side chain in this residue, and a further rotation of ~130 around Asp194 C--C. 

Phrase: "This"

Phrase: "is"

Phrase: "mainly"

Phrase: "permitted by a ~150 rotation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0035868:Rotation [Functional Concept]
   760   C0329040:permitted [Fish]
   760   C0677597:Rotation [Functional Concept]
   726 E C0023636:Permit [Regulation or Law]

Phrase: "around Gly188A N-C,"

Phrase: "facilitated by the absence of a side chain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0332197:absence [Quantitative Concept]
   744   C0337112:Chain [Manufactured Object]
   744   C0441987:Side [Spatial Concept]
   744   C1524075:Chain [Idea or Concept]
   744   C1689985:Absence [Anatomical Abnormality]

Phrase: "in this residue,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "a further rotation of ~130 around Asp194"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C0050323:A-130 [Organic Chemical]
   748   C0035868:Rotation [Functional Concept]
   748   C0677597:Rotation [Functional Concept]
   748   C1517331:Further [Spatial Concept]
   714 E C0205108:far [Spatial Concept]

Phrase: "C--C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.227: In this way, the acidic side chain of the latter residue would rotate to establish the classical salt bridge with the new N terminus, Leu16 N, and the oxyanion hole-shaping main-chain nitrogen atom of Gly193 would be properly positioned. 

Phrase: "In this way,"

Phrase: "the acidic side chain of the latter residue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0337112:Chain [Manufactured Object]
   744   C0441987:Side [Spatial Concept]
   744   C1524075:Chain [Idea or Concept]

Phrase: "would"

Phrase: "rotate"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0231458:rotate [Spatial Concept]
   944 E C0040480:Twisting [Physiologic Function]
   944 E C0231467:Twisted [Spatial Concept]
   944 E C1265748:Twisting [Pathologic Function]
   944 E C1881716:TWISTING [Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the classical salt bridge with the new N terminus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0036140:Salt [Chemical Viewed Structurally]
   742   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C0206136:Salt [Food,Inorganic Chemical]
   742   C0456378:Bridge [Medical Device]

Phrase: "Leu16 N,"

Phrase: "and"

Phrase: "the oxyanion hole-shaping main-chain nitrogen atom of Gly193"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0567415:Atom [Element, Ion, or Isotope]
   739   C1706222:Atom [Conceptual Entity]

Phrase: "would"

Phrase: "be"

Phrase: "properly"

Phrase: "positioned."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0733755:Position [Spatial Concept]
Processing 00000000.tx.228: Also, these changes might trigger a ~180 rotation of the side chain of active site Ser195 around its 1 angle to reach the negative value observed in neuropsin and other active serine proteinases. 

Phrase: "Also,"

Phrase: "these changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "might"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "a ~180 rotation of the side chain of active site Ser195"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035868:Rotation [Functional Concept]
   738   C0677597:Rotation [Functional Concept]

Phrase: "around its 1 angle to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205143:Angle [Spatial Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "the negative value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "observed in neuropsin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1416679:neuropsin [Gene or Genome]
   790   C1426589:NEUROPSIN [Gene or Genome]
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "other active serine proteinases."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C2717971:Serine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   793 E C1622131:proteinase [Molecular Function]
   793 E C1947941:Proteinase [Enzyme]
Processing 00000000.tx.229: The residue following the N terminus, Val17, would be trapped by Asp189 via a main-chain double hydrogen bond. 

Phrase: "The residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the N terminus,"

Phrase: "Val17,"

Phrase: "would"

Phrase: "be"

Phrase: "trapped by Asp189"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0184047:Trapped [Medical Device]

Phrase: "via a main-chain double hydrogen bond."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0020276:hydrogen bond [Natural Phenomenon or Process]
   804   C0020275:Hydrogen [Element, Ion, or Isotope]
   804   C0523702:HYDROGEN [Laboratory Procedure]
   804   C0885426:hydrogen [Inorganic Chemical]
Processing 00000000.tx.230: The further intrusion of the new N terminus would also rearrange the autolysis loop (Fig. 4c, ), induced by rotations around the C--C bonds of Asp153 (~130) and Trp141 (~90), to occupy the space left by Gly188A-Asp194. 

Phrase: "The further intrusion of the new N terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2825978:Intrusion [Therapeutic or Preventive Procedure]

Phrase: "would"

Phrase: "also"

Phrase: "rearrange"

Phrase: "the autolysis loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "(Fig. 4c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "induced by rotations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0035868:Rotations [Functional Concept]
   790   C0205263:Induced [Functional Concept]
   756 E C0677597:Rotation [Functional Concept]
   706 E C0445237:Rotational [Spatial Concept]

Phrase: "around the C--C bonds"

Phrase: "of Asp153"

Phrase: "(~130"

Phrase: ")"

Phrase: "and"

Phrase: "Trp141"

Phrase: "(~90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occupy"

Phrase: "the space"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883067:Space [Spatial Concept]

Phrase: "left by Gly188A-Asp194."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205091:Left [Spatial Concept]
   770   C1552822:left [Functional Concept]
Processing 00000000.tx.231: These movements also affect the connecting disulfide bridge SS6 (Cys191-Cys220), since Cys191 C- would move for about ~7-8 inward in the mature structure, inducing the extrusion of loop Gly216-Glu223 (Fig. 4c, ) by a ~90 rotation around Gly216 N-C-. 

Phrase: "These movements also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026649:Movement [Organism Function]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the connecting disulfide bridge SS6"

Phrase: "(Cys191-Cys220"

Phrase: ")"

Phrase: ","

Phrase: "since"

Phrase: "Cys191"

Phrase: "C-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "would"

Phrase: "move for about ~7-8 inward"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0439786:Inward [Spatial Concept]
   753   C0560560:move [Organism Function]
   753   C0578671:move [Finding]
   753   C1269909:move [Functional Concept]
   753   C1299988:move [Functional Concept]
   753   C2699029:Move [Activity]

Phrase: "in the mature structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "the extrusion of loop Gly216-Glu223"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443213:Extrusion [Finding]

Phrase: "(Fig. 4c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: "by a ~90 rotation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0035868:Rotation [Functional Concept]
   827   C0677597:Rotation [Functional Concept]
   755 E C0445237:Rotational [Spatial Concept]

Phrase: "around Gly216 N-C-."
Processing 00000000.tx.232: Furthermore, the rearrangement of the autolysis loop could push out the vicinal calcium-binding loop to adopt the conformation observed in neuropsin (partially undefined in this structure however), but also in kallikrein A, tonin, and kallikrein 13(see Fig. 

Phrase: "Furthermore,"

Phrase: "the rearrangement of the autolysis loop"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511695:Rearrangement [Genetic Function]

Phrase: "could"

Phrase: "push"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719958:Push [Functional Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the vicinal calcium-binding loop to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   840   C1516144:Calcium Binding [Molecular Function]
   804   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0006726:Calcium [Inorganic Chemical]
   804   C0243122:binding [Functional Concept]
   804   C0419518:Loop [Medical Device]
   804   C0445022:Loop [Spatial Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C2936886:Calcium [Pharmacologic Substance]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "the conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "observed in neuropsin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1416679:neuropsin [Gene or Genome]
   790   C1426589:NEUROPSIN [Gene or Genome]
   790   C1441672:Observed [Functional Concept]

Phrase: "(partially undefined in this structure however"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750600:undefined [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "also in kallikrein A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "tonin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0087052:tonin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "kallikrein 13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0084194:kallikrein-13 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1416673:KALLIKREIN 13 [Gene or Genome]
   861   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.233: 3, a-d). 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "a-d)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.234: This structural element would be folded out with a maximum displacement of ~13 for Gln76, explaining the susceptibility of this region to autolytic cleavage upon proteolytic activation. 

Phrase: "This structural element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "would"

Phrase: "be"

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "out with a maximum displacement of ~13"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0012725:Displacement [Mental Process]
   748   C0012727:Displacement [Spatial Concept]
   748   C0439787:Out [Spatial Concept]
   748   C0456080:Displacement [Qualitative Concept]
   748   C0806909:Maximum [Quantitative Concept]
   748   C0849355:Out [Qualitative Concept]
   748   C1552615:maximum [Quantitative Concept]
   748   C2347509:Displacement [Phenomenon or Process]
   748   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "for Gln76,"

Phrase: "explaining"

Phrase: "the susceptibility of this region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to autolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "upon proteolytic activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]
Processing 00000000.tx.235: In any case, this movement, mainly enabled by a ~60 rotation around Leu73 N-C- and a second of ~90 around Glu81 C--C, would imply the rupture of the strong double main chain hydrogen bond between Leu73 and Asp153 observed in pro-hK6. 

Phrase: "In any case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "this movement,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026649:Movement [Organism Function]

Phrase: "mainly"

Phrase: "enabled by a ~60 rotation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0035868:Rotation [Functional Concept]
   760   C0562342:Enabled [Mental Process]
   760   C0677597:Rotation [Functional Concept]
   726 E C1171285:enable [Mental Process]

Phrase: "around Leu73 N-C-"

Phrase: "and"

Phrase: "a second of ~90 around Glu81"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205436:Second [Quantitative Concept]
   753   C0439083:>90 [Quantitative Concept]
   753   C0439087:<90 [Quantitative Concept]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]

Phrase: "C--C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "would"

Phrase: "imply"

Phrase: "the rupture of the strong double main chain hydrogen bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1881712:RUPTURE [Phenomenon or Process]
   739   C3203359:Rupture [Injury or Poisoning]

Phrase: "between Leu73"

Phrase: "and"

Phrase: "Asp153"

Phrase: "observed in pro-hK6."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1441672:Observed [Functional Concept]
   770   C2987124:PRO [Intellectual Product]
Processing 00000000.tx.236: Conclusion-- Despite close overall structural similarity with other members of the trypsin/chymotrypsin-like family of serine (pro)proteinases, the structure of pro-hK6 has unique features that mainly affect those regions involved in rearrangement upon activation. 

Phrase: "Conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "-"

Phrase: "-"

Phrase: "Despite close overall structural similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2348205:Similarity [Qualitative Concept]

Phrase: "with other members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0680022:members [Population Group]
   966 E C2698041:Member [Professional or Occupational Group]

Phrase: "of the trypsin/chymotrypsin-like family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:Family [Family Group]
   812   C1704727:Family [Conceptual Entity]
   741 E C0241888:Familial [Functional Concept]

Phrase: "of serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(pro)proteinases,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2987124:PRO [Intellectual Product]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "the structure of pro-hK6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678594:Structure [Spatial Concept]

Phrase: "has"

Phrase: "unique"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710548:Unique [Qualitative Concept]

Phrase: "features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "that mainly"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "those regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "involved in rearrangement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1314939:Involved [Functional Concept]
   790   C1511695:Rearrangement [Genetic Function]

Phrase: "upon activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.237: The close sequential and structural similarity and tissue distribution of pro-hK6 with mouse neuropsin makes the latter a valid structural model for active human hK6 in the absence of an experimental structure and allows the formulation of a novel activation mechanism. 

Phrase: "The close sequential"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1548958:Sequential [Idea or Concept]
   861   C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "structural similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "tissue distribution of pro-hK6"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0040287:Tissue Distribution [Quantitative Concept]
   806   C0220927:tissue distribution [Functional Concept]
   760   C0040300:Tissue [Tissue]
   760   C0520511:distribution [Idea or Concept]
   760   C1547928:Tissue [Intellectual Product]
   760   C1704711:Distribution [Functional Concept]

Phrase: "with mouse neuropsin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0757902:neuropsin, mouse [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1416679:neuropsin [Gene or Genome]
   861   C1426589:NEUROPSIN [Gene or Genome]

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the latter"

Phrase: "a valid structural model for active human hK6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026349:Structural Model [Manufactured Object]
   744   C3161035:Model [Intellectual Product]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of an experimental structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the formulation of a novel activation mechanism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0524527:Formulation [Research Activity]
Processing 00000000.tx.238: The proposed activation may be achieved either by extrinsic trypsin(-like) activity involving other kallikreins or intrinsically due to a regulatory autoactivation mechanism. 

Phrase: "The proposed activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "be"

Phrase: "achieved"

Phrase: "either by extrinsic trypsin(-like"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0205101:Extrinsic [Spatial Concept]
   760   C0595947:Extrinsic [Functional Concept]

Phrase: ")"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "other kallikreins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022478:Kallikreins [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "or"

Phrase: "intrinsically due to a regulatory autoactivation mechanism."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0220905:regulatory [Regulation or Law]
   748   C0441712:Mechanism [Functional Concept]
   748   C1704735:Regulatory [Conceptual Entity]
   748   C1706376:Mechanism [Manufactured Object]
   748   C3146286:Due [Idea or Concept]
Processing 00000000.tx.239: In addition to this activation pathway, the autolysis-sensitive position after Arg76 leads to an inactive species and may provide a second regulatory mechanism; 

Phrase: "In addition to this activation pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "the autolysis-sensitive position after Arg76"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "leads to an inactive species"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0205254:Inactive [Qualitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1705920:Species [Conceptual Entity]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a second regulatory mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.240: once mature protein has been generated from pro-hK6 in the presence of adequate stimuli and in the proper environment, the capacity for autolysis at this position may provide a complementary autoinactivation strategy, acting when the local concentration of hK6 becomes too high or its activity is no longer required.  

Phrase: "once mature protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "generated from pro-hK6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2987124:PRO [Intellectual Product]
   770   C3146294:Generated [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of adequate stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "and in the proper environment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014406:Environment [Spatial Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "the capacity for autolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1516240:Capacity [Quantitative Concept]

Phrase: "at this position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a complementary autoinactivation strategy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategy [Mental Process]

Phrase: "acting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "the local concentration of hK6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "becomes"

Phrase: "too high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "or"

Phrase: "its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "no longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.241: ACKNOWLEDGEMENTS We are indebted to Rosa Prez-Luque and Tnia Gonzlez for technical assistance in crystallization experiments and Dimitrios Vahliotis for DNA sequencing. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "indebted to Rosa Prez-Luque"

Phrase: "and"

Phrase: "Tnia Gonzlez for technical assistance"

Phrase: "in crystallization experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "Dimitrios Vahliotis for DNA sequencing."
Processing 00000000.tx.242: We especially thank the ESRF and EMBL local contacts and the team of the Spanish CRG Beamline BM-14-S at ESRF for providing assistance and support for measurements.  

Phrase: "We especially"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the ESRF"

Phrase: "and"

Phrase: "EMBL local contacts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0332158:contact [Functional Concept]
   793   C0337611:Contact [Population Group]
   793   C1705415:Contact [Idea or Concept]

Phrase: "and"

Phrase: "the team of the Spanish CRG Beamline BM-14-S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0871489:Team [Group]

Phrase: "at ESRF"

Phrase: "for providing assistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018896:Assistance [Social Behavior]

Phrase: "and"

Phrase: "support for measurements."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0183683:Support [Medical Device]
   790   C1521721:Support [Conceptual Entity]
Processing 00000000.tx.243: FOOTNOTES * This work was supported in part by Ministerio de Educacin y Cultura and Ministerio de Ciencia y Tecnologa, Spain, Grants PB98-1631, BIO2000-1659, BIO98-0362, BIO2001-2046, and 2FD97-0518. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by Ministerio de Educacin y Cultura"

Phrase: "and"

Phrase: "Ministerio de Ciencia y Tecnologa,"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "Grants PB98-1631,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0018173:Grants [Quantitative Concept]
   793 E C1548284:Grant [Idea or Concept]

Phrase: "BIO2000-1659,"

Phrase: "BIO98-0362,"

Phrase: "BIO2001-2046,"

Phrase: "and"

Phrase: "2FD97-0518."
Processing 00000000.tx.244: Grants 1999SGR188 and 2001SGR346 and the Centre de Referncia en Biotecnologia (all from the Generalitat de Catalunya) further funded this work. 

Phrase: "Grants 1999SGR188"

Phrase: "and"

Phrase: "2001SGR346"

Phrase: "and"

Phrase: "the Centre de Referncia en Biotecnologia"

Phrase: "("

Phrase: "all from the Generalitat de Catalunya"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0011198:DE [Geographic Area]
   753   C0017480:DE [Geographic Area]
   753   C0444868:All [Quantitative Concept]
   753   C3539085:All [Idea or Concept]
   753   C3541240:DE [Idea or Concept]

Phrase: ")"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "funded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016820:funded [Quantitative Concept]

Phrase: "this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]
Processing 00000000.tx.245: Diffraction data collection as performed at EMBL and BM-14-S protein crystallography beamlines (ESRF, Grenoble) was supported financially by the ESRF and by European Union Grant HPRI-CT-1999-00022 (awarded to the EMBL).

Phrase: "Diffraction data collection"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0010995:Data Collection [Research Activity]
   827   C1511726:Data [Idea or Concept]
   827   C1516698:Collection [Functional Concept]
   827   C1704814:Collection [Idea or Concept]
   827   C3245479:data [Medical Device]
   755 E C1516695:Collected [Idea or Concept]

Phrase: "as"

Phrase: "performed at EMBL"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "BM-14-S protein crystallography beamlines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C0872107:beamline [Manufactured Object]

Phrase: "(ESRF,"

Phrase: "Grenoble"

Phrase: ")"

Phrase: "was"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "financially by the ESRF"

Phrase: "and by European Union Grant HPRI-CT-1999-00022"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0015179:European Union [Organization]
   742   C0018173:Grant [Quantitative Concept]
   742   C0239307:European [Population Group]
   742   C1515981:And [Idea or Concept]
   742   C1535514:European [Population Group]
   742   C1548284:Grant [Idea or Concept]
   742   C2825217:Union [Classification]
   742   C3540513:CT [Gene or Genome]

Phrase: "("

Phrase: "awarded to the EMBL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004446:awarded [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.246: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.247: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.248: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.249: This work is dedicated to Prof. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "dedicated to Prof."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0599518:Prof. [Professional or Occupational Group]
Processing 00000000.tx.250: Wolfram Bode on the occasion of his 60th birthday to acknowledge his hallmark contribution to the structural biology of serine proteinases over the past 3decades. 

Phrase: "Wolfram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041383:Wolfram [Element, Ion, or Isotope]

Phrase: "Bode on the occasion of his 60th birthday to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C1412323:HIS [Gene or Genome]

Phrase: "acknowledge"

Phrase: "his hallmark contribution to the structural biology of serine proteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880177:Contribution [Activity]

Phrase: "over the past 3decades."
Processing 00000000.tx.251: The atomic coordinates and the structure factors (code 1gvl) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).  

Phrase: "The atomic coordinates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0427184:coordinates [Finding]
   861   C0700114:coordinates [Functional Concept]
   861   C1707511:Coordinates [Spatial Concept]

Phrase: "and"

Phrase: "the structure factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678594:Structure [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(code 1gvl"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "deposited in the Protein Data Bank,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1705318:Protein Data Bank [Intellectual Product]
   790   C0242356:Data Bank [Intellectual Product]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0333562:deposited [Functional Concept]
   753   C0442598:Bank [Manufactured Object]
   753   C0872261:Bank [Manufactured Object]
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "Research Collaboratory for Structural Bioinformatics,"

Phrase: "Rutgers University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "New Brunswick,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027963:New Brunswick [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.rcsb.org/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.252: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.253: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.254: 3493-400-61-44; 

Phrase: "3493-400-61-44"

Phrase: ";"
Processing 00000000.tx.255: Fax: 3493-204-59-04; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "3493-204-59-04"

Phrase: ";"
Processing 00000000.tx.256: E-mail: xgrcri@ibmb.csic.es. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "xgrcri@ibmb.csic.es."
Processing 00000000.tx.257: ** Supported by a NATO collaborative research grant (contract 973152) and by the "K. Karatheodoris" grant awarded by the Research Committee of the University of Patras (contract 1950). 

Phrase: "*"

Phrase: "*"

Phrase: "Supported by a NATO collaborative research grant"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0260206:research grant [Research Activity]
   774   C0035176:research supported [Quantitative Concept]
   748   C0018173:Grant [Quantitative Concept]
   748   C0035168:research [Research Activity]
   748   C0242481:Research [Research Activity]
   748   C0282116:collaborative [Social Behavior]
   748   C1521721:Supported [Conceptual Entity]
   748   C1548284:Grant [Idea or Concept]
   714 E C0183683:Support [Medical Device]

Phrase: "(contract 973152"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332522:Contract [Intellectual Product]
   861   C1705564:Contract [Conceptual Entity]

Phrase: ")"

Phrase: "and by the ""K. Karatheodoris"" grant"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0018173:Grant [Quantitative Concept]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1515981:And [Idea or Concept]
   753   C1548284:Grant [Idea or Concept]
   753   C1708601:K' [Quantitative Concept]

Phrase: "awarded by the Research Committee of the University of Patras"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0004446:awarded [Manufactured Object]
   739   C0035168:research [Research Activity]
   739   C0041740:University [Manufactured Object,Organization]
   739   C0242481:Research [Research Activity]
   739   C2699414:Committee [Group]

Phrase: "(contract 1950"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332522:Contract [Intellectual Product]
   861   C1705564:Contract [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.258: Published, JBC Papers in Press, May 16,2002,DOI 10.1074/jbc.M201534200 2 T. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "May 16,"

Phrase: "2002,"

Phrase: "DOI 10.1074/jbc.M201534200 2 T."
Processing 00000000.tx.259: Tsetsenis, unpublished results.  

Phrase: "Tsetsenis,"

Phrase: "unpublished results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.260: ABBREVIATIONS The abbreviations used are: KLKx, kallikrein-family gene ascription number x according to Ref. 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "KLKx,"

Phrase: "kallikrein-family gene ascription number x according to Ref."
Processing 00000000.tx.261: 5 and the human gene nomenclature committee (www.gene.ucl.ac.uk/nomenclature/); 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "the human gene nomenclature committee"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1709239:Nomenclature Committee [Organization]
   812   C2699414:Committee [Group]

Phrase: "(www.gene.ucl.ac.uk/nomenclature/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0600281:Nomenclature [Intellectual Product]
   799   C1524067:Nomenclature [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.262: hK6, human kallikrein 6; 

Phrase: "hK6,"

Phrase: "human kallikrein 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1416677:KALLIKREIN 6 [Gene or Genome]
   827   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0086418:Human [Human]

Phrase: ";"
Processing 00000000.tx.263: PDB, Protein Data Bank; 

Phrase: "PDB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029401:PDB [Disease or Syndrome]
  1000   C0048243:PDB [Hazardous or Poisonous Substance,Organic Chemical]
  1000   C1705318:PDB [Intellectual Product]

Phrase: "Protein Data Bank"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1705318:Protein Data Bank [Intellectual Product]
   901   C0242356:Data Bank [Intellectual Product]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0442598:Bank [Manufactured Object]
   827   C0872261:Bank [Manufactured Object]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: ";"
Processing 00000000.tx.264: PSA, prostate-specific antigen; 

Phrase: "PSA,"

Phrase: "prostate-specific antigen"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0138741:Prostate-Specific Antigen [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1366489:PROSTATE-SPECIFIC ANTIGEN [Gene or Genome]
   913   C1704988:Prostate Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0456981:Specific antigen [Immunologic Factor]
   827   C0003320:Antigen [Immunologic Factor]
   827   C0033572:Prostate [Body Part, Organ, or Organ Component]
   827   C0205369:Specific [Qualitative Concept]
   827   C1278980:Prostate [Body Part, Organ, or Organ Component]
   827   C1552740:specific [Intellectual Product]
   727 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: ";"
Processing 00000000.tx.265: S1, S2, etc. and P1, P2, etc., protease active site cleft and substrate subsites, respectively, N-terminal of the scissile peptide bond, S1', S2', etc. and P1', P2', etc., protease active site cleft and substrate subsites, respectively, at the C terminus of the scission, in accordance with Ref. 

Phrase: "S1,"

Phrase: "S2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179705:S2 [Body Location or Region]
  1000   C1419032:S2 [Gene or Genome]
  1000   C1419718:S2 [Gene or Genome]

Phrase: "etc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]

Phrase: "and"

Phrase: "P1,"

Phrase: "P2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "etc.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]

Phrase: "protease active site cleft"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205242:Cleft [Spatial Concept]

Phrase: "and"

Phrase: "substrate subsites,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710234:Subsite [Spatial Concept]

Phrase: "respectively,"

Phrase: "N-terminal of the scissile peptide bond,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205088:Terminal [Temporal Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]

Phrase: "S1',"

Phrase: "S2',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179705:S2 [Body Location or Region]
  1000   C1419032:S2 [Gene or Genome]
  1000   C1419718:S2 [Gene or Genome]

Phrase: "etc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]

Phrase: "and"

Phrase: "P1',"

Phrase: "P2',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "etc.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]

Phrase: "protease active site cleft"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205242:Cleft [Spatial Concept]

Phrase: "and"

Phrase: "substrate subsites,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710234:Subsite [Spatial Concept]

Phrase: "respectively,"

Phrase: "at the C terminus"

Phrase: "of the scission,"

Phrase: "in accordance with Ref."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425988:REF [Gene or Genome]
Processing 00000000.tx.266: 64; 

Phrase: "64"

Phrase: ";"
Processing 00000000.tx.267: SP, Swiss-Prot/TrEMBL sequence database accession number (www.expasy.org/sprot); 

Phrase: "SP,"

Phrase: "Swiss-Prot/TrEMBL sequence database accession number"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   845   C2348184:Sequence Number [Quantitative Concept]
   818   C1510755:Accession Number [Intellectual Product]
           Accession
   795   C0237753:*Number [Quantitative Concept]
   795   C0449788:Number [Quantitative Concept]
   795   C1706078:Accession [Activity]

Phrase: "(www.expasy.org/sprot"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.268: RF, rotation function; 

Phrase: "RF,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "rotation function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.269: CC, correlation coefficient in amplitudes.  

Phrase: "CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538933:CC [Cell Component]

Phrase: "correlation coefficient in amplitudes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1707429:*Coefficient [Quantitative Concept]
   770   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.270: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   822   C2825142:Experimental Result [Finding]
           Result
   766   C1274040:Result [Functional Concept]
   766   C1546471:Result [Idea or Concept]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.271: Schachter, M. 

Phrase: "Schachter,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.272: (1979) Pharmacol. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Pharmacol."
Processing 00000000.tx.273: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.274: 31, 1-17[Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "1-17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.275: Kraut, H., Frey, E. 

Phrase: "Kraut,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Frey,"

Phrase: "E."
Processing 00000000.tx.276: K., and Werle, E. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Werle,"

Phrase: "E."
Processing 00000000.tx.277: (1930) Hoppe-Seylers Z.

Phrase: "(1930"

Phrase: ")"

Phrase: "Hoppe-Seylers Z."
Processing 00000000.tx.278: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.279: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.280: 189, 97-106 3. 

Phrase: "189,"

Phrase: "97-106 3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439073:97 [Intellectual Product]
   827   C0439082:>97 [Quantitative Concept]
Processing 00000000.tx.281: Nustad, K., Orstavik, T. 

Phrase: "Nustad,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Orstavik,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.282: B., Gautvik, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gautvik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.283: M., and Pierce, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Pierce,"

Phrase: "J."
Processing 00000000.tx.284: V. 

Phrase: "V."
Processing 00000000.tx.285: (1978) Gen. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Gen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704351:GEN [Quantitative Concept]
  1000   C2239486:Gen [Gene or Genome]
Processing 00000000.tx.286: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.287: 9, 1-9[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "9,"

Phrase: "1-9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.288: Fiedler, F. 

Phrase: "Fiedler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.289: (1979) in Bradykinin, Kallidin, and Kallikrein (Erds, E. G., ed) , pp. 

Phrase: "(1979"

Phrase: ")"

Phrase: "in Bradykinin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "Kallidin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022474:Kallidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Kallikrein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(Erds,"

Phrase: "E. G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.290: 103-161, Springer, Berlin 5. 

Phrase: "103-161,"

Phrase: "Springer,"

Phrase: "Berlin 5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005125:Berlin [Geographic Area]
Processing 00000000.tx.291: Yousef, G. 

Phrase: "Yousef,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.292: M., and Diamandis, E. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Diamandis,"

Phrase: "E."
Processing 00000000.tx.293: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.294: (2001) Endocr. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Endocr."
Processing 00000000.tx.295: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.296: 22, 184-204[Abstract/Free FullText] 6. 

Phrase: "22,"

Phrase: "184-204"

Phrase: "[Abstract/Free FullText"

Phrase: "] 6."
Processing 00000000.tx.297: Clements, J. 

Phrase: "Clements,"

Phrase: "J."
Processing 00000000.tx.298: A. 

Phrase: "A."
Processing 00000000.tx.299: (1997) in The Kinin System (Farmer, S. G., ed) , pp. 

Phrase: "(1997"

Phrase: ")"

Phrase: "in The Kinin System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Farmer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221460:Farmer [Professional or Occupational Group]

Phrase: "S. G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.300: 71-97, Academic Press, Inc., San Diego, CA 7. 

Phrase: "71-97,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
   861   C0450389:71 [Intellectual Product]

Phrase: "Academic Press,"

Phrase: "Inc.,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA 7."
Processing 00000000.tx.301: Gerald, W. 

Phrase: "Gerald,"

Phrase: "W."
Processing 00000000.tx.302: L., Chao, J., and Chao, L. 

Phrase: "L., Chao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1194380:chao [Eukaryote]

Phrase: "J.,"

Phrase: "and"

Phrase: "Chao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1194380:chao [Eukaryote]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.303: (1986) Biochim. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.304: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.305: Acta 866, 1-14[Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "Acta 866,"

Phrase: "1-14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.306: Chen, Z. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Z."
Processing 00000000.tx.307: L., Momota, Y., Kato, K., Taniguchi, M., Inoue, N., Shiosaka, S., and Yoshida, S. 

Phrase: "L., Momota,"

Phrase: "Y.,"

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Taniguchi,"

Phrase: "M."

Phrase: ","

Phrase: "Inoue,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Shiosaka,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Yoshida,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.308: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.309: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.310: Cytochem. 

Phrase: "Cytochem."
Processing 00000000.tx.311: 46, 313-320[Abstract/Free FullText] 9. 

Phrase: "46,"

Phrase: "313-320"

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.312: Fujinaga, M., and James, M. 

Phrase: "Fujinaga,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "James,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.313: N.G. 

Phrase: "N.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.314: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.315: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.316: Biol. 

Phrase: "Biol."
Processing 00000000.tx.317: 195, 373-396[Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "195,"

Phrase: "373-396"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.318: Timm, D. 

Phrase: "Timm,"

Phrase: "D."
Processing 00000000.tx.319: E. 

Phrase: "E."
Processing 00000000.tx.320: (1997) Protein Sci. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Protein Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.321: 6, 1418-1425[Abstract/Free FullText] 11. 

Phrase: "6,"

Phrase: "1418-1425"

Phrase: "[Abstract/Free FullText"

Phrase: "] 11."
Processing 00000000.tx.322: Prez-Polo, J. 

Phrase: "Prez-Polo,"

Phrase: "J."
Processing 00000000.tx.323: R., De, Jong, W. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "De,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011198:DE [Geographic Area]
  1000   C0017480:DE [Geographic Area]
  1000   C3541240:DE [Idea or Concept]

Phrase: "Jong,"

Phrase: "W."
Processing 00000000.tx.324: W., Straus, D., and Shooter, E. 

Phrase: "W., Straus,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Shooter,"

Phrase: "E."
Processing 00000000.tx.325: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.326: (1972) Adv. 

Phrase: "(1972"

Phrase: ")"

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.327: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.328: Med. 

Phrase: "Med."
Processing 00000000.tx.329: Biol. 

Phrase: "Biol."
Processing 00000000.tx.330: 32, 91-97[Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "32,"

Phrase: "91-97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.331: Evans, B. 

Phrase: "Evans,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.332: A., Yun, Z. 

Phrase: "A.,"

Phrase: "Yun,"

Phrase: "Z."
Processing 00000000.tx.333: X., Close, J. 

Phrase: "X.,"

Phrase: "Close,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:Close [Functional Concept]

Phrase: "J."
Processing 00000000.tx.334: A., Tregear, G. 

Phrase: "A.,"

Phrase: "Tregear,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.335: W., Kitamura, N., Nakanishi, S., Callen, D. 

Phrase: "W., Kitamura,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Nakanishi,"

Phrase: "S."

Phrase: ","

Phrase: "Callen,"

Phrase: "D."
Processing 00000000.tx.336: F., Baker, E., Hyland, V. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "E.,"

Phrase: "Hyland,"

Phrase: "V."
Processing 00000000.tx.337: J., and Sutherland, G. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Sutherland,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.338: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.339: (1988) Biochemistry 27, 3124-3129[Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Biochemistry 27,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "3124-3129"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.340: Schedlich, L. 

Phrase: "Schedlich,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.341: J., Bennetts, B. 

Phrase: "J.,"

Phrase: "Bennetts,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.342: H., and Morris, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Morris,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.343: J. 

Phrase: "J."
Processing 00000000.tx.344: (1987) DNA 6, 429-437[Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "(1987"

Phrase: ")"

Phrase: "DNA 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "429-437"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.345: Riegman, P. 

Phrase: "Riegman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.346: H., Vlietstra, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Vlietstra,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.347: J., van der Korput, J. 

Phrase: "J.,"

Phrase: "van der Korput,"

Phrase: "J."
Processing 00000000.tx.348: A., Romijn, J. 

Phrase: "A.,"

Phrase: "Romijn,"

Phrase: "J."
Processing 00000000.tx.349: C., and Trapman, J. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Trapman,"

Phrase: "J."
Processing 00000000.tx.350: (1989) Biochem. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.351: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.352: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.353: Commun. 

Phrase: "Commun."
Processing 00000000.tx.354: 159, 95-102[Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "159,"

Phrase: "95-102"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.355: Liu, X. 

Phrase: "Liu,"

Phrase: "X."
Processing 00000000.tx.356: L., Wazer, D. 

Phrase: "L., Wazer,"

Phrase: "D."
Processing 00000000.tx.357: E., Watanabe, K., and Band, V. 

Phrase: "E.,"

Phrase: "Watanabe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Band,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "V."
Processing 00000000.tx.358: (1996) Cancer Res. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.359: 56, 3371-3379[Abstract] 16. 

Phrase: "56,"

Phrase: "3371-3379"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 16."
Processing 00000000.tx.360: Anisowicz, A., Sotiropoulou, G., Stenman, G., Mok, S. 

Phrase: "Anisowicz,"

Phrase: "A.,"

Phrase: "Sotiropoulou,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Stenman,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mok,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366622:MOK [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.361: C., and Sager, R. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Sager,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.362: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.363: Med. 

Phrase: "Med."
Processing 00000000.tx.364: 2, 624-636[Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "624-636"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.365: Nelson, P. 

Phrase: "Nelson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.366: S., Gan, L., Ferguson, C., Moss, P., Gelinas, R., Hood, L., and Wang, K. 

Phrase: "S."

Phrase: ","

Phrase: "Gan,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ferguson,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Moss,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282635:Moss [Plant]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gelinas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1199058:gelinas [Eukaryote]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hood,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2720748:hood [Medical Device]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Wang,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.367: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.368: Natl. 

Phrase: "Natl."
Processing 00000000.tx.369: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.370: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.371: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.372: 96, 3114-3119[Abstract/Free FullText] 18. 

Phrase: "96,"

Phrase: "3114-3119"

Phrase: "[Abstract/Free FullText"

Phrase: "] 18."
Processing 00000000.tx.373: Hartley, B. 

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.374: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.375: (1964) Nature 201, 1284-1287 19. 

Phrase: "(1964"

Phrase: ")"

Phrase: "Nature 201,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "1284-1287 19."
Processing 00000000.tx.376: Neurath, H. 

Phrase: "Neurath,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.377: (1975) in Proteases and Biological Control (Reich, E. , Rifkins, D. B. , and Shaw, E., eds), Vol. 

Phrase: "(1975"

Phrase: ")"

Phrase: "in Proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "and"

Phrase: "Biological Control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0678661:Biological control [Biologic Function]
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Reich,"

Phrase: "E. ,"

Phrase: "Rifkins,"

Phrase: "D. B. ,"

Phrase: "and"

Phrase: "Shaw,"

Phrase: "E.,"

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.378: 2 , pp. 

Phrase: "2 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "pp."
Processing 00000000.tx.379: 51-64, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 20. 

Phrase: "51-64,"

Phrase: "Cold Spring Harbor Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022877:Laboratory [Manufactured Object,Organization]
   812   C3244292:laboratory [Functional Concept]

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY 20."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]
Processing 00000000.tx.380: Clements, J. 

Phrase: "Clements,"

Phrase: "J."
Processing 00000000.tx.381: A. 

Phrase: "A."
Processing 00000000.tx.382: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.383: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.384: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.385: 99, C1-C6[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "99,"

Phrase: "C1-C6[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.386: Harvey, T. 

Phrase: "Harvey,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.387: J., Hooper, J. 

Phrase: "J.,"

Phrase: "Hooper,"

Phrase: "J."
Processing 00000000.tx.388: D., Myers, S. 

Phrase: "D."

Phrase: ","

Phrase: "Myers,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.389: A., Stephenson, S. 

Phrase: "A.,"

Phrase: "Stephenson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.390: A., Ashworth, L. 

Phrase: "A.,"

Phrase: "Ashworth,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.391: K., and Clements, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Clements,"

Phrase: "J."
Processing 00000000.tx.392: A. 

Phrase: "A."
Processing 00000000.tx.393: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.394: Biol. 

Phrase: "Biol."
Processing 00000000.tx.395: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.396: 275, 37397-37406[Abstract/Free FullText] 22. 

Phrase: "275,"

Phrase: "37397-37406"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.397: Pericak-Vance, M. 

Phrase: "Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.398: A., Bebout, J. 

Phrase: "A.,"

Phrase: "Bebout,"

Phrase: "J."
Processing 00000000.tx.399: L., Gaskell Jr, P. 

Phrase: "L., Gaskell Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.400: C., Yamaoka, L. 

Phrase: "C., Yamaoka,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.401: H., Hung, W. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "W."
Processing 00000000.tx.402: Y., Alberts, M. 

Phrase: "Y.,"

Phrase: "Alberts,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.403: J., Walker, A. 

Phrase: "J.,"

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "A."
Processing 00000000.tx.404: P., Bartlett, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bartlett,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.405: J., Haynes, C. 

Phrase: "J.,"

Phrase: "Haynes,"

Phrase: "C."
Processing 00000000.tx.406: A., and Welsh, K. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Welsh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.407: A. 

Phrase: "A."
Processing 00000000.tx.408: (1991) Am. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.409: J.Hum. 

Phrase: "J.Hum."
Processing 00000000.tx.410: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.411: 48, 1034-1050[Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "48,"

Phrase: "1034-1050"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.412: Mitelman, F. 

Phrase: "Mitelman,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.413: (1994) Catalog of Chromosome Aberrations in Cancer , 5th Ed. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Catalog of Chromosome Aberrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0376658:Catalog [Intellectual Product]

Phrase: "in Cancer ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "5th Ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]
Processing 00000000.tx.414: , John Wiley &Sons, Inc., New York 24. 

Phrase: ", John Wiley &Sons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037683:Son [Family Group]

Phrase: "Inc.,"

Phrase: "New York 24."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]
Processing 00000000.tx.415: Amfo, K., Neyns, B., Teugels, E., Lissens, W., Bourgain, C., De, Sutter, P., Vandamme, B., Vamos, E., and De Greve, J. 

Phrase: "Amfo,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Neyns,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Teugels,"

Phrase: "E.,"

Phrase: "Lissens,"

Phrase: "W.,"

Phrase: "Bourgain,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "De,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011198:DE [Geographic Area]
  1000   C0017480:DE [Geographic Area]
  1000   C3541240:DE [Idea or Concept]

Phrase: "Sutter,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vandamme,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Vamos,"

Phrase: "E.,"

Phrase: "and"

Phrase: "De Greve,"

Phrase: "J."
Processing 00000000.tx.416: (1995) Oncogene 11, 351-358[Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Oncogene 11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "351-358"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.417: Ozen, M., Hopwood, V. 

Phrase: "Ozen,"

Phrase: "M."

Phrase: ","

Phrase: "Hopwood,"

Phrase: "V."
Processing 00000000.tx.418: L., Balbay, M. 

Phrase: "L., Balbay,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.419: D., Johnston, D. 

Phrase: "D."

Phrase: ","

Phrase: "Johnston,"

Phrase: "D."
Processing 00000000.tx.420: A., Babaian, R. 

Phrase: "A.,"

Phrase: "Babaian,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.421: J., Logothetis, C. 

Phrase: "J.,"

Phrase: "Logothetis,"

Phrase: "C."
Processing 00000000.tx.422: J., von Eschenbach, A. 

Phrase: "J.,"

Phrase: "von Eschenbach,"

Phrase: "A."
Processing 00000000.tx.423: C., and Pathak, S. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Pathak,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.424: (2000) Int. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.425: J.Oncol. 

Phrase: "J.Oncol."
Processing 00000000.tx.426: 17, 113-117[Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "17,"

Phrase: "113-117"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.427: Diamandis, E. 

Phrase: "Diamandis,"

Phrase: "E."
Processing 00000000.tx.428: P., Okui, A., Mitsui, S., Luo, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Okui,"

Phrase: "A.,"

Phrase: "Mitsui,"

Phrase: "S."

Phrase: ","

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.429: Y., Soosaipillai, A., Grass, L., Nakamura, T., Howarth, D. 

Phrase: "Y.,"

Phrase: "Soosaipillai,"

Phrase: "A.,"

Phrase: "Grass,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018210:Grass [Plant]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nakamura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Howarth,"

Phrase: "D."
Processing 00000000.tx.430: J., and Yamaguchi, N. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Yamaguchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.431: (2002) Cancer Res. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.432: 62, 295-300[Abstract/Free FullText] 27. 

Phrase: "62,"

Phrase: "295-300"

Phrase: "[Abstract/Free FullText"

Phrase: "] 27."
Processing 00000000.tx.433: Yamashiro, K., Tsuruoka, N., Kodama, S., Tsujimoto, M., Yamamura, Y., Tanaka, T., Nakazato, H., and Yamaguchi, N. 

Phrase: "Yamashiro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuruoka,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kodama,"

Phrase: "S."

Phrase: ","

Phrase: "Tsujimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Tanaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakazato,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Yamaguchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.434: (1997) Biochim. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.435: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.436: Acta 1350, 11-14[Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "Acta 1350,"

Phrase: "11-14"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.437: Little, S. 

Phrase: "Little, S."
Processing 00000000.tx.438: P., Dixon, E. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dixon,"

Phrase: "E."
Processing 00000000.tx.439: P., Norris, F., Buckley, W., Becker, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Norris,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Buckley,"

Phrase: "W.,"

Phrase: "Becker,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.440: W., Johnson, M., Dobbins, J. 

Phrase: "W., Johnson,"

Phrase: "M."

Phrase: ","

Phrase: "Dobbins,"

Phrase: "J."
Processing 00000000.tx.441: R., Wyrick, T., Miller, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wyrick,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.442: R., MacKellar, W., Hepburn, D., Corvalan, J., McClure, D., Liu, X., Stephenson, D., Clemens, J., and Johnstone, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "MacKellar,"

Phrase: "W.,"

Phrase: "Hepburn,"

Phrase: "D."

Phrase: ","

Phrase: "Corvalan,"

Phrase: "J.,"

Phrase: "McClure,"

Phrase: "D."

Phrase: ","

Phrase: "Liu,"

Phrase: "X.,"

Phrase: "Stephenson,"

Phrase: "D."

Phrase: ","

Phrase: "Clemens,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Johnstone,"

Phrase: "E."
Processing 00000000.tx.443: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.444: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.445: Biol. 

Phrase: "Biol."
Processing 00000000.tx.446: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.447: 272, 25135-25142[Abstract/Free FullText] 29. 

Phrase: "272,"

Phrase: "25135-25142"

Phrase: "[Abstract/Free FullText"

Phrase: "] 29."
Processing 00000000.tx.448: Mason, A. 

Phrase: "Mason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331857:Mason [Health Care Related Organization]

Phrase: "A."
Processing 00000000.tx.449: J., Evans, B. 

Phrase: "J.,"

Phrase: "Evans,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.450: A., Cox, D. 

Phrase: "A.,"

Phrase: "Cox,"

Phrase: "D."
Processing 00000000.tx.451: R., Shine, J., and Richards, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Shine,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Richards,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.452: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.453: (1983) Nature 303, 300-307[Medline] [OrderarticleviaInfotrieve] 30. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Nature 303,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "300-307"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 30."
Processing 00000000.tx.454: Evans, B. 

Phrase: "Evans,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.455: A., Drinkwater, C. 

Phrase: "A.,"

Phrase: "Drinkwater,"

Phrase: "C."
Processing 00000000.tx.456: C., and Richards, R. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Richards,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.457: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.458: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.459: Biol. 

Phrase: "Biol."
Processing 00000000.tx.460: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.461: 262, 8027-8034[Abstract/Free FullText] 31. 

Phrase: "262,"

Phrase: "8027-8034"

Phrase: "[Abstract/Free FullText"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.462: MacDonald, R.J., Southard-Smith, E.M., and Kroon, E.(1996) 271,13684-13690 32. 

Phrase: "MacDonald,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Southard-Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Kroon,"

Phrase: "E.(1996"

Phrase: ")"

Phrase: "271,"

Phrase: "13684-13690 32."
Processing 00000000.tx.463: Kishi, T., Kato, M., Shimizu, T., Kato, K., Matsumoto, K., Yoshida, S., Shiosaka, S., and Hakoshima, T. 

Phrase: "Kishi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "M."

Phrase: ","

Phrase: "Shimizu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Matsumoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yoshida,"

Phrase: "S."

Phrase: ","

Phrase: "Shiosaka,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Hakoshima,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.464: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.465: Biol. 

Phrase: "Biol."
Processing 00000000.tx.466: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.467: 274, 4220-4224[Abstract/Free FullText] 33. 

Phrase: "274,"

Phrase: "4220-4224"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.468: Ogawa, K., Yamada, T., Tsujioka, Y., Taguchi, J., Takahashi, M., Tsuboi, Y., Fujino, Y., Nakajima, M., Yamamoto, T., Akatsu, H., Mitsui, S., and Yamaguchi, N. 

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tsujioka,"

Phrase: "Y.,"

Phrase: "Taguchi,"

Phrase: "J.,"

Phrase: "Takahashi,"

Phrase: "M."

Phrase: ","

Phrase: "Tsuboi,"

Phrase: "Y.,"

Phrase: "Fujino,"

Phrase: "Y.,"

Phrase: "Nakajima,"

Phrase: "M."

Phrase: ","

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Akatsu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mitsui,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Yamaguchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.469: (2000) Psych. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Psych."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1306597:psych [Mental or Behavioral Dysfunction]
Processing 00000000.tx.470: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.471: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.472: 54, 419-426[CrossRef][Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "54,"

Phrase: "419-426"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.473: Okui, A., Kominami, K., Uemura, H., Mitsui, S., and Yamaguchi, N. 

Phrase: "Okui,"

Phrase: "A.,"

Phrase: "Kominami,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Uemura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mitsui,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Yamaguchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.474: (2001) Neuroreport 12, 1345-1350[CrossRef][Medline] [OrderarticleviaInfotrieve] 35. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neuroreport 12,"

Phrase: "1345-1350"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 35."
Processing 00000000.tx.475: Petraki, C. 

Phrase: "Petraki,"

Phrase: "C."
Processing 00000000.tx.476: D., Karavana, V. 

Phrase: "D."

Phrase: ","

Phrase: "Karavana,"

Phrase: "V."
Processing 00000000.tx.477: N., Skoufogiannis, P. 

Phrase: "N., Skoufogiannis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.478: T., Little, S. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Little,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.479: P., Howarth, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Howarth,"

Phrase: "D."
Processing 00000000.tx.480: J., Yousef, G. 

Phrase: "J.,"

Phrase: "Yousef,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.481: M., and Diamandis, E. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Diamandis,"

Phrase: "E."
Processing 00000000.tx.482: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.483: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.484: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.485: Cytochem. 

Phrase: "Cytochem."
Processing 00000000.tx.486: 49, 1431-1441[Abstract/Free FullText] 36. 

Phrase: "49,"

Phrase: "1431-1441"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.487: Yousef, G. 

Phrase: "Yousef,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.488: M., Luo, L. 

Phrase: "M."

Phrase: ","

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.489: Y., Scherer, S. 

Phrase: "Y.,"

Phrase: "Scherer,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.490: W., Sotiropoulou, G., and Diamandis, E. 

Phrase: "W., Sotiropoulou,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Diamandis,"

Phrase: "E."
Processing 00000000.tx.491: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.492: (1999) Genomics 62, 251-259[CrossRef][Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genomics 62,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "251-259"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.493: Lpez-Otn, C., and Diamandis, E. 

Phrase: "Lpez-Otn,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Diamandis,"

Phrase: "E."
Processing 00000000.tx.494: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.495: (1998) Endocr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Endocr."
Processing 00000000.tx.496: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.497: 19, 365-396[Abstract/Free FullText] 38. 

Phrase: "19,"

Phrase: "365-396"

Phrase: "[Abstract/Free FullText"

Phrase: "] 38."
Processing 00000000.tx.498: Tanimoto, H., Underwood, L. 

Phrase: "Tanimoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Underwood,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.499: J., Shigemasa, K., Parmley, T. 

Phrase: "J.,"

Phrase: "Shigemasa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Parmley,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.500: H., and O'Brien, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "O'Brien,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.501: J. 

Phrase: "J."
Processing 00000000.tx.502: (2001) Tumour Biol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Tumour Biol."
Processing 00000000.tx.503: 22, 11-18[CrossRef][Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "22,"

Phrase: "11-18"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.504: Tomizawa, K., He, X., Yamanaka, H., Shiosaka, S., and Yoshida, S. 

Phrase: "Tomizawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "He,"

Phrase: "X.,"

Phrase: "Yamanaka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shiosaka,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Yoshida,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.505: (1999) Brain Res. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.506: 824, 308-311[CrossRef][Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "824,"

Phrase: "308-311"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.507: Diamandis, E. 

Phrase: "Diamandis,"

Phrase: "E."
Processing 00000000.tx.508: P., Yousef, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yousef,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.509: M., Soosaipillai, A. 

Phrase: "M."

Phrase: ","

Phrase: "Soosaipillai,"

Phrase: "A."
Processing 00000000.tx.510: R., and Bunting, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Bunting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326922:Bunting [Bird]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.511: (2000) Clin. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.512: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.513: 33, 579-583[CrossRef][Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "33,"

Phrase: "579-583"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.514: Diamandis, E. 

Phrase: "Diamandis,"

Phrase: "E."
Processing 00000000.tx.515: P., Yousef, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yousef,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.516: M., Petraki, C., and Soosaipillai, A. 

Phrase: "M."

Phrase: ","

Phrase: "Petraki,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Soosaipillai,"

Phrase: "A."
Processing 00000000.tx.517: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.518: (2000) Biochemistry 33, 663-667[CrossRef] 42. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochemistry 33,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "663-667"

Phrase: "[CrossRef"

Phrase: "] 42."
Processing 00000000.tx.519: Diamandis, E. 

Phrase: "Diamandis,"

Phrase: "E."
Processing 00000000.tx.520: P., Yousef, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yousef,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.521: M., Soosaipillai, A. 

Phrase: "M."

Phrase: ","

Phrase: "Soosaipillai,"

Phrase: "A."
Processing 00000000.tx.522: R., Grass, L., Porter, A., Little, S., and Sotiropoulou, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Grass,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018210:Grass [Plant]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Porter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0402671:Porter [Professional or Occupational Group]
  1000   C2244327:porter [Molecular Function]

Phrase: "A.,"

Phrase: "Little,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Sotiropoulou,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.523: (2000) Clin. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.524: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.525: 33, 369-375[CrossRef][Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "33,"

Phrase: "369-375"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.526: Ventura, S., Villegas, V., Sterner, J., Larson, J., Vendrell, J., Hershberger, C. 

Phrase: "Ventura,"

Phrase: "S."

Phrase: ","

Phrase: "Villegas,"

Phrase: "V.,"

Phrase: "Sterner,"

Phrase: "J.,"

Phrase: "Larson,"

Phrase: "J.,"

Phrase: "Vendrell,"

Phrase: "J.,"

Phrase: "Hershberger,"

Phrase: "C."
Processing 00000000.tx.527: L., and Avils, F. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Avils,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0733431:Avil [Organic Chemical,Pharmacologic Substance]
   966   C1422473:AVIL [Gene or Genome]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.528: X. 

Phrase: "X."
Processing 00000000.tx.529: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.530: Biol. 

Phrase: "Biol."
Processing 00000000.tx.531: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.532: 28, 19925-19933[CrossRef] 44. 

Phrase: "28,"

Phrase: "19925-19933"

Phrase: "[CrossRef"

Phrase: "] 44."
Processing 00000000.tx.533: Gomis-Rth, F. 

Phrase: "Gomis-Rth,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.534: X., Gmez-Ortiz, M., Vendrell, J., Ventura, S., Bode, W., Huber, R., and Avils, F. 

Phrase: "X.,"

Phrase: "Gmez-Ortiz,"

Phrase: "M."

Phrase: ","

Phrase: "Vendrell,"

Phrase: "J.,"

Phrase: "Ventura,"

Phrase: "S."

Phrase: ","

Phrase: "Bode"

Phrase: ","

Phrase: "W.,"

Phrase: "Huber,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Avils,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0733431:Avil [Organic Chemical,Pharmacologic Substance]
   966   C1422473:AVIL [Gene or Genome]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.535: X. 

Phrase: "X."
Processing 00000000.tx.536: (1998) Eur. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.537: J.

Phrase: "J."
Processing 00000000.tx.538: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.539: 251, 839-844[Abstract] 45. 

Phrase: "251,"

Phrase: "839-844"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 45."
Processing 00000000.tx.540: Matthews, B. 

Phrase: "Matthews,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.541: W. 

Phrase: "W."
Processing 00000000.tx.542: (1968) J. 

Phrase: "(1968"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.543: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.544: Biol. 

Phrase: "Biol."
Processing 00000000.tx.545: 33, 491-497[Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "33,"

Phrase: "491-497"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.546: Leslie, A. 

Phrase: "Leslie,"

Phrase: "A."
Processing 00000000.tx.547: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.548: (1999) Acta Crystallogr. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.549: Sect. 

Phrase: "Sect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061878:SECT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415380:SECT [Gene or Genome]
  1000   C3538708:SECT [Gene or Genome]
Processing 00000000.tx.550: D 55, 1696-1702[CrossRef][Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "D 55,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0450382:55 [Intellectual Product]

Phrase: "1696-1702"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.551: Evans, P. 

Phrase: "Evans,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.552: (1993) in Data collection and Processing: Proceedings of the CCP4 Study Weekend 29-30 January 1993 (Sawyer, L. , Isaacs, N. , and Bailey, S., eds) , pp. 

Phrase: "(1993"

Phrase: ")"

Phrase: "in Data collection"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0010995:Data Collection [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   861   C3245479:data [Medical Device]
   789 E C1516695:Collected [Idea or Concept]

Phrase: "and"

Phrase: "Processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: ":"

Phrase: "Proceedings of the CCP4 Study Weekend 29-30 January 1993"

Phrase: "(Sawyer,"

Phrase: "L. ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Isaacs,"

Phrase: "N. ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Bailey,"

Phrase: "S."

Phrase: ","

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.553: 114-122, SERC Daresbury Laboratory, Warrington, UK 48. 

Phrase: "114-122,"

Phrase: "SERC Daresbury Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C3244292:laboratory [Functional Concept]

Phrase: "Warrington,"

Phrase: "UK 48."
Processing 00000000.tx.554: Navaza, J. 

Phrase: "Navaza,"

Phrase: "J."
Processing 00000000.tx.555: (1994) Acta Crystallogr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.556: Sect. 

Phrase: "Sect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061878:SECT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415380:SECT [Gene or Genome]
  1000   C3538708:SECT [Gene or Genome]
Processing 00000000.tx.557: A 50, 157-163[CrossRef] 49. 

Phrase: "A 50,"

Phrase: "157-163"

Phrase: "[CrossRef"

Phrase: "] 49."
Processing 00000000.tx.558: Brnger, A. 

Phrase: "Brnger,"

Phrase: "A."
Processing 00000000.tx.559: T., Adams, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.560: D., Clore, G. 

Phrase: "D."

Phrase: ","

Phrase: "Clore,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.561: M., DeLano, W. 

Phrase: "M."

Phrase: ","

Phrase: "DeLano,"

Phrase: "W."
Processing 00000000.tx.562: L., Gros, P., Grosse-Kunstleve, R. 

Phrase: "L., Gros,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1332652:GRO [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1705593:GRO [Gene or Genome]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Grosse-Kunstleve,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.563: W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N. 

Phrase: "W., Jiang,"

Phrase: "J.-S.,"

Phrase: "Kuszewski,"

Phrase: "J.,"

Phrase: "Nilges,"

Phrase: "M."

Phrase: ","

Phrase: "Pannu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.564: S., Read, R. 

Phrase: "S."

Phrase: ","

Phrase: "Read"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Read [Daily or Recreational Activity]
  1000   C1705179:read [Finding]

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.565: J., Rice, L. 

Phrase: "J.,"

Phrase: "Rice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035567:Rice [Food]
  1000   C1140671:rice [Plant]
  1000   C1509547:RICE [Organic Chemical,Pharmacologic Substance]
  1000   C3484401:RICE [Pharmacologic Substance]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.566: M., Simonson, T., and Warren, G. 

Phrase: "M."

Phrase: ","

Phrase: "Simonson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Warren,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.567: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.568: (1998) Acta Crystallogr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.569: Sect. 

Phrase: "Sect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061878:SECT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415380:SECT [Gene or Genome]
  1000   C3538708:SECT [Gene or Genome]
Processing 00000000.tx.570: D 54, 905-921[CrossRef][Medline] [OrderarticleviaInfotrieve] 50. 

Phrase: "D 54,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "905-921"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 50."
Processing 00000000.tx.571: Roussel, A., and Cambilleau, C. 

Phrase: "Roussel,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Cambilleau,"

Phrase: "C."
Processing 00000000.tx.572: (1989) Silicon Graphics Geometry Partners Directory , pp. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Silicon Graphics Geometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449829:Geometry [Spatial Concept]

Phrase: "Partners"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0682323:Partner [Family Group]

Phrase: "Directory ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282426:Directory [Intellectual Product,Manufactured Object]
  1000   C0920318:directory [Intellectual Product,Manufactured Object]

Phrase: "pp."
Processing 00000000.tx.573: 77-79, Silicon Graphics, Mountain View, CA 51. 

Phrase: "77-79,"

Phrase: "Silicon Graphics,"

Phrase: "Mountain View,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "CA 51."
Processing 00000000.tx.574: Perrakis, A., Sixma, T. 

Phrase: "Perrakis,"

Phrase: "A.,"

Phrase: "Sixma,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.575: K., Wilson, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wilson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.576: S., and Lamzin, V. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Lamzin,"

Phrase: "V."
Processing 00000000.tx.577: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.578: (1997) Acta Crystallogr. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.579: Sect. 

Phrase: "Sect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061878:SECT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415380:SECT [Gene or Genome]
  1000   C3538708:SECT [Gene or Genome]
Processing 00000000.tx.580: D 53, 448-455[CrossRef] 52. 

Phrase: "D 53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0057021:D 53 [Immunologic Factor,Pharmacologic Substance]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "448-455"

Phrase: "[CrossRef"

Phrase: "] 52."
Processing 00000000.tx.581: Murshudov, G. 

Phrase: "Murshudov,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.582: N., Vagin, A. 

Phrase: "N., Vagin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522570:VAGIN [Functional Concept]

Phrase: "A."
Processing 00000000.tx.583: A., and Dodson, E. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Dodson,"

Phrase: "E."
Processing 00000000.tx.584: J. 

Phrase: "J."
Processing 00000000.tx.585: (1997) Acta Crystallogr. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.586: Sect. 

Phrase: "Sect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061878:SECT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415380:SECT [Gene or Genome]
  1000   C3538708:SECT [Gene or Genome]
Processing 00000000.tx.587: D 53, 240-255[CrossRef][Medline] [OrderarticleviaInfotrieve] 53. 

Phrase: "D 53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0057021:D 53 [Immunologic Factor,Pharmacologic Substance]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "240-255"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 53."
Processing 00000000.tx.588: Winn, M. 

Phrase: "Winn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.589: D., Isupov, M. 

Phrase: "D."

Phrase: ","

Phrase: "Isupov,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.590: N., and Murshudov, G. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Murshudov,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.591: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.592: (2001) Acta Crystallogr. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.593: Sect. 

Phrase: "Sect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061878:SECT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415380:SECT [Gene or Genome]
  1000   C3538708:SECT [Gene or Genome]
Processing 00000000.tx.594: D 57, 122-133[CrossRef][Medline] [OrderarticleviaInfotrieve] 54. 

Phrase: "D 57,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "122-133"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 54."
Processing 00000000.tx.595: Laskowski, R. 

Phrase: "Laskowski,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.596: A., Macarthur, M. 

Phrase: "A.,"

Phrase: "Macarthur,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.597: W., and Thornton, J. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Thornton,"

Phrase: "J."
Processing 00000000.tx.598: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.599: (1998) Curr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.600: Opin. 

Phrase: "Opin."
Processing 00000000.tx.601: Struct. 

Phrase: "Struct."
Processing 00000000.tx.602: Biol. 

Phrase: "Biol."
Processing 00000000.tx.603: 8, 631-639[CrossRef][Medline] [OrderarticleviaInfotrieve] 55. 

Phrase: "8,"

Phrase: "631-639"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.604: Collaborative Computing Project 4. 

Phrase: "Collaborative Computing Project 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0282116:collaborative [Social Behavior]
   812   C1709701:Project [Conceptual Entity]
   812   C1880157:Computing [Activity]
Processing 00000000.tx.605: (1994) Acta Crystallogr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.606: Sect. 

Phrase: "Sect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061878:SECT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415380:SECT [Gene or Genome]
  1000   C3538708:SECT [Gene or Genome]
Processing 00000000.tx.607: D 50, 760-763[CrossRef][Medline] [OrderarticleviaInfotrieve] 56. 

Phrase: "D 50,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "760-763"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 56."
Processing 00000000.tx.608: Holm, L., and Sander, C. 

Phrase: "Holm,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sander,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "C."
Processing 00000000.tx.609: (1998) Nucleic Acids Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.610: 26, 316-319[Abstract/Free FullText] 57. 

Phrase: "26,"

Phrase: "316-319"

Phrase: "[Abstract/Free FullText"

Phrase: "] 57."
Processing 00000000.tx.611: Shindyalov, I. 

Phrase: "Shindyalov,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.612: N., and Bourne, P. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Bourne,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.613: E. 

Phrase: "E."
Processing 00000000.tx.614: (1998) Prot. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Prot."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0555903:PROT [Laboratory Procedure]
  1000   C1420218:PROT [Gene or Genome]
Processing 00000000.tx.615: Eng. 

Phrase: "Eng."
Processing 00000000.tx.616: 11, 739-747[Abstract] 58. 

Phrase: "11,"

Phrase: "739-747"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 58."
Processing 00000000.tx.617: Kraulis, P. 

Phrase: "Kraulis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.618: J. 

Phrase: "J."
Processing 00000000.tx.619: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.620: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.621: Crystallogr. 

Phrase: "Crystallogr."
Processing 00000000.tx.622: 24, 946-950[CrossRef] 59. 

Phrase: "24,"

Phrase: "946-950"

Phrase: "[CrossRef"

Phrase: "] 59."
Processing 00000000.tx.623: Lesk, A. 

Phrase: "Lesk,"

Phrase: "A."
Processing 00000000.tx.624: M., and Fordham, W. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Fordham,"

Phrase: "W."
Processing 00000000.tx.625: D. 

Phrase: "D."
Processing 00000000.tx.626: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.627: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.628: Biol. 

Phrase: "Biol."
Processing 00000000.tx.629: 258, 501-537[CrossRef][Medline] [OrderarticleviaInfotrieve] 60. 

Phrase: "258,"

Phrase: "501-537"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 60."
Processing 00000000.tx.630: Rawlings, N. 

Phrase: "Rawlings,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.631: D., and Barrett, A. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Barrett,"

Phrase: "A."
Processing 00000000.tx.632: J. 

Phrase: "J."
Processing 00000000.tx.633: (1994) Methods Enzymol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.634: 244, 19-60[Medline] [OrderarticleviaInfotrieve] 61. 

Phrase: "244,"

Phrase: "19-60"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 61."
Processing 00000000.tx.635: Gomis-Rth, F. 

Phrase: "Gomis-Rth,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.636: X., Gmez, M., Bode, W., Huber, R., and Avils, F. 

Phrase: "X.,"

Phrase: "Gmez,"

Phrase: "M."

Phrase: ","

Phrase: "Bode"

Phrase: ","

Phrase: "W.,"

Phrase: "Huber,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Avils,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0733431:Avil [Organic Chemical,Pharmacologic Substance]
   966   C1422473:AVIL [Gene or Genome]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.637: X. 

Phrase: "X."
Processing 00000000.tx.638: (1995) EMBO J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.639: 14, 4387-4394[Abstract] 62. 

Phrase: "14,"

Phrase: "4387-4394"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 62."
Processing 00000000.tx.640: Bode, W., and Schwager, P. 

Phrase: "Bode"

Phrase: ","

Phrase: "W.,"

Phrase: "and"

Phrase: "Schwager,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.641: (1975) FEBS Lett. 

Phrase: "(1975"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.642: 56, 139-143[CrossRef][Medline] [OrderarticleviaInfotrieve] 63. 

Phrase: "56,"

Phrase: "139-143"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 63."
Processing 00000000.tx.643: Harel, M., Su, C.T., Frolow, F., Silman, I., and Sussman, J. 

Phrase: "Harel,"

Phrase: "M."

Phrase: ","

Phrase: "Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "C.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Frolow,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Silman,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Sussman,"

Phrase: "J."
Processing 00000000.tx.644: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.645: (1991) Biochemistry 30, 5217-5225[Medline] [OrderarticleviaInfotrieve] 64. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Biochemistry 30,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "5217-5225"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 64."
Processing 00000000.tx.646: Schechter, I., and Berger, A. 

Phrase: "Schechter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Berger,"

Phrase: "A."
Processing 00000000.tx.647: (1967) Biochem. 

Phrase: "(1967"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.648: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.649: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.650: Commun. 

Phrase: "Commun."
Processing 00000000.tx.651: 27, 157-162[Medline] [OrderarticleviaInfotrieve] 65. 

Phrase: "27,"

Phrase: "157-162"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]
Processing 00000000.tx.652: Wang, D., Bode, W., and Huber, R. 

Phrase: "Wang,"

Phrase: "D."

Phrase: ","

Phrase: "Bode"

Phrase: ","

Phrase: "W.,"

Phrase: "and"

Phrase: "Huber,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.653: (1985) J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.654: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.655: Biol. 

Phrase: "Biol."
Processing 00000000.tx.656: 185, 595-624[Medline] [OrderarticleviaInfotrieve] 66. 

Phrase: "185,"

Phrase: "595-624"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 66."
Processing 00000000.tx.657: Madison, E. 

Phrase: "Madison,"

Phrase: "E."
Processing 00000000.tx.658: L., Kobe, A., Gething, M.-J., Sambrook, J. 

Phrase: "L., Kobe,"

Phrase: "A.,"

Phrase: "Gething,"

Phrase: "M.-"

Phrase: "J.,"

Phrase: "Sambrook,"

Phrase: "J."
Processing 00000000.tx.659: F., and Goldsmith, E. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Goldsmith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0403010:Goldsmith [Professional or Occupational Group]

Phrase: "E."
Processing 00000000.tx.660: J. 

Phrase: "J."
Processing 00000000.tx.661: (1993) Science 262, 419-421[Medline] [OrderarticleviaInfotrieve] 67. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 262,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "419-421"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 67."
Processing 00000000.tx.662: Bode, W., Chen, Z., Bartels, K., Kutzbach, C., Schmidt-Kastner, G., and Bartunik, H. 

Phrase: "Bode"

Phrase: ","

Phrase: "W.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Z.,"

Phrase: "Bartels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kutzbach,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schmidt-Kastner,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Bartunik,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.663: (1983) J. 

Phrase: "(1983"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.664: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.665: Biol. 

Phrase: "Biol."
Processing 00000000.tx.666: 164, 237-282[Medline] [OrderarticleviaInfotrieve] 68. 

Phrase: "164,"

Phrase: "237-282"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 68."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]
Processing 00000000.tx.667: Watt, K. 

Phrase: "Watt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439261:Watt [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.668: W.K., Lee, P.-J., M'Timkulu, T., Chan, W.-P., and Loor, R. 

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "P.-J.,"

Phrase: "M'"

Phrase: "Timkulu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chan,"

Phrase: "W.-P.,"

Phrase: "and"

Phrase: "Loor,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.669: (1986) Proc. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.670: Natl. 

Phrase: "Natl."
Processing 00000000.tx.671: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.672: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.673: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.674: 83, 3166-3170[Abstract] 69. 

Phrase: "83,"

Phrase: "3166-3170"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]
Processing 00000000.tx.675: James, M. 

Phrase: "James,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.676: N.G., Delbaere, L. 

Phrase: "N.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Delbaere,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.677: T.J., and Brayer, G. 

Phrase: "T.J.,"

Phrase: "and"

Phrase: "Brayer,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.678: D. 

Phrase: "D."
Processing 00000000.tx.679: (1978) Can. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Can."
Processing 00000000.tx.680: J.

Phrase: "J."
Processing 00000000.tx.681: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.682: 56, 396-402[Medline] [OrderarticleviaInfotrieve] 70. 

Phrase: "56,"

Phrase: "396-402"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 70."
Processing 00000000.tx.683: Young, C. 

Phrase: "Young, C."
Processing 00000000.tx.684: L., Barker, W. 

Phrase: "L., Barker,"

Phrase: "W."
Processing 00000000.tx.685: C., Tomaselli, C. 

Phrase: "C., Tomaselli,"

Phrase: "C."
Processing 00000000.tx.686: M., and Dayhoff, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Dayhoff,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.687: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.688: (1978) in Atlas of Protein Sequence and Structure (Dayhoff, M. O., ed), Vol. 

Phrase: "(1978"

Phrase: ")"

Phrase: "in Atlas"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0004170:Atlas [Body Part, Organ, or Organ Component]
  1000   C0004171:atlas [Intellectual Product,Manufactured Object]
  1000   C2652343:Atla [Fungus]

Phrase: "of Protein Sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0002518:Protein Sequence [Amino Acid Sequence]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "(Dayhoff,"

Phrase: "M. O.,"

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.689: 5, Suppl. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "Suppl."
Processing 00000000.tx.690: 3 , pp. 

Phrase: "3 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "pp."
Processing 00000000.tx.691: 73-94, National Biomedical Research Foundation, Silver Spring, MD 71. 

Phrase: "73-94,"

Phrase: "National Biomedical Research Foundation,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   819   C2986512:Research Base [Organization]
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "Silver Spring,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0037125:Silver [Element, Ion, or Isotope]
   861   C0241232:Spring [Temporal Concept]
   861   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   861   C1305285:Silver [Qualitative Concept]
   861   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   861   C1705204:Spring [Manufactured Object]
   777 E C0079853:Moon [Geographic Area]
   768 E C0003782:Argyria [Injury or Poisoning]
   768 E C3463959:Argyria [Eukaryote]

Phrase: "MD 71."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]
Processing 00000000.tx.692: Scarisbrick, I. 

Phrase: "Scarisbrick,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.693: A., Isackson, P. 

Phrase: "A.,"

Phrase: "Isackson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.694: J., Ciric, B., Windebank, A. 

Phrase: "J.,"

Phrase: "Ciric,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Windebank,"

Phrase: "A."
Processing 00000000.tx.695: J., and Rodriguez, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Rodriguez,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.696: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.697: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.698: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.699: 431, 347-361[CrossRef][Medline] [OrderarticleviaInfotrieve] 72. 

Phrase: "431,"

Phrase: "347-361"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 72."
Processing 00000000.tx.700: Yousef, G. 

Phrase: "Yousef,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.701: M., Magklara, A., Chang, A., Jung, K., Katsaros, D., and Diamandis, E. 

Phrase: "M."

Phrase: ","

Phrase: "Magklara,"

Phrase: "A.,"

Phrase: "Chang,"

Phrase: "A.,"

Phrase: "Jung,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Katsaros,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Diamandis,"

Phrase: "E."
Processing 00000000.tx.702: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.703: (2001) Cancer Res. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.704: 61, 3425-3431[Abstract/Free FullText] 73. 

Phrase: "61,"

Phrase: "3425-3431"

Phrase: "[Abstract/Free FullText"

Phrase: "] 73."
Processing 00000000.tx.705: Quattrocchi, C. 

Phrase: "Quattrocchi,"

Phrase: "C."
Processing 00000000.tx.706: C., Wannenes, F., Persico, A. 

Phrase: "C., Wannenes,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Persico,"

Phrase: "A."
Processing 00000000.tx.707: M., Ciafre, S. 

Phrase: "M."

Phrase: ","

Phrase: "Ciafre,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.708: A., D'Arcangelo, G., Farace, M. 

Phrase: "A.,"

Phrase: "D'"

Phrase: "Arcangelo,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Farace,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.709: G., and Keller, F. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Keller,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.710: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.711: Biol. 

Phrase: "Biol."
Processing 00000000.tx.712: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.713: 277, 303-309[Abstract/Free FullText] 74. 

Phrase: "277,"

Phrase: "303-309"

Phrase: "[Abstract/Free FullText"

Phrase: "] 74."
Processing 00000000.tx.714: Yamaguchi, N., Okui, A., Yamada, T., Nakazato, H., and Mitsui, S. 

Phrase: "Yamaguchi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Okui,"

Phrase: "A.,"

Phrase: "Yamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakazato,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mitsui,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.715: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.716: Biol. 

Phrase: "Biol."
Processing 00000000.tx.717: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.718: 277, 6806-6812[Abstract/Free FullText] 75. 

Phrase: "277,"

Phrase: "6806-6812"

Phrase: "[Abstract/Free FullText"

Phrase: "] 75."
Processing 00000000.tx.719: Gschwend, T. 

Phrase: "Gschwend,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.720: P., Krueger, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Krueger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.721: R., Kozlov, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kozlov,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.722: V., Wolfer, D. 

Phrase: "V., Wolfer,"

Phrase: "D."
Processing 00000000.tx.723: P., and Sonderegger, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Sonderegger,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.724: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.725: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.726: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.727: 9, 207-219[CrossRef][Medline] [OrderarticleviaInfotrieve] 76. 

Phrase: "9,"

Phrase: "207-219"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 76."
Processing 00000000.tx.728: Cerf, M. 

Phrase: "Cerf,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.729: E., and Raidoo, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Raidoo,"

Phrase: "D."
Processing 00000000.tx.730: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.731: (2000) Metab. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Metab."
Processing 00000000.tx.732: Brain Dis. 

Phrase: "Brain Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.733: 15, 315-323[CrossRef][Medline] [OrderarticleviaInfotrieve] 77. 

Phrase: "15,"

Phrase: "315-323"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 77."
Processing 00000000.tx.734: Bax, B., Blundell, T. 

Phrase: "Bax,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Blundell,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.735: L., Murray-Rust, J., and McDonald, N. 

Phrase: "L., Murray-Rust,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0319862:Rust, NOS [Fungus]
   827   C1321554:Rust [Disease or Syndrome]

Phrase: "J.,"

Phrase: "and"

Phrase: "McDonald,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.736: Q. 

Phrase: "Q."
Processing 00000000.tx.737: (1997) Structure 5, 1275-1285[Medline] [OrderarticleviaInfotrieve] 78. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Structure 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "1275-1285"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 78."
Processing 00000000.tx.738: Fehlhammer, H., Bode, W., and Huber, R. 

Phrase: "Fehlhammer,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bode"

Phrase: ","

Phrase: "W.,"

Phrase: "and"

Phrase: "Huber,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.739: (1977) J. 

Phrase: "(1977"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.740: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.741: Biol. 

Phrase: "Biol."
Processing 00000000.tx.742: 111, 415-438[Medline] [OrderarticleviaInfotrieve] 79. 

Phrase: "111,"

Phrase: "415-438"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 79."
Processing 00000000.tx.743: Huber, R., Kukla, D., Bode, W., Schwager, P., Bartels, K., Deisenhofer, J., and Steigemann, W. 

Phrase: "Huber,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kukla,"

Phrase: "D."

Phrase: ","

Phrase: "Bode"

Phrase: ","

Phrase: "W.,"

Phrase: "Schwager,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bartels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Deisenhofer,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Steigemann,"

Phrase: "W."
Processing 00000000.tx.744: (1974) J. 

Phrase: "(1974"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.745: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.746: Biol. 

Phrase: "Biol."
Processing 00000000.tx.747: 89, 73-101[Medline] [OrderarticleviaInfotrieve] Copyright  2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "89,"

Phrase: "73-101"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2002 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

